













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 















Thesis presented for the degree of Doctor of Philosophy 
School of Chemistry 







Restriction Modification (R-M) systems prevent the invasion of foreign genetic material into 
bacterial cells and are therefore important in maintaining the integrity of the host genome. The 
spread of antibiotic resistance, which is proposed to occur via the transfer of foreign genes to 
the bacterial genome, makes the subject of R-M systems extremely relevant. 
 
R-M systems are currently classified into four types (I to IV) on the basis of differences in 
composition, target recognition, cofactors and the manner in which they cleave DNA. 
Kennaway et al (2012) proposed that there is an evolutionary link between Types I and II. 
Comparing the structures of examples from two of the subfamilies of Type II systems (IIB and 
IIG) to those of Type I structures, similarities can be observed.  
 
Due to the fact that Type II R-M systems cut DNA at fixed positions, they can be used to 
obtain genetic material selectively. They have therefore proven to be invaluable in molecular 
biology. One aspect of this project aims to create a novel R-M system, a pseudo-Type II 
system, by removing the molecular motors from the restriction subunit of a Type I system and 
fusing the remaining nuclease domain to a known Type I methyltransferase (MTase). This will 
not only provide evidence to support the theory that evolution has produced a pared down form 
of the Type I systems in the Type II systems, but it may also become a useful biological tool. 
This thesis describes the several attempts at doing this and how the subsequent constructs were 
expressed, purified and assayed to varying degrees of success. 
 
An important characteristic of the Type I systems is their ability to methylate DNA, and it is 
the mechanism via which host DNA is protected from restriction. This is another subject 
investigated in this project. As with the nuclease activity of the Type I systems, the site at 
which DNA is methylated is dictated by the HsdS subunit. It is described here how this subunit 
can be altered to change the sequence of DNA that is recognised by the system. Again, using 
Type II system subtypes as a reference, various mutations were made to the HsdS subunit of 
an MTase from Staphylococcus aureus. This is in an effort to bring about a new mode of 
action, but also to provide further evidence for an evolutionary link between the two system 
types. 
 
The HsdM and HsdS subunits are expressed from two separate genes at the same locus. There 
is a frameshift between the genes where the start of the hsdS gene occurs a few base pairs 
upstream from the stop codon of the hsdM gene. This work shows that removing this 
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frameshift creates an MS fusion product, and in vivo studies show that this product has 
methylase activity and can form an active restriction complex when the HsdR subunit is added. 
The product can also be over-expressed and purified, and shows in vitro restriction activity on 
addition of the HsdR subunit protein. 
 
The HsdS subunit is composed of two target recognition domains (TRDs), each dictating one 
part of the bipartite recognition sequence. These TRDs can be altered, bringing about a change 
in the sequence of DNA recognised by the enzyme. In this thesis, it is shown that the C-
terminal TRD can be removed and that the subsequent “Half S” enzyme possesses both 
methylase and restriction activity in vivo and that its recognition sequence is different from 
that of the wild-type enzyme.   
 
After the successful creation of both “MS fusion” and “Half S” recombinant proteins of the 
Sau1, Type I system from a CC398 strain of Staphylococcus aureus, a further construct was 
produced. This possesses both in vivo and in vitro activity. The novel “M Half S Fusion” 
enzyme not only links the two aspects of this project but also creates a structure similar to 
some seen in the Type II systems. This shows that the Type I systems can be manipulated to 
change their mode of action but also supports the idea that Types I and II are evolutionarily 
linked. By making the alterations in a step-wise fashion identifies that these structural changes 









Restriction enzymes are proteins that cut DNA. They do this by recognising specific sequences 
of the nucleotides (or bases) that make up DNA, and then catalysing the break of the chemical 
bonds between them. The opposing action to restriction is modification. Nucleotides can be 
modified in a number of different ways, but in the case of restriction-modification (R-M) 
systems, this modification is methylation. A methyl group is a small hydrocarbon group, and 
this can be added to specific DNA bases. There is a great deal of research into the implications 
of this relatively small change to DNA, but in this context, the methyl group can prevent 
restriction at that site on DNA. 
 
R-M systems are a family of enzymes found in bacteria, which carry out both restriction and 
modification functions. The primary benefit to the bacterial host is that restriction activity 
serves as a barrier to the invasion of foreign genetic elements, such as viruses (bacteriophage). 
The recognition sequences of restriction enzymes can occur on viruses, so the enzymes are 
able to bind to the virus and then degrade it by cutting it into smaller, non-coding fragments. 
The host’s own genetic material is protected from this action by modification. As such, the R-
M system is a “cognate” pair of enzymes, which recognise the same DNA sequence and help 
to preserve the integrity of the genetic material of the host organism. The transfer of genetic 
material to bacteria is of particular concern, as this is proposed as the reason for the spread of 
antibiotic resistance. Methicillin-resistant Staphylococcus aureus (MRSA) has long been in 
the public consciousness due to its links to harmful diseases and its resistance to a growing 
number of antibiotics. The main R-M system in S. aureus is the Sau1 family of Type I systems, 
enzymes from which form the basis of the work shown in this thesis. 
 
In the context of the work presented here, a crucial detail of the R-M system family of enzymes 
is that they are split into four different types, depending on their structure and mode of action. 
Perhaps the most important type of these enzymes, in terms of their practical application, is 
Type II. Restriction enzymes of this type are able to recognise DNA sequences and then cut 
directly on or around these sites. Given that these sites can be easily identified, these enzymes 
can be used to manipulate sequences of genetic material selectively. This means that the 
discovery of these enzymes gave birth to genetic engineering. However, the focus of this 
project is in fact Type I systems. These are larger, multi-subunit proteins, which carry out both 
R-M functions in a single enzyme complex. In contrast to Type II systems, Type I enzymes 
recognise DNA sequences and then translocate (energetically move) the DNA through their 
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structure, and eventually cut at a random, distant site. The implications of this are that their 
recognition sequence is not as easily discovered, and they are less useful to biological practice. 
 
What is of key interest, is the relationship between Type I and II R-M systems. A paper 
published in 2012 by Kennaway et al. proposed that structural and mechanical similarities 
between the two types indicate that they are evolutionarily linked. Sub-types of Type II, IIB 
and IIG systems, possess both R-M functions in a single enzyme but they lack the 
characteristic motor function of a Type I. As such, Type IIG and IIB can be thought of as 
“motor-less” Type I systems. The work presented in this thesis aims to provide evidence for 
this evolutionary link between the types, by attempting to engineer a pseudo Type II enzyme 
from the template of a Type I enzyme. By doing this in a step-wise fashion identifies that these 
structural changes can create viable enzymes, and that they could have occurred through the 
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A genome holds more information than just its sequence of nucleotides. The nucleotide bases 
can be specifically altered or “modified” in a way that provides further information to cellular 
machinery. Epigenetics is the study of these other factors, which influence gene expression, 
regulation and maintenance (Bird 2007). As it is a subject that has been studied quite 
extensively, a great deal is already known about DNA modifications and their associated 
enzymes.  
 
Figure 1: Common DNA modifications (Loenen & Raleigh 2014). 
 
The most common epigenetic modification is methylation, which is facilitated by enzymes 
known as methyltransferases (MTases) (Furuta et al. 2014). Methylated DNA occurs in both 
prokaryotes and eukaryotes but seems to involve a more diverse process in prokaryotes (Furuta 
& Kobayashi 2012; Jeltsch et al. 1999). In Bacteria, there are several different types of DNA 
MTase that can affect gene expression, and they can do this by methylating the coding or 
promoter regions of bacterial DNA in a highly specific way (Furuta et al. 2014). Examples of 
methylated nucleotides that occur frequently in prokaryotes are C5-methylcytosine (m5C), 
N4-methylcytosine (m4C) and N6-methyladenine (m6A) (Fig. 1). These methyl groups avoid 
disrupting the base pairs by extending into the major groove of the DNA double helix (Bujnicki 
2001). Although they do not affect the secondary structure of DNA, it has been shown that 
just one of these modifications at a specific target site can regulate the expression of a nearby 
gene (Furuta & Kobayashi 2012). Studies on bacteriophage have found other methylation 
modifications. 5-hydroxymethylcytosine (hm5C) and its sugar-attached derivative, 5-
glycosylhydroxymethylcytosine (ghm5C), occur as base substitutions in phage DNA. These 
are therefore not modifications in the traditional sense, as they are not added site-specifically. 
The phosphate backbone of DNA can also be modified. In prokaryotes, phosphothioester DNA 
(PT-DNA) can arise, where a sulfur replaces a free oxygen in the phosphate group between 
the bases (Loenen & Raleigh 2014) This can inhibit both endonuclease and polymerase 
activities (Xu & Kool 1998). 
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Of all the DNA modifications, cytosine methylation (mC) is the most well characterised. In 
fact, m5C is so important to gene regulation, that it is often referred to as the “Fifth nucleotide” 
(Meng et al. 2015). In mammalian cells, methylation occurs mainly at CpG sites (Furuta & 
Kobayashi 2012). Therefore, CpG-rich regions of the genome (known as CpG islands) possess 
a high potential for gene regulation (Kubik & Summerer 2016). In higher eukaryotes, CpG 
methylation is used to silence genes. It is thought that this occurs when the topology of the 
DNA changes, due to the increase in hydrophobicity with additional methyl groups (Kaur et 
al. 2012). Around 60 % of mammalian gene promoter regions consists of CpG islands (Rasool 
et al. 2015). 70-80 % of mammalian CpG dinucleotides are methylated but this generally does 
not occur in the promoter regions. The lack of promoter methylation indicates that alterations 
to the patterns of DNA methylation can have serious consequences on the cell cycle (Meng et 
al. 2015). In a broader context, DNA methylation has been implicated as the cause of many 
human diseases, and the number of those that are known is rising (Robertson 2005). The 
existence and maintenance of DNA methylation is crucial for normal mammalian development 
and the general fitness of the organism. This has led to an increase in research into controlling 
epigenetic differences pharmacologically (Robertson 2005).  
 
Most bacterial cells contain restriction endonucleases (REases), which cleave DNA. However, 
uncontrolled cleavage of DNA would be lethal to the host cell. Therefore, it is often the case 
that an REase is associated with an MTase, which prevents REase cleavage by methylating 
the same DNA recognition sequence. An REase paired with its cognate MTase makes up a 
restriction and modification (R-M) system (Makovets et al. 2004). A popular belief is that 
methylated nucleotides are too large to fit in the active site of the REase, and as such, the DNA 
is protected on the basis of steric clashes (Mierzejewska et al. 2016). MTases without a 
restriction enzyme pair are known as orphan/ solitary MTases (Vasu & Nagaraja 2013). A well 
characterised example is the DNA-adenine methylation (Dam) methylase, which modifies the 
adenine in a GATC nucleotide motif (Ratel & Ravanat 2006). Orphan MTases are also 
sometimes encoded by bacteriophage as an anti-restriction measure. The MTase coded by 
Bacillus phage H2 shares a recognition sequence with the bacterial hosts REase, BamHI. The 
phage is therefore able to evade restriction by this enzyme (Wilson & Murray 1991). All of 
the methylation modifications protect the DNA from being cleaved by the conventional 
REases. However, for each modification, there is also at least one enzyme that attacks DNA 
only when the modification is present (Loenen & Raleigh 2014). R-M enzymes that possess 
this characteristic fall into the IIM or Type IV categories. Type IV enzymes differ from Type 
IIM, due to their lack of a defined recognition sequence (Roberts et al. 2003). 
4 
 
There is a proposed mechanism for the methylation of the C5 of cytosine, and another distinct 
mechanism for the amino MTases, which methylate the N4 of cytosine or the N6 of adenine. 
Amino methylation probably occurs via the deprotonation of the exocyclic nitrogen target, and 
to it the direct transfer of the methyl group. The N6 is activated when it is polarised by the 
formation of hydrogen bonds between the hydrogens in the amino group and the surrounding 
active site residues (Bheemanaik et al. 2006) (Fig. 2A and B). The active site of m6A MTases 
consists of a well conserved (D/N)PP(Y/F) motif, whilst the majority of the m4C MTases 
possess an SPP(Y/F) sequence (Jeltsch et al. 1999). It has been found that some enzymes (such 
as M.EcoRI) can methylate N4 of cytosine, despite their target being N6 adenine. This low 
specificity in the amino MTases and their shared exocyclic NH2 target, provides evidence that 
the methylation of N4 cytosine and N6 adenine proceed via the same mechanism (Jeltsch et al. 
1999).  
 
The proposed mechanism for the methylation of the cytosine pyrimidine ring requires an 
enzyme-bound intermediate (Fig. 2C). The cysteine thiol acts as a nucleophile and forms a 
covalent link to the C6 of the cytosine. This activates the C5 for the addition of the methyl 
group, donated by SAM (Scavetta et al. 2000). The activation of the C5 by the enzyme is 
necessary as it is not otherwise a strong nucleophile. The enzyme nucleophile is eliminated 
when the C5 deprotonates (Zangi et al. 2010). Several other amino acids play key roles in this 
mechanism. Alignments of MTases from different sources highlighted a number of conserved 
motifs. A glutamic acid, valine and two arginines (Glu, Val, Arg, Arg), along with the cysteine 
are the five amino acids that make up the enzyme active site. It is thought that the Glu and two 
Arg residues allow the nucleophilic attack by the cysteine, whilst the Val stabilises the cytosine 
(Zangi et al. 2010). Much about this mechanism has been elucidated by examining the 
structure of M.HhaI, an MTase from the bacterium Haemophilus haemolyticus. The crystal 
structure of this protein showed it bound to its DNA substrate and the SAM cofactor (Shieh & 
Reich 2007). The structure of the SAM-enzyme complex appears to have two conformations, 
dictated by a large loop formed by nineteen residues. In the presence of a non-specific DNA 
sequence, the loop is open but closes when the enzyme is bound to its target sequence 






Figure 2: The proposed mechanisms for adenine methylation (A) (Scavetta et al. 2000),  




There is a conserved structural motif amongst the MTases, which consists of a seven stranded 
β-sheet core known as the “SAM-dependent MTase fold” (Cheng & Roberts 2001). Questions 
are raised as to how this structure can facilitate the methylation of such a diverse range of 
substrates, like RNA, protein and small molecules. In particular, it was hard to imagine how it 
could act on large proteins as well as specific DNA bases, which would otherwise appear to 
be inaccessible. The answer was given by the M.HhaI structure, which had turned its cytosine 
substrate 180o out of the DNA helix (Shieh & Reich 2007). This process by which the 
nucleotide is extra-helically bound is known as base flipping. It allows access to target bases 
and enables the enzyme to bind the DNA tightly (Estabrook et al. 2004). Substituting valine 
with alanine inhibits base flipping and enzyme activity. The DNA binding affinity of the 
enzyme also decreases dramatically, but can be recovered using a DNA substrate that does not 
contain the target cytosine. This confirms that base flipping is necessary for catalysis and that 
it is stabilised by the valine residue (Estabrook et al. 2004). The high structural conservation 
between the C5 MTases suggests that base flipping is a common mechanism, and has been 
shown to occur in several other systems (Roberts & Cheng 1998). Human uracil DNA 
glycosylase, which removes uracil from double or single stranded DNA has also been found 
to use base flipping to facilitate its reaction (Poole et al. 2001). Despite this phenomenon being 
observed in a m5C MTase, it is also the most likely mechanism in the amino MTases. All of 
the known MTases show a higher binding affinity for their recognition sequence if their target 
base is in a mismatch pair. It is assumed that this eases base flipping due to the weakened 
Watson-Crick bonds between the bases (Jeltsch et al. 1999). It is not yet known precisely how 
base flipping occurs, but there are two different suggestions. One proposes that flipping occurs 
via three steps, where specific residues in the protein are inserted into the DNA helix, these 
then lengthen the distance between the phosphates surrounding the target base. The enzyme 
then pulls the base out and into its active site, where it remains for the duration of the reaction. 
The opposing view is that the DNA helix is a dynamic structure, and the bases flip out as part 
of its normal movement. It is thought that the enzymes recognise and take advantage of this 
transient state. Structural and biochemical evidence from M.HhaI and T4 endonuclease V 
suggests that the three-step mechanism is most likely (Roberts & Cheng 1998).  
 
In bacteria, m5C and m4C are considered responsible mainly for protection against restriction, 
whilst m6A plays a part in several different processes. These include DNA replication and 
repair, and control of virulence (Ratel & Ravanat 2006). It was long thought that m6A did not 
occur at all in eukaryotes, but it has been discovered that not only does it exist in higher 
eukaryotes, such as insects and algae, but that it has a key role in gene regulation (Sun et al. 
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2015). That this modification has been undiscovered until recently is most likely due to the 
lack of sensitivity in any of the techniques used to analyse the DNA (Ratel & Ravanat 2006). 
The poor sensitivity is not the only reason quantification of methylated bases is difficult. It is 
also an inherent structural issue of m5C, which can lead to mutations in the genome. m5C can 
deaminate to become thymine, and cytosine to uracil, and this can happen spontaneously (Fig. 
3). It is the responsibility of uracil DNA glycosylase to repair this mutation (Poole et al. 2001). 
m6A MTases can also be encoded by viruses and have been found in bacteriophages T4 and 
Mx8, and archeal viruses ϕCH1 and SNDV. This implies that m6A is involved in viral 
infection, and highlights the ubiquity, and by extension the importance of m6A, which is 
becoming known as the 6th base (Ratel & Ravanat 2006). 
 
 
Figure 3: The spontaneous change from cytosine to uracil  
and m5C to thymine (Poole et al. 2001). 
 
The most frequently used biological methyl donor is a sulfonium compound called S-
adenosylmethionine (SAM or AdoMet), which is also the second most common enzyme 
substrate after ATP (Salyan et al. 2006; Fontecave et al. 2004). SAM is made when methionine 
and ATP are joined in a stereospecific reaction, catalysed by SAM synthetase (or methionine 
adenosyltransferase). This biosynthesis only produces an S-configuration at the positively 
charged sulfur atom (Fontecave et al. 2004). The methylthiol of the methionine would 
otherwise be relatively inert but the charged sulfur makes it thermodynamically unstable, 
making it far more reactive. There are a number of different atoms to which SAM can transfer 
its methyl group. These include sulfur, nitrogen and oxygen, which are polarisable 
nucleophiles, and carbon, in the form of a carbocation (Cheng & Roberts 2001). MTases 
transfer a methyl group from SAM to a number of different substrates, including proteins, 
RNA and DNA (Salyan et al. 2006). Interestingly, there is very little sequence homology 
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between the SAM-dependent MTases. They do however share some structural homology. The 
SAM cofactor is often bound by an α/β/α sandwich structure, which provides specific contacts 
to the SAM and the enzyme substrate (Salyan et al. 2006). This substrate accepts the methyl 
group from SAM, via an SN2 mechanism (Figure 2). The reaction proceeds by the methyl 
acceptor acting as a nucleophile, whilst the SAM is very electrophilic (Fontecave et al. 2004). 
The methyl group is donated, and the SAM is converted to S-adenosylhomocysteine (SAH or 
AdoHcy). This product can be hydrolysed to adenosine and homocysteine by SAH hydrolase 
(Fontecave et al. 2004). All MTases possess an FXGXG amino acid motif, or variant thereof, 
which coordinates with the SAM cofactor (Jeltsch et al. 1999). 
 
DNA in the cell consists of two strands of nucleotides wound together to form a B-form double 
helix. In this state, a recognition sequence of an MTase can occur on either side of the helix. 
This leads to a distinction between levels of methylation, where both sides can be methylated 
in fully methylated DNA or only one strand in hemimethylated. The semi-conservative 
replication of fully methylated DNA results in hemimethylated DNA. Given the necessity to 
protect host DNA, hemimethylation is enough to prevent restriction (Wilson & Murray 1991). 
Additionally, R-M system MTases strongly prefer hemimethylated DNA as a substrate 
(Mierzejewska et al. 2016). These MTases can modify non-methylated DNA, but at a slower 
rate. This leads to the distinction between host and foreign DNA (Powell & Murray 1995). 
Adenine methylation is also crucial to the post-replicative mismatch repair system. The 
difference in strand methylation produced after replication is used to identify the daughter 
strand, and allows mismatched bases to be changed (Horton et al. 2006).  
 
The other aspect to the pattern of methylation is its effect on cellular processes. As such, 
MTases are responsible for establishing and continuing the correct distribution of methyl 
groups on DNA. In eukaryotes, MTases are divided into different groups, depending on the 
pre-existing state of their DNA substrate. Maintenance MTases act on hemimethylated DNA, 
and therefore regulate methylation after DNA replication by adding a methyl group to the 
newly synthesised strand. De novo MTases on the other hand, act on either hemi- or non-
methylated DNA, and can establish a new pattern of methylation (Piccolo & Fisher 2014). The 
control of these gene signals plays a key role in the response of higher organisms to their 
environment and stage of development. Given that it is critical, DNA methylation, even de 
novo methylation, was thought to be inherited and stable. Breaking the C-C bond between C5 
and the methyl group would take a high reaction energy, and so was considered not 
thermodynamically possible (Ramchandani et al. 1999). Nevertheless, it was acknowledged 
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that changes had to occur throughout the lifetime of an organism, and so it was proposed to 
occur via base excision or other indirect pathways. Surprisingly, it was discovered that DNA 
methylation can actually be reversed in higher organisms. DNA demethyltransferases 
(dMTases) remove the methyl group from m5C, in a reaction that produces methanol 
(Ramchandani et al. 1999). dMTases act site-specifically on CpG dinucleotides in fully or 
hemimethylated DNA, in a process known as active demethylation. Demethylation can also 
occur passively when the expression of MTases is halted or the enzymes themselves are 




1.2. SMRT Sequencing (Pacific Biosciences) 
 
DNA sequencing provides a surfeit of information and has been vital to the better 
understanding of biological systems (Korlach & Turner 2012). Since its introduction in the 
1970s, Sanger sequencing has been the dominant technique for obtaining the sequence of the 
four canonical bases in genes. It provided an automated, high-throughput method, which used 
analogues of the deoxynucleoside triphosphates (dNTPs) to terminate the DNA chain. The 
analogues 2’, 3’-dideoxynucleoside (ddNTP) and arabinonucleoside inhibit DNA polymerase, 
and therefore stop the further addition of bases to the DNA molecule (Sanger et al. 1977). The 
low error rate of DNA polymerases has meant that this method has been a mainstay for 
decades. However, Sanger sequencing does not utilise the high catalytic rate or turnover of the 
polymerase (Eid et al. 2009). Furthermore, the study of epigenetics makes it necessary to go 
beyond the four bases and identify their modifications.  
 
Recently, a way of determining large sequences of DNA and detecting base methylation has 
come into practice. This can be done relatively quickly, with very little labour (Korlach & 
Turner 2012). Single-molecule real-time (SMRT) sequencing from Pacific Biosciences is an 
significant advance in the new generation of sequencing techniques (R. J. Roberts et al. 2013). 
The different technologies from Illumina, 454 and Ion Torrent seem to be limited by short read 
lengths and amplification bias. There are several benefits to increasing read length. These 
include a decrease to the duration of the procedure and the subsequent sequence assembly, 
reducing cost and increasing accuracy. Other next-generation technologies have achieved this 
but as their methods involve regulating the activity of the enzyme, they have not been able to 
produce sequences above 400 bp (Eid et al. 2009). SMRT sequencing on the other hand, can 
read much longer sequences with incredible accuracy, and identify DNA modifications. This 
is an extremely powerful tool in the study of DNA MTases, as it can identify DNA recognition 
sequences (Murray et al. 2012; R. J. Roberts et al. 2013). This is particularly useful when it 
comes to studying R-M systems. which possess a nuclease that does not cleave DNA at a fixed 
position, and do not therefore have an easily identified recognition sequence (Clark et al. 
2012). 
 
The Sanger method uses ddNTP analogues of each of the bases, in a mixture with the canonical 
base. The analogues terminate the chain of transcription wherever the normal base would be 
incorporated, in a process known as sequencing by synthesis (SBS) (Sanger et al. 1977; 
Shendure et al. 2011). Originally, the ddNTPs were labelled with P32 but this has now been 
replaced with fluorescent-tagged dideoxynucleotides, resolved temporally (Prober et al. 1987). 
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Despite this quite significant improvement to the technique, a compromise still has to be made 
between turnover and read length (Shendure et al. 2011). SMRT sequencing is similar in many 
ways. It too uses fluorescence-tagged nucleotides in an SBS reaction using DNA polymerase. 
In contrast though, SMRT is conducted in “real-time”, which means that DNA polymerisation 
can actually be observed directly, with base pair resolution. The benefit of using “single 
molecules” in SMRT is that the signals only end when the polymerase dissociates from the 
template (Eid et al. 2009). The result is an average read length of around 3000 bp, with a 
maximum of over 20,000 bp (R. J. Roberts et al. 2013). 
 
The novel chemistry used by SMRT is a key part of the real-time process. The normal 
nucleotides are replaced entirely with labelled dNTPs. The fluorophore label is phospholinked 
to the end of the nucleotide, and leaves when the dNTP is incorporated by DNA polymerase 
into the growing DNA chain. Each dNTP possesses a fluorophore with a distinct emission 
wavelength, which is detected in what is known as the Zero-Mode Wavelength (ZMW) region 
when the nucleotide is being added. The phospholinked dNTPs are A555-dATP, A568-dTTP, 
A647-dGTP and A660-dCTP. None of these inhibits the polymerase, allowing close to normal 
reaction kinetics. The period of fluorescence ends when the tag leaves the ZMW, after the 
formation of the phosphodiester bonds cleaves the tag from the nucleotide. A new period 
begins with the next tagged nucleotide (Eid et al. 2009). This means that the period of 
fluorescence is a measure of polymerase turnover, whilst the colour emitted is specific to each 
tag (Flusberg et al. 2010). It has been shown that the secondary structure of the template DNA 
has an effect on enzyme kinetics, and so too does methylation. Put simply, methylated bases 
slow the action of the polymerase and result in a longer duration of fluorescence relative to a 
non-methylated control (Fig. 4).  
 
There are two potential problems with the SMRT technique. The first is that perhaps not all 
bases will be methylated at each specific site in a genomic sample, whilst the other is an 11 to 
14 % error in individual reads. However, both of these issues are resolved by circular 
consensus sequencing (R. J. Roberts et al. 2013). This involves the reading of individual 
molecules multiple times to provide an average (Flusberg et al. 2010). This also significantly 











Figure 4: Method of sequencing DNA and identifying modification  





1.3. DNA Cleavage 
 
The cleavage of DNA is integral to the regulation of a multitude of cellular processes (Gowda 
et al. 2014). These include unwinding DNA to facilitate replication, to initiate recombination, 
and as a barrier to mobile genetic elements (MGEs) in prokaryotes (Yang 2011; Jurėnaitė-
urbanavičienė et al. 2016). Breaks in the DNA chain can occur in many different ways. These 
range from methods controlled by the cells themselves, to an effect of external forces such as 
radiation (Schulte-Frohlinde 1987). Different techniques to cleave DNA experimentally are 
also wide-spread, and can provide a wealth of information on DNA structure and binding 
(Tsen & Levene 2004). Breaks to the nucleotide chain can be made intentionally, using 
synthetic chemical agents, such as ferrous EDTA or uranyl acetate, or by biological agents 
like bleomycin (Sigman & Chen 1990). Perhaps most important though, was the discovery of 
enzymes that cut DNA at specific, predetermined sites, allowing the deliberate selection and 
excision of genes from a genome (Saravanan et al. 2016). This makes them invaluable 
biological tools (Bickle & Kruger 1993).   
 
Enzymes that cut DNA are known as nucleases, and these are separated into groups depending 
on their substrate and mode of action (Yang 2011). Single or double stranded (ds) DNA can 
be cut at any site within it, by endonucleases, or one nucleotide at a time from its ends, by 
exonucleases (Kushner 1974). Some nucleases bind and cleave RNA and are vitally important 
to gene expression (Abelson et al. 1998). Some provide other enzymes access to the DNA, for 
example the 3’ to 5’ exonuclease that facilitates proof-reading. Other nucleases cut DNA in 
order to change its tertiary structure. Topoisomerases are a family of enzymes that create a 
temporary break in one or both strands of DNA (Liu & Wang 2016). Enzymes in the 
Topoisomerase I subfamily break one stand, causing it to unwind around the other, whilst 
Topoisomerase II enzymes create a double stranded break (DSB), allowing another double 
helix to pass through (Champoux 2001). 
 
Nucleases are also involved in apoptosis (Yang 2011). Apoptosis is the name given to 
programmed cell death, or the regulated killing of cells by the host organism. It is important 
in the formation of correct structures during development, the continual renewal of blood cells 
and the disposal of damaged cells (Parrish & Xue 2006; Thompson 1995). The disruption of 
such a significant process also has serious implications, and is linked to several diseases, like 
cancer and neurodegenerative disorders (Thompson 1995). One of the steps in apoptosis is the 
cleavage of chromosomal DNA into fragments of around 180 bp. This prevents the cell from 
further replication, and passing on its genetic material. In mammals, one of the nucleases 
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responsible for this degradation of DNA is the 40-kd DNA fragmentation factor (DFF40) or 
Caspase-activated deoxyribonuclease (CAD) (Parrish & Xue 2006). 
 
 
Figure 5: Proposed mechanism for the cleavage of DNA 
by the hydrolysis of its phosphodiester bonds (Gowda et al. 2014). 
 
DNA hydrolysis is the path by which DNA is cleaved enzymatically. This is where the 
phosphodiester bonds are broken by the enzyme in the presence of water (Gowda et al. 2014). 
Due to the extremely high stability of DNA in water, an enzyme is required to speed up the 
hydrolysis reaction by over 103-fold, to bring the reaction time to within a couple of minutes 
(Wolfenden & Snider 2001). The metal ion cofactors of the enzyme activate water by acting 
as Lewis acids, which initiates the first step of the proposed SN2 mechanism. It proceeds with 
the nucleophilic attack of the phosphate group between the bases by the subsequent hydroxide 
ion. This leads to the formation of a five-coordinate intermediate, which is stabilised by the 
enzyme. The collapse of the intermediate results in the separation of the bases, one of which 
leaves as an alcohol (Fig. 5) (Gowda et al. 2014). 
 
The two divalent metal ions (2M) bound by the enzyme, are crucially important nuclease 
cofactors (Yang et al. 2006). In most metallonucleases these are Mg2+ ions, are on the 
phosphate backbone side of the chain, and are 3.8 to 4 Å apart, either side of the scissile 
phosphate (Steitz & Steitz 1993; Palermo et al. 2015). A theory put forward in 1993 suggested 
that the two ions have separate mechanistic responsibilities (Yang et al. 2006). Both ions 
activate water for nucleophilic attack but they do so with complimentary and distinct actions. 
One ion lowers the pKa of the water molecule and binds the hydroxide ion to allow the attack 
of the target phosphate (Yang et al. 2006). The second ion enables the exit of the oxygen, 
whilst both ions then play a role in stabilising the subsequent five-coordinated transition state 
(Steitz & Steitz 1993). After this, it is the second ion that destabilises the intermediate and 
facilitates the formation of the products (Yang et al. 2006). Studies of the metal binding sites 
of Klenow fragment have shown that this second ion is not present when no DNA is bound. 
This suggests that the second ion binds the enzyme after the substrate (Sträter et al. 1996). 
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Although since validated, the 2M theory was under some debate. It was shown that some 
mutated enzymes remain active, despite lacking the ability to bind the first metal ion (Palermo 
et al. 2015; Yang et al. 2006). On the other hand, mutants lacking the ability to bind the second 
ion lose activity almost completely. This highlights the importance of stabilising the reaction 
intermediate (Sträter et al. 1996). There was also a dispute as to how many metal ions were 
required for catalysis (Yang et al. 2006). Several more structures have been found that 
corroborate the 2M theory however, and have also provided further information. The cations 
are bound by a motif of acidic residues, conserved in the metallonucleases. The “DEDD” motif 
chelates the metal ions into the enzyme active site and directs them towards the DNA substrate. 
The carboxylate side chains of each residue can bind one or both ions, and are aided by the 
slight negative charge of nearby oxygen atoms from water molecules (Palermo et al. 2015). 
Surprisingly, despite the charged nature of their acidic side chains, the metal-binding residues 
appear to have no role in stabilising the reaction directly (Sträter et al. 1996). Computational 
studies by Palermo et al have investigated the effect of a third ion in the active site of 
metallonucleases. They found that in RNase H, the presence of a third ion does not affect 
activity. However, at concentrations of 50 mM and above, the third Mg2+ is closer to the site 
of catalysis, moving the active water molecule away from its optimal location (Palermo et al. 
2015). This mostly results in enzyme inhibition but does not appear to be the case for all of 
the metallonucleases. Several of the enzymes possess three metal ion binding sites, which have 
been shown to be required for catalysis. They also still adhere to the general 3- 4 Å spacing of 
their closest two cations (Sträter et al. 1996). Interestingly, EcoRV also has three ion-binding 
pockets but its reaction appears to be coordinated by only two ions. It has therefore been 
proposed that the cations are mobile and move positions during the reaction (Dupureur 2008). 
Whether there is a role for a third ion in the metallonucleases is uncertain, but it has been 
suggested that it could be to allow the reaction products to leave the active site (Palermo et al. 
2015).  
 
Mg2+ is the most commonly used metal ion cofactor in metalloenzymes, due to its ability to 
bind six ligands with octahedral geometry. It also maintains a uniform coordination distance 
of 2.1 Å. (Yang et al. 2006). The Ca2+ divalent cation has a relatively large atomic radius and 
can coordinate up to nine ligands, with various geometries. The accommodating nature of Ca2+ 
makes it less appropriate for hydrolysis of phosphodiester bonds, as it is less able to destabilise 
the enzyme-substrate complex (Yang et al. 2006). The metal cation Mn2+ has similar properties 
to Mg2+, and is therefore an adequate alternative. However, the cellular concentration of Mg2+ 
is much higher than Mn2+, and it is therefore a more likely enzyme cofactor. Interestingly, 
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Mn2+ can exist in several different coordination states, of various different lengths. As such, it 
continues to facilitate catalysis, despite mutations of the catalytic residues and changes to 
substrate sequence. (Yang et al. 2006). Zn2+ ions are also common nuclease cofactors (Yang 
et al. 2006). Zn2+ can accommodate octahedral or tetrahedral geometries and binds ligands 
with higher affinity than Mg2+, creating complexes with higher stability (Dudev & Lim 2014). 
This means that Zn2+ can replace the Mg2+ cofactor in some proteins and inhibit others. The 
relative concentrations of these metals in the cell is again what selects Mg2+  for most 
metallonucleases (Dudev & Lim 2014).  
 
Despite lower cellular concentrations, Zn2+ is still found in many metalloenzymes. A pertinent 
example of this is zinc fingers (Dudev & Lim 2014). Zinc fingers were first described in 1985, 
as a repeating motif of the 40 kDa Transcription factor IIA protein (Klug 2010). Biochemical 
characterisation of this protein showed that the motif consisted of nine independent 3 kDa 
sections, each with a strong affinity for DNA. Each 25-amino-acid unit was separated by a 
linker of 5 amino acids and stabilised by a Zn2+ ion, bound in a tetrahedral conformation by a 
Cys-Cys-His-His consensus sequence (Miller et al. 1985). These sections were later referred 
to as zinc fingers, due to the manner in which they protrude from the main protein structure, 
and the way they “grip” DNA (Klug 2010). Also conserved were three large hydrophobic 
amino acids. A repeating pattern of leucine, phenylalanine and tyrosine residues are proposed 
to stabilise the structure by creating a large hydrophobic region (Klug 2010). Each consecutive 
“finger” binds a sequential DNA triplet, and does so via the side chains of only three specific 
residues (Klug 2010; Pavletich & Pabo 1991). This discovery led to the suggestion that the 
DNA recognition sequences could be easily altered with the mutation of these key residues 
(Carroll 2011). 
 
FokI is a Type IIS restriction enzyme from the bacterium Flavobacterium okeanokoites (Wah 
et al. 1998). Type IIS systems cleave DNA at a non-uniform position to one side of their 
recognition site (Halford et al. 2011). FokI cleaves the 5’ to 3’ DNA strand 9 bp downstream 
from its 5’-GGATG-3’ recognition sequence, whilst the 3’ to 5’ strand is cleaved 13 bp away 
(Carroll 2011). Interestingly, although FokI is a monomer in solution, it is not active in this 
state. A single unit of this protein will bind to the 3’ to 5’ strand but shows no nuclease activity. 
FokI dimerises when a second monomer binds the 5’ to 3’ strand, and the enzyme becomes an 
active nuclease. The FokI monomer consists of two separate domains. Its C-terminal carries 
the nuclease, whilst its N-terminus is responsible for DNA recognition (Halford et al. 2011). 
This domain is made up of three separate subdomains (D1, 2 and 3), all of which possess a 
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helix-turn-helix (HTH) motif. The symmetry of the HTH often corresponds to a palindromic 
DNA substrate, although the HTH is found in most sequence-specific DNA binding proteins 
(Klug 2010; Pabo & Sauer 1984). Remarkably, the recognition of specific bases can be linked 
directly to these subdomains, where D1 binds GGATG and D2 binds GGATG. D3 appears not 
to make contact with the nucleotides, but with the second FokI monomer (Pingoud & Jeltsch 
2001). Li et al found that in the presence of its substrate, trypsin digestion separates FokI into 
41 kDa and 25 kDa peptides. The 25 kDa fragment was found to cleave both methylated and 
non-methylated DNA non-specifically (Li et al. 1992). This led to the realisation that the 
nuclease domain could be separated from the rest of the protein and attached to other DNA-
binding domains, imparting new specificity (Carroll 2011). By joining zinc fingers to the 
nuclease domain of FokI, a new method for targeting and editing genomic DNA was born 
(Carroll 2011; Swarthout et al. 2011). Zinc finger nucleases (ZFNs) provide an adaptable way 
of creating a site-specific DSB in DNA, which can be used to target and replace genes in a 
genome (Fig. 6A). Homologous recombination (HR) is the way in which a cell maintains 
genome integrity after a DSB, but it can be used for the modification of a desired gene (Durai 
et al. 2005). Therefore, creating a specific DSB with a ZFN can make changes to the genome 
by enlisting the cells own machinery for DNA repair (Swarthout et al. 2011). However, 
Halford et al argues that as a tool for genome therapy, ZFNs might not be as powerful as 
hoped. Despite the necessity for dimerisation, the two parts of the recognition site may only 
be close to each other in space but not on the DNA chain. Therefore, ZFNs often produce off-
site cleavage (Halford et al. 2011). Whether or not ZFNs are a viable tool for gene therapy is 
still up for debate. In principle however, they prove that nucleases can be manufactured using 
the DNA cleavage domain of FokI.  
 
Transcription activator-like effectors (TALEs) from the bacterial plant pathogen, 
Xanthomonas campestris, were discovered in 1989 (Boch et al. 2009). TALE proteins are 
important virulence factors, which are secreted into the plant cell cytoplasm and change 
transcription of the host genome by behaving like eukaryotic transcription factors. Most often, 
TALEs promote transcription of genes, whose products make the plant more vulnerable to the 
bacterium (Christian et al. 2010). The protein possesses three separate domains, for 
transcription activation, nuclear localisation, and a region of tandem repeats that binds DNA 
(Boch et al. 2009). Each repeat consists of 30 to 35 residues but only corresponds to a single 
nucleotide (Chandrasegaran & Carroll 2016). Importantly, only two amino acids (at positions 
12 and 13 of the repeat unit) correspond to the identity of the bound nucleotide (Ain et al. 
2015). Therefore, these can be altered in order to engineer a new recognition sequence (Boch 
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et al. 2009). Continuing from the work on ZFNs, TALE proteins can also be used to create 
another way to cut DNA in vivo. Transcription activator-like effector nucleases (TALENs) are 
the combination of TALE repeats and the cleavage domain of FokI (Ain et al. 2015). TALENS 
can produce specific DSBs in genomic DNA, but given the off-site cleavages seen using ZFNs, 
do so with a lower level of cytotoxicity (Fig. 6B) (Chandrasegaran & Carroll 2016). A 
significant drawback to this technique is in the design and production of new specificities. The 
several amino acid repeats in the structure make it difficult to avoid mis-priming during PCR 
and therefore, special cloning techniques have to be employed (Ain et al. 2015). 
 
 
Figure 6: Diagram to show the mode of action of the three nucleases used 
for genome engineering. Zinc finger nucleases (A) Transcription activator-
like effector nucleases (B) and CRIPR-Cas9 (C). Adapted from 
Chandrasegaran & Carroll 2016. 
 
ZFNs and TALENs were significant advances in the effort to create a tool for genome 
modification, but are not without their problems. Utilising the clustered, regularly interspersed, 
short palindromic repeat (CRISPR) and the CRISPR associated protein 9 (Cas9) system has 
revolutionised the field, by providing an easy way to edit genomes (Doudna & Charpentier 
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2014). Prokaryotes use CRISPR-Cas9 as an acquired and adaptive immune response against 
foreign genetic elements (Ceasar et al. 2016). The CRISPR loci contain short nucleotide 
repeats, with intercalated sequences derived from plasmids and phage (Doudna & Charpentier 
2014). From the CRISPR sequences are transcribed CRISPR RNA (crRNA), which anneal to 
trans-activating RNAs (tracrRNAs). This RNA duplex is bound to the Cas nuclease, and used 
to guide it to a target sequence (protospacer) in invading viruses, via complementary base-
pairing (Doudna & Charpentier 2014). The Cas protein creates a DSB in the foreign genetic 
material at a site 3 bp away from the Protospacer Adjacent Motif (PAM), which results in the 
degradation of the foreign element. In the case of the most widely used Cas protein (from 
Streptococcus pyogenes), the PAM is an NGG sequence (Ceasar et al. 2016) (Fig. 6C). A 
significant breakthrough came when it was discovered that the crRNA/tracrRNA duplex could 
be manufactured as a single guide RNA (sgRNA), whilst maintaining its ability to bind both 
the target DNA and the Cas protein (Doudna & Charpentier 2014). Therefore, engineered 
sgRNAs can be used to direct Cas9 to create DSBs at desired sites. Designing custom sgRNAs 
is easy compared to the protein engineering involved in the ZFN and TALEN techniques, and 




1.4. Restriction-Modification Systems and Bacteriophage λ  
 
Found exclusively in single-celled organisms and their viruses (phage), restriction-
modification systems are a prokaryotic organism’s foremost defence against invading foreign 
DNA (Bujnicki 2001). Although thought to be a “primitive” prokaryotic immune system, the 
ubiquity of R-M systems indicates their importance (Vasu & Nagaraja 2013). In the early 
1950s, it was observed that the survival of phage was affected by the organism that it had last 
infected. Phage that had successfully infected a specific bacterial strain could then spread to 
other cultures of the same strain. Conversely, it was not very common for phage to proliferate 
in different strains. This was the point at which the notion of modification was first conceived; 
the bacterial strain had left an imprint on the phage such that it could propagate in the same 
strain. It was later discovered that this “imprint” was a DNA modification by methylation 
(Murray 2000). It was also shown that without this modification, R-M systems would 
recognise the phage as foreign and it would therefore be subject to degradation, which in most 
cases produced specific fragments of DNA. It is due to this characteristic that the term 
“restriction” was used for these enzymes, as they restrict the growth of the phage virus 
(Williams 2003). Since their discovery, many more R-M systems have been identified. The 
introduction of more efficient techniques for identification has resulted in over 6000 known 
sequences and over 4000 cloned R-M systems, which include approximately 300 DNA 
specificities (Vasu & Nagaraja 2013; Mokrishcheva et al. 2011; Roberts et al. 2015). 
 
 
Figure 7: Cartoon diagram of the activity of a generic R-M 
system (Vasu & Nagaraja 2013). 
 
A typical R-M system includes a restriction endonuclease (REase, also known as a DNA 
endodeoxyribonuclease or ENase), whose cleavage of DNA is triggered by the recognition of 
a specific DNA sequence. The other constituent part of the R-M system is an MTase, whose 
action prevents cleavage of host DNA (Fig. 7) (Bujnicki 2001). In most cases, these functions 
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are carried out by separate enzymes from the same system (cognate). However, in some 
systems both of these activities are fulfilled by a multi-subunit protein or even a single peptide 
(Wilson & Murray 1991). REases and their cognate MTases share the same DNA recognition 
site, which is normally a specific sequence of around four to eight nucleotides. The 
modification of the specific site on DNA by the MTase stops it becoming a viable target for 
its cognate REase. This can also have an inhibitory effect on non-cognate REases. The 
sequence can be symmetric or asymmetric and can be continuous or interspersed by a defined 
number of random nucleotides (N) (Wilson & Murray 1991). The genes from which R-M 
enzymes are expressed often occur at the same loci in the bacterial genome and can be 
transcribed in sequence or in opposing directions (Williams 2003). It is also possible for 
enzymes from different systems to share a DNA recognition sequence. The first of these to be 
discovered is referred to as the “prototype”, whilst all other enzymes are known as 
isoschizomers. Enzymes that share a sequence but cut at different positions within it, are 
known as neoschizomers. These classifications apply only to REases, and not MTases, due to 
the difficulty of adequately defining MTase function (Roberts et al. 2003). Generally, R-M 
systems require a double stranded substrate but there are examples of enzymes that act on 
single stranded DNA. Most R-M systems are Mg2+ dependent and are believed to follow the 
2M mechanism (Sträter et al. 1996). 
 
R-M systems are named according to the particular bacterial strain from which they originate. 
The method follows a three letter code derived from the name of the host organism, taking the 
first letter of the genus and the first two letters of the species. Systems from the same strain 
are numbered with reference to the order in which they were discovered (Smith & Nathans 
1973). For example, EcoKI was the first of the R-M systems to be identified in E. coli K-12 
(Murray 2000). The genes that code for these enzymes are most often denoted using this same 
nomenclature, with an additional subunit determination. For example, the REase gene of 
EcoKI is ecoKIR. The loci of the genes that code for the REase (R) and MTase (M) are often 
only separated by a few bp and in some cases can overlap. The genes can occur on plasmids, 
such as with EcoRI, or on viruses, as in the case of EcoPI (Wilson & Murray 1991). At the 
stage of identification by sequencing, the genes are regarded as encoding putative enzymes, 
and as such their names are preceded by a “P”. This is removed when proof of their activity 
has been attained (Roberts et al. 2003). 
 
Although similar in enzymatic activity, the R-M systems show great variety in protein 
structure and gene sequence (Wilson & Murray 1991). To date, there are four classes of R-M 
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system (Types I to IV), which are separated due to differences in composition, target 
recognition, cofactors and the manner in which they cleave DNA (Murray 2000). Type I 
enzymes are large, multi-subunit proteins, which facilitate both restriction and methylation 
activities. In Type II systems, the two functions are often carried out by separate enzymes. 
Like Type I systems, Type III enzymes are multi-subunit proteins. They occur as heterotrimers 
or tetramers, with an M2R1 or M2R2 stoichiometry respectively. Type III enzymes typically 
possess a 5 to 6 bp long, asymmetrical DNA recognition sequence, from which they translocate 
and cleave at the 3’ side (Vasu & Nagaraja 2013). The last group is the Type IV systems, 
which cleave only methylated DNA (Roberts et al. 2003). However, recently discovered were 
enzymes that cut glycosylated DNA exclusively. As such, the Type IV class encompasses all 
of the modification-dependent enzymes (Sitaraman 2016). With increasing numbers of and 
diversity within the known R-M systems, these broad enzyme classes have become less useful. 
It is also more difficult to assign to them a unique name, as it is possible to have the same three 
letter code for enzymes from a different genera of bacteria. In an effort to ameliorate this 
problem, enzymes in one class can be further separated by several subtypes (Roberts et al. 
2003). There is also another protein, which is associated with R-M systems. The “C” or 
“Control” protein is encoded by a gene found upstream from that of the REase, and regulates 
the expression of the REase in a positive feedback mechanism. In contrast, the MTase gene is 
expressed constitutively. It is therefore more likely to be able to modify and protect host DNA. 
Some C proteins can be used to promote the expression of the REases of different bacteria, 
which suggests the mechanism is derived from a common progenitor (Williams 2003). 
 
Their effect on lambda (λ) phage was the evidence by which R-M systems were first 
discovered, but also how key characterisation was conducted by Arber and Dussoix in 1962 
(Rao et al. 2014). Their work involved inoculating the four E. coli strains, K12, B, 15T- and 
the K12 (P1) lysogen, with λ phage and examining the results. Importantly, they observed that 
the K12 (P1) lysogen would restrict phage recovered from K12, but not phage used to inoculate 
the same strain (Arber & Dussoix 1962).With this in mind, it can be reasonably asserted that 
λ phage was instrumental to the arrival of genetic engineering, as it was the tool used to identify 
R-M activity (Casjens & Hendrix 2015). Key characteristics of λ made it an ideal model for 
studying viral infection of bacteria. At 48,502 bp, the bacteriophage is relatively small, such 
that it was manageable but still comparable to other systems. Like many other viruses, λ can 
also switch between lytic and lysogenic states (Casjens & Hendrix 2015). These are two 
different cycles by which a virus uses the cellular machinery of the host to reproduce. The 
lysogenic cycle involves the integration of the viral DNA into that of the host, a process which 
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depends on the host survival. In contrast, a lytic virus moves feely in the infected cell and 
replicates to the extent that it eventually causes cell death. The changeable state of this 
coliphage has provided a great deal of information about the regulation of viral latency, giving 
an insight to the activity of human latent viruses, like herpes simplex (Gandon 2016). Phage λ 
was discovered accidentally in 1951, when K-12 E. coli cells were lysed by ultraviolet 
radiation. It was revealed that most of the laboratory cultures of this strain had been infected 
by the phage but that this had gone unnoticed. Since then, λ has been the basis for studies on 
“lysogenicity” (Lederberg & Lederberg 1953). This process is mainly governed by a repressor 
gene called cl  ̧whose protein product activates the expression of its own gene but is able to 
switch other genes off (Gandon 2016). This maintains the lysogenic state by blocking the 
transcription of mRNAs necessary for the lytic cycle (Casjens & Hendrix 2015). The lytic 
cycle is regulated by the product of the cro gene. The discovery of other associated proteins 
(CI and CII) suggests that this system is quite complex, but ostensibly, Cro and CI compete to 
bind the same operator (Casjens & Hendrix 2015). Although not fully understood, the switch 
between these two states seems to be determined by the environment in the host cell. Higher 
numbers of phage make the lysogenic cycle more likely (Gandon 2016). Cyclic AMP (cAMP) 
knockout mutants showed an increased level of phage lysogeny. As such, cAMP levels are 
also believed to a determining factor (Hong et al. 1971; Casjens & Hendrix 2015). 
 
 
Figure 8: Diagram representing the lytic (A) and lysogenic cycles (B)  
of bacteriophage λ. Adapted from Gandon 2016. 
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The sensitivity of phage to restriction can be quantified by “efficiency of plating” (E.O.P.). 
This value gives the probability of phage survival, by calculating phage plaque formation on 
a restricting bacterial strain as a proportion of those formed in a non-restricting variant of the 
same strain. For example, phage infection of a non-restricting bacterial strain would result in 
an E.O.P. of 1, whereas a restriction active strain can give an E.O.P. of around 10-4 (Wilson & 
Murray 1991). This value varies depending on the R-M system and how many recognition 
sites are present on the virus. Interestingly, it seems that non-native R-M systems, ie. systems 
that have been cloned result in a much lower phage E.O.P., often around 10-8 (Wilson & 
Murray 1991). Viruses that successfully avoid restriction are then able to propagate within that 
same strain. Therefore, subsequent infections will give an E.O.P. of 1. As has been explained, 
this is due to modification of the virus. With the modification of its own DNA, some viruses 
will also be modified by the host (Wilson & Murray 1991). Phage also avoid restriction 
through a lack of recognition sequences, and anti-R-M systems, such as proteins that mimic 
DNA (McMahon et al. 2009). Smaller viruses are also less likely to contain the recognition 
sequences of larger REases. Without degradation by REases, phage are able to propagate and 
therefore duplicate their successful genetic material (Williams 2003). 
 
Given their significant role in protecting the host cell, it is surprising that R-M systems are not 
essential to prokaryotic life. Knockout mutants are more vulnerable to viral infection but 
display no other signs of ill-health. As such, R-M systems should be viewed as necessary for 
the survival of the population, and not the individual cell; R-M activity prevents the spread of 
foreign DNA to neighbouring cells (Wilson & Murray 1991). R-M systems have other roles, 
which include involvement in genetic recombination and transposition (Pingoud & Jeltsch 
2001). This is of particular significance, as the part played by R-M systems in producing 
genetic diversity is a subject of increasing concern. More important than their contribution to 
changes in the host genome are the ways in which the barrier they pose to invading DNA can 
be overcome. Without this protection, the host genome can be subject to changes caused by 
Mobile Genetic Elements (MGEs), more specifically by horizontal gene transfer (HGT). This 
is the phenomenon by which whole genes from outside sources can be incorporated into the 
genome of an organism, and is proposed as the main cause of the spread of antibiotic resistance 
(Lindsay 2014). Given this, R-M systems can be regarded as directing evolution. The effect of 
degrading foreign genetic elements is actually processing them, such that they can be 
incorporated into the host genome (Bujnicki 2001). Another consideration, is the spread of the 
systems themselves, and the effect that this can have on bacterial evolution. Sequence 
homology and codon usage suggests that R-M systems have been transported between 
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different bacteria by HGT. Their presence on plasmids and viruses is further evidence that 
they can act as MGEs. The movement of R-M genes can lead to genome rearrangements, the 
disappearance of specific nucleotide sequences and even host cell death. Together with their 
primary activity of degrading other foreign elements, R-M systems exhibit behaviour 
comparable to a “selfish gene”. From one perspective, they seem to function as a mechanism 
for cellular defence, whilst another view is that they are simply insuring their own survival 




1.5. Type II (Classical) R-M Systems  
 
The defining characteristic of Type II R-M systems, and the most important in terms of their 
use to molecular biology, is that their REase cleaves double stranded DNA at fixed (easily 
identified) positions. In most cases this cleavage occurs within their recognition site, but the 
exceptions cut within 20 bp either side (Marshall & Halford 2010). Some enzymes produce 
dsDNA with either no overhanging strand (blunt end), or strands protruding by up to 5 
nucleotides (sticky ends) (Pingoud et al. 2005). The REase and the MTase in the majority of 
Type II systems are separate (Marshall & Halford 2010). The MTase is denoted using an “M.” 
prefix, whilst an “R” is added to the name of the REase (although this is often omitted) 
(Pingoud et al. 2014). On average, the REases are composed of 300 amino acids, whilst 
MTases are typically 400 (Wilson & Murray 1991). Being relatively small and with few 
cofactor requirements, these enzymes are compact and efficient molecular machines (Roberts 
2005). Despite the thousands of known Type II systems, this only represents a relatively low 
number of DNA recognition sequences. Given their importance to all walks of biology, there 
are many efforts to create novel REases with new specificities (Jurėnaitė-urbanavičienė et al. 
2016). 
 
Most of the Type II enzymes, such as EcoRI and BglI, conform to the general description of 
the system as a whole. These “Orthodox” enzymes are ~60 kDa homodimeric complexes, 
which cleave within or next to their recognition sequence, resulting in a 5’-phosphate and a 
3’-hydroxyl end (Pingoud & Jeltsch 2001). As they bind and cleave palindromic sequences, 
they are known as the Type IIP enzymes (Marshall & Halford 2010). Not all of the Type II 
enzymes conform to this narrow definition, and so they are separated into other sub-categories 
(Fig. 9) (Pingoud & Jeltsch 2001; Roberts et al. 2003). The factors that differentiate the many 
Type II sub-types are: the nature of the recognition sequence, their tertiary and quaternary 
structure, and the type of cut they produce on DNA (Marshall & Halford 2010; Pingoud & 





Figure 9: Cartoon showing the subunit organisation and method of DNA cleavage of the 
Type II REase sub-types. The green boxes represent MTase domains, whilst yellow ovals 
are TRDs, and “Me” circles on sticks are sites of methylation. Adapted from Bujnicki 2001. 
 
The Type IIS REases have an asymmetric recognition sequence and cleave at set distances 
away from it (Bujnicki 2001). Characterisation of FokI showed that enzymes in this family 
consist of two distinct domains and dimerise upon binding DNA (Pingoud et al. 2005). Type 
IIF enzymes are tetrameric and require two copies of the recognition sequence. They cut at 
both sites in one action (Bujnicki 2001). The members of the IIE sub-family are homodimers 
and also need two sites to be active. Interestingly, each monomer has two domains, both of 
which have a DNA binding site. One of these acts an allosteric site, which binds one copy of 
the DNA sequence, known as the “effector”. The other site binds the “target” sequence and 
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catalyses DNA hydrolysis. Therefore, this complicated process involves two monomers of the 
enzyme, each binding two recognition sequences, resulting in cleavage at one site (Bujnicki 
2001). Sub-type IIM REases recognise and cleave methylated sequences. A widely known 
example of this type is DpnI, which has a Type IIE subunit organisation but recognises 
adenines methylated at the N6 position (m6A). It is widely used in the process of site directed 
mutagenesis to remove non-mutated DNA (Pingoud & Jeltsch 2001; Siwek et al. 2012). The 
two classes, Types IIB and IIT, both have an unusual subunit organisation. IIT systems are 
heterodimeric and recognise an asymmetric sequence, although there are exceptions (Pingoud 
& Jeltsch 2001). Whilst the subunits in IIB systems are also different from one another, they 
have an organisation and activity not unlike Type I systems. These trimeric enzymes consist 
of A and B polypeptides, in a A2B1 stoichiometry. They possess both their MTase and REase 
in the one enzyme, and can methylate either symmetrical or asymmetrical sequences. They 
cleave DNA in a SAM-dependent reaction, and do so either side of their recognition sequence. 
This results in the removal of a short fragment (Bujnicki 2001; Pingoud & Jeltsch 2001). Like 
Type IIB systems, IIG REases also possess MTase activity. These enzymes consist of a single 
polypeptide, which cuts 14 to 16 bp away (depending on the enzyme) from their site in a 3’ 
direction. However, these single chains can methylate only one strand, and so are paired to a 
cognate MTase, which can modify both (Bujnicki 2001). There is clearly a great deal of variety 
in structure, topology and sequence specificity within the Type II systems. Nevertheless, they 
all cleave DNA at a fixed position (Pingoud et al. 2014). 
 
Under normal conditions, the DNA with which a Type II enzyme is interacting would be 
relatively large. This increases the complexity of the enzyme/DNA interaction. Put simply 
however, the process begins with non-specific DNA binding by the enzyme, which then 
randomly diffuses across the DNA. During this step, the enzyme may encounter its recognition 
sequence, resulting in the activation of phosphodiester bond cleavage. If the enzyme does not 
come across its recognition sequence, it may dissociate from the DNA. After cleavage has 
occurred, the enzyme dissociates from the DNA directly or by having transferred across to a 
non-specific sequence. The dissociation of the REase is the rate limiting step of the reaction, 
and so will affect its turnover when cutting at multiple sites (Pingoud & Jeltsch 2001). 
Evidence shows that the sequences either side of the target have an effect on rate. Not only 
can surrounding nucleotides affect DNA topology, but certain enzymes can accommodate 
more bases in their active site than just their recognition sequence (Pingoud et al. 2014). DNA-
binding proteins that recognise specific sequences can also bind at other positions, but do so 
with much less affinity. When this occurs, the enzyme undergoes a conformational change, 
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which involves opening the active site and allowing the DNA to pass through, regardless of 
whether it contains the recognition sequence. This mechanism has been observed for several 
DNA-binding proteins, including EcoRV and T7 helicase. When the enzyme is bound to non-
specific DNA, there are fewer contacts to the phosphate groups and none to the bases. In 
general, when bound to their specific sequence, these enzymes reduce in size and bind the 
DNA more tightly. Of course, the lack of affinity when bound to non-specific DNA enables 
the enzyme to diffuse along the chain, either by following the contour of a groove in the helix 
(“sliding”) or by moving over the entire chain (“hopping”). It has been proposed that up to 2 
X 106 base pairs at a rate of 1.7 X 106 bp s-1 can diffuse through EcoRV upon binding (Williams 
2003). Although a change of only one base in the target site results in a significant reduction 
in binding affinity, cutting at non-specific sites can be observed in vitro (Williams 2003). This 
is known as “Star activity”, but only occurs at very high concentrations and under optimum 
conditions (Pingoud et al. 2014). Other factors which increase its likelihood are the presence 
of a volume excluder, such as glycerol, or substitution of the divalent metal cofactors. For 
example, replacing the native Mg2+ ions with Mn2+ makes binding less specific, but also 
decreases the rate of the reaction (Williams 2003). 
 
The cognate enzymes in a system recognise and act on the same sequence of DNA, and often, 
the target base for methylation is next to the point of cleavage (Wilson & Murray 1991). 
Nevertheless, the enzyme pairs appear to share no sequence homology, even in their target 
recognition domains (TRDs). It has been proposed that this is due to their difference in 
quaternary structure. As the MTase is a monomer, the protein must correspond to the complete 
recognition sequence. Conversely, REases are mostly dimeric, and as such recognise only half 
the sequence. Their difference suggests that they have evolved independently. MTase function 
protects host DNA from restriction and prevents cell death. This has selected which REases 
have survived, and provides a theory for why orphan MTases have no cognate REase (Bickle 
& Kruger 1993). What is more surprising is that not only is there very little sequence homology 
between different Type II REases, but that it is rare between isoschizomers. This indicates that 
their shared specificity is not the product of mutations of a shared precursor, but that these 
enzymes too have evolved independently. A key example of isoschizomers that are similar, 
and so are exceptions to this, are EcoRI and RsrI. However, as has been mentioned, EcoRI is 
encoded on a plasmid. This suggests that this pair share sequence as a result of HGT. 
 
The REases do possess a structural similarity. A five-stranded, mixed β-sheet enclosed by α-
helices make up a conserved catalytic core, at the centre of which is a PD…D/EXK motif (Fig. 
30 
 
10). This brings together two carboxylates (one aspartate and one glutamate or aspartate), 
which are proposed to bind the Mg2+ cofactors (Pingoud & Jeltsch 2001). Simple comparisons 
show that there are often differences in the α-helices and one of the β-strands. The remaining 
four β-strands are entirely conserved however, two of which hold the PD…D/EXK motif 
(Pingoud & Jeltsch 2001). The ubiquity of these shared catalytic residues indicates that 
cleavage by the Type II REases occurs via the same mechanism. Not only can this structure 
be found in the Type II REases, but also in some other enzymes that possess nuclease activity 
(Pingoud & Jeltsch 2001). A key example of these is λ-exonuclease, a 5’ to 3’ single stranded 
exonuclease encoded by bacteriophage λ (Pingoud & Jeltsch 2001). This enzyme creates 3’ 
sticky ends in the dsDNA of the virus, facilitating recombination and leading to DNA repair 
(Kovall & Matthews 1998). Despite having an opposing purpose, the conserved structural 
motif in the λ-exonuclease and the bacterial REases indicates that they are related (Kovall & 
Matthews 1998). This led to the suggestion that this whole group of REases could be regarded 
as having developed along one of two branches. Those enzymes that bind the major groove of 
DNA and produce sticky ends were thought to belong to the “EcoRI family”, which includes 
BamHI and FokI. λ-exonuclease belongs to the “EcoRV family” of enzymes, which move 
along the DNA minor groove, resulting in blunt-end cleavage. The difference in mechanism 
is a product of a difference in the topology of the dimer and suggests that this factor is 
important when considering the evolution of the REase (Pingoud & Jeltsch 2001). 
 
 
Figure 10: The EcoRV homodimer with two of the conserved catalytic motifs (A) (Kostrewa & Winkler 
1995) PDB:1AZ0. λ-exonuclease trimer with three catalytic motifs (B) (Kovall & Matthews 1997) PDB: 




As opposed to the lack of sequence conservation in the REases, there is some within MTases, 
and in the 5mC MTases in particular (Bickle & Kruger 1993). There are several conserved 
motifs between large regions of non-homologous sequence. Depending on the limit of 
definition, there are up 10 motifs within 5mC MTases, 6 of which show higher similarity 
(Kumar et al. 1994). As would be expected, the amino MTases share a higher degree of 
similarity with each other than they do with the 5mC MTases (Bickle & Kruger 1993). The 
TRDs are the most variable region, but similar sequences often produce similar specificities. 





1.6. Type I R-M Systems 
 
Type I systems were the first R-M systems to be discovered and although not as useful to 
molecular biology as other types, they are arguably the most interesting (Roberts et al. 2011). 
These are large hetero-oligomeric complexes, which perform cleavage of DNA away from 
their recognition site, in an ATP-dependent reaction (Fig. 11) (Murray 2000). 
 
 
Figure 11: Cartoon diagram of the mode of action of a generic Type I R-M system. 
Adapted from Tock & Dryden 2005. 
 
A Type I restriction enzyme is composed of a combination of three separate subunits, each 
having its own role in enzyme activity. These subunits are denoted by Hsd (host specificity 
for DNA) R, for the restriction subunit, M for the methylase subunit, and S for the specificity 
subunit (Murray 2000). In general, a Type I system has a ~60 kDa HsdM subunit and a ~130 
kDa HsdR subunit, which enables DNA restriction (Taylor et al. 2010). The working ~440 
kDa restriction complex has a R2M2S1 stoichiometry, whilst a M2S1 stoichiometry acts as a 
cognate MTase for the system (Kennaway et al. 2012). The Type I MTase modifies adenines 
almost exclusively, and does so on both strands of DNA (Murray 2000). Specific DNA 
sequences are recognised and subsequently bound by the ~50 kDa HsdS (Taylor et al. 2010). 
For the most part, these sequences possess the same general organisation of three specific 
nucleotides followed by a variable spacer of five to eight nucleotides (N), and then a further 
three to four specific nucleotides (Adamczyk-Poplawska et al. 2011). For example, the target 
sequence of EcoKI is AACN6GTGC (Roberts et al. 2011). The S subunit contains two TRDs, 
separated by a central domain, which is conserved in members of the same family (Adamczyk-
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Poplawska et al. 2011). One of the TRDs is specific for one part of the bipartite DNA sequence, 
while the other TRD recognises the other. The central conserved domain serves to coordinate 
interactions with the other subunits and more importantly, to separate the TRDs to a defined 
distance, which corresponds to the non-specific DNA spacer (Powell et al. 2003). This was 
originally inferred from studying the two Type I systems, EcoR124I and EcoR124II. It is 
proposed that a recombination event has caused an increase in the conserved sequence and 
resulted in a change in the nucleotide spacer between the two specific sequences, from 6 bp to 
7. This increase of 1 bp was caused by the addition of 4 amino acids to the helical spacer 
(Murray 2000).  
 
Depending on enzymatic properties, amino acid conservation and the order of the genes from 
which these systems are expressed, the Type I systems of E. coli and Salmonella enterica are 
separated into four sub-families (IA-D) (Roberts et al. 2012). There is relatively little 
homology between families. For example, EcoKI and EcoAI (from IA and IB families 
respectively) share only 32% amino acid sequence identity. This indicates that they are indeed 
evolutionarily linked but that they are further separated than even E. coli from Salmonella 
(Murray et al. 1993). The concept of these families originated from the observation that 
subunits from one Type I enzyme could be used to complement another, and has been a 
significant step in the understanding of the group as a whole. Unsurprisingly, the biggest 
region of difference in enzymes from the same family is their S subunit (Murray 2000). 
Interestingly, it was found that TRDs could be exchanged between common Type I enzymes 
and doing so would elicit a new DNA specificity. This was a combination of the respective 
halves of the parental sequences (Janscak & Bickle 1998). 
 
The two TRDs of the Type I MTase do not bind the bipartite DNA target sequentially (i.e. in 
a 5’ to 3’ direction), with the HsdM subunits positioned above. A circular model has been 
proposed, which put the TRDs facing each other on opposing strands. The N-terminal and 
central conserved regions would form a “split linker”, which is interacting with the M subunits 
(Kneale 1994). TRD 1 binds the top strand of the helix, whilst TRD 2 loops around the DNA 
via the conserved spacer, and binds the bottom strand in a 3’ to 5’direction (relative to the top 
strand) (Fig. 12). There were a number of results that led to this conclusion. There is a 
significant level of homology between the amino acid sequences of N-terminal and spacer 
domains. In one sub-family, this consists of a repeated sequence, which is split between the 
two regions (Kneale 1994). This suggested that the N- and C-termini were linked. Truncations 
of the HsdS that contained only TRD 1 and the spacer, retained their function and bound a 
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novel DNA sequence. The new target was a palindrome of that recognised by TRD 1, separated 
by random nucleotides (Abadjieva et al. 1993). This implied the circular arrangement, with 
the TRDs binding opposite strands. Further evidence for this model was provided by the work 
of Janscak and Bickle (1998), which created several “permutions” (sic), with covalently fused 
termini and breaks at different points along the HsdS peptide chain. By creating four structural 
variants of the HsdS of EcoAI, they showed that engineered C-termini (end points) in the N-
terminal and central conserved region had no detrimental effect to DNA binding. These results 
reinforced the idea that the N-terminal and the spacer were bound to and consequently 
coordinated in close proximity by the M subunits (Janscak & Bickle 1998). 
 
 
Figure 12: Cartoon model of the subunit organisation of a Type I MTase around its 
target DNA sequence. Below is an example sequence of the CC398-1 MTase, showing 
the modified adenine bases on the top and bottom strands (Janscak & Bickle 1998). 
 
Type I enzymes use energy from ATP hydrolysis to translocate DNA. The HsdR subunit binds 
both the two Mg2+ cations and ATP to perform the complicated process involved in producing 
DSBs in unmethylated DNA (Roberts et al. 2011; Davies et al. 1999). Its N-terminal holds the 
PD-(D/E)XK motif, and the C-terminal contains several α-helices, which are proposed to 
facilitate HsdM subunit interaction (Uyen et al. 2009). The HsdR subunit alone possesses no 
DNA recognition or cleavage properties, although does have a reduced ATPase activity 
(Šišáková, Weiserová, et al. 2008). For normal activity, it is necessary for two HsdR subunits 
to bind to the MTase trimer (Holubová et al. 2004). The nuclease domain of HsdR is in a 
region towards the N-terminal, known as “Region X”. Towards the end of Region X, there is 
also a conserved QXXXY motif. This is also found in RecB nucleases, which are specific to 
ssDNA. The similarity between the two enzyme classes is difficult to distinguish, and it seems 
simply that they both translocate DNA and subsequently cleave it non-specifically. It has 
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therefore been proposed that this shared motif acts as an anchor to the DNA, compensating for 
the reduced binding affinity for non-specific DNA (Šišáková, Stanley, et al. 2008). Beyond 
Region X, there are DEAD-box motifs, which are a characteristic of DNA and RNA helicases. 
These can be found in the HsdR of all known Type I systems. As this is the case, it is widely 
thought that the translocation of DNA through Type I systems proceeds via a helicase 
mechanism (Davies et al. 1999). The D-E-A-D box is an ATP binding motif, with the 
conserved amino acid sequence: (V/I)-L-D-E-A-D-X-(M/L)-L-X-X-G-F (Linder et al. 1989). 
Mutagenesis studies have shown that these motifs are also essential to the restriction activity 
of these enzymes (Davies et al. 1999). The HsdR consists of several regions, each important 
to the different functions of the subunit. Additionally, there seems to be a significant functional 
relationship between these domains. Mutations at points in the nuclease domain not only 
eliminate cleavage activity, but also have a negative impact on both ATPase and motor 
activities (Šišáková et al. 2008). The publication of the crystal structure of the HsdR from 
EcoR124I, provided a great deal of information and supported previous conclusions about the 
domain organisation of the subunit. Four distinct domains were highlighted in the solved 
structure, two helicase (motor) domains above a “helical” (largely α-helices) and an 
endonuclease domain (Fig. 13). If the helical region interacts with the MTase trimer, and DNA 
is moved inwards, both the two motor domains and the nuclease domain will face out across 
the DNA (Lapkouski et al. 2009). 
 
 
Figure 13: The four domains of the EcoR124I HsdR. The endonuclease domain is 
highlighted in yellow, the helical region in green and the two motor domains in purple 
and cyan. The conserved α-helical and β-strand structural motif in coloured red, with the 
key, Pro-Asp-Lys catalytic motif in blue. EcoR124I HsdR PDB:2W00 (Lapkouski et al. 2009). 
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The Type I enzyme binds its recognition sequence and the two motor domains reel through 
the DNA in opposite directions (Davies et al. 1999). The enzyme does not separate the DNA 
strands, but rather the grooves in the helix act as tracks over which the enzyme moves. The 
DNA is moved inwards through the enzyme and is thought only to be cut when two HsdR 
motors collide (Šišáková et al. 2008). This can occur at anything from 40 bp to several kbp 
away from the recognition site, but is generally about half way between it and the next target 
site (Davies et al. 1999; Roberts et al. 2011). One molecule of ATP is hydrolysed by the 
enzyme for every bp translocated (Šišáková et al. 2008). Interestingly, even after DNA 
cleavage, the enzyme can continue to perform ATP hydrolysis. This can be stopped by cutting 
the DNA using other enzymes. The protein complex can hydrolyse ATP even when lacking 
an R subunit (R1M2S1). This means that the complex continues to translocate DNA, but is 
unable to perform cleavage. By observing the translocation process, it was found that the 
enzymes sometimes became smaller. This, along with the fact that an incomplete complex 
retains some function, suggested that the R subunits dissociate reversibly from the foundation 
of a DNA-bound MTase trimer (Roberts et al. 2011). It is this aspect that has led to the 
conclusion that the Type I systems are able to recycle their subunits, allowing catalytic 
turnover after cleavage. On linear DNA, it is thought that the R subunits are able to dissociate 
via the ends and bind a different MTase unit. Conversely, there is no free end on circular DNA 
and so the HsdR subunits remain bound. In this case, only the MTase can dissociate and can 
only form a restriction complex when HsdR is in excess (Simons & Szczelkun 2011). Roberts 
et al. carried out further investigations into the conditions required for restriction activity. 
These elucidated that one or more recognition sequences were required for effective cleavage 
of circular DNA, whilst at least two sites are needed to restrict linear DNA. However, results 
from investigations using atomic force microscopy showed that to produce multiple double 
stranded breaks in DNA that contained multiple sites, the amount of enzyme had to be 
increased to a 1:1 ratio of enzyme to recognition sequence. As such, Type I systems can be 
thought of as ‘honorary’ enzymes, due to their apparent lack of turnover (Roberts et al. 2011).  
 
The consequence of the translocation of up to 50,000 bp, at speeds of up to 1000 bp s-1, is the 
creation of extruded loops of DNA (Kennaway et al. 2012). These loops are generally very 
big and can be clearly observed under an electron microscope (Yuan et al. 1980). As DNA is 
twisted 360o for every 10 bp of translocation, within these large loops is also a very high degree 
of positive supercoiling (Yuan et al. 1980; Smith et al. 2009). This type of supercoiling occurs 
when additional turns to the double helix cause it to wind in on itself (Champoux 2001). This 
increase in helical density is relaxed when the enzyme eventually cuts the DNA, or if the 
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enzyme dissociates (Endlich & Linn 1985). Investigations into translocation inhibition 
concluded that DNA topology does not inhibit the Type I systems, although fluorescence 
studies have shown that the enzyme can make several attempts before translocation of DNA 
results in cleavage (McClelland et al. 2005; Janscak et al. 1999).  
 
The three subunits of the Type I system are encoded by the genes, hsdR hsdM and hsdS, which 
are expressed from the two promotors, PRes (transcribing hsdR) and PMod (transcribing hsdM 
and hsdS). The hsdM and S genes can be transferred to different bacteria via conjugation or 
transformation, and they confer non-native modification activity immediately. Equally, the 
inclusion of the hsdR gene will also cause non-native restriction activity. This results in the 
degradation of the unmodified host DNA, but seems only to be expressed after several 
generations of the bacteria (Prakash-Cheng & Ryu 1993). Alterations to the TRDs, which are 
encoded by the hsdS gene, can establish a new DNA specificity. Not only can TRDs be 
swapped, truncated and switched, but also the addition of nucleotides to the region between 
those that encode them, increases the spacer between the two parts of the recognition sequence 
(N number) (Murray et al. 1993). Not only do the hsdM and hsdS genes share the same 
promoter, but they also share DNA sequence at a junction created by the end of hsdM and the 
start of hsdS. Hence, the genes are transcribed from overlapping reading frames and the 
subsequent translation is coupled. Therefore, during translation, a jump is required to create 
the two separate polypeptides (Roberts et al. 2012). Roberts et al. were able to remove this 
frameshift from the MTase genes of the Type IA enzyme, EcoKI, to create a fusion of the M 
and S subunits. Not only did this protein product show full R-M activity in vivo, but it could 
also be over-expressed and purified. With the addition of stoichiometric amounts of EcoKI 
HsdM protein, the purified fusion formed an active restriction complex in vitro. The successful 
creation of this fusion protein provided a model for an evolutionary intermediate between the 
Types IA and IB, where the frameshift in the IB systems occurs sooner along the MTase genes 
(Roberts et al. 2012). The subunits of members of each of the families are approximately the 
same. This is with the exception of the IB enzymes, which have a smaller M subunit and larger 
conserved regions either side of their TRDs. This indicates that the evolutionary divergence 
of the IB systems might have been caused by a gene duplication of a common “half S” ancestor 





Figure 14: Schematic delineating the changes proposed in the evolution of Type IB systems 
from Type IA/C systems. 
The HsdM is coloured green and blue, where the blue represents the catalytic portion of 
the subunit. The HsdS is coloured yellow and orange, where the yellow represents the 
TRDs and the orange blocks are the central conserved and C-terminal sequences. The 
diagram shows the movement of sequence (grey) from the C-terminal of the Type IA/C 
HsdM, to the N-terminal of the Type IB HsdS, through subunit rearrangements. Adapted 
from Roberts et al. 2012. 
 
A relatively recent addition to the Type I sub-families is Type ISP, enzymes from which 
possess all the functions of a Type I enzyme but within a single polypeptide (SP) (Kulkarni et 
al. 2016). ISP enzymes were proposed after the discovery of an R-M system from the 
bacterium Lactococcus lactis ssp. Cremoris W10 in 2001. Within this organism is a 12.1 kbp 
plasmid, pEW104, which encodes a single polypeptide with both restriction and modification 
activities. It was observed that this protein, subsequently known as LlaGI, contained seven 
DEAD box motifs, and four motifs conserved within adenine methylases. It also possessed a 
catalytic motif formed by two acidic residues and one basic residue (E-E-K), which can be 
found in the HsdR of the Type I enzymes, EcoAI and EcoPI (Madsen & Josephsen 2001). 
Subsequent characterisation of this and its sister prototype, LlaBIII, shows that these systems 
contain a single TRD, which recognises a 6 to 7 bp asymmetrical target. The enzymes perform 
ATP-dependent dsDNA translocation, and SAM-dependent modification of single DNA 
strands. After binding their target, they hydrolyse one to two molecules of ATP for each bp 
translocated in an exclusively 3’ direction. DSBs are created when target sites are facing each 
other (5’ to 3’ and 5’ to 3’ on the bottom strand). If only one site is present, or the sites are not 
in the correct orientation, cleavage activity amounts only to nicking. This was evidence that, 
like the classical Type I systems, translocation of DNA by the ISPs results in double strand 
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cleavage only after collision with another motor. In this case, the ISP enzymes are effectively 
dimerising to initiate restriction activity (Chand et al. 2015). In the N-terminal region of the 
peptide there is an SF2-like helicase domain, which performs the translocation. This was 
thought to form large loops of DNA in the fashion of the classical Type I systems (Smith et 
al. 2009). However, the crystal structure of LlaBIII brought a new perspective on the Type ISP 
mechanism of translocation. The structure shows an arrangement of six distinct domains, with 
its MTase at the C-terminal and the TRD at the very end of the protein. This portion of the 
protein makes the majority of contact to its DNA substrate. It has a structural motif in common 
with TRD 2 of Type I systems, and the TRD of the Type IIG enzyme, BpuSI. It is responsible 
for guiding DNA to the upstream ATPase and nuclease domains at the N-terminal of the 
protein. From this information it was decided that, contrary to belief, the enzyme would not 
extrude loops of DNA, as movement in this direction would likely displace the nuclease 
domain. Equally, if the nuclease domain lies upstream from the bound MTase, enzymes 
translocating towards each other would not have an adequate orientation to produce 
dimerisation for double strand cleavage. Instead, what is proposed is that the MTase domain 
feeds the DNA to the helicase, which then allows the MTase and TRD to dissociate from the 
DNA. As the C-terminal portion is now uncoupled from the substrate, the helicase is able to 
translocate the DNA. This leads to the movement of the enzyme in a 3’ direction, without the 
creation of DNA loops. Furthermore, this model proposes that DSBs are caused by the 
combination of nicks by separate ISP peptides (Chand et al. 2015). Interestingly, the crystal 
structure also includes the target adenine, which is flipped out into the MTase catalytic site 
(Chand et al. 2015). 
 
As with all the R-M systems, an important aspect of the Type I enzymes is how their defence 
of the host cell is countered by invading genetic elements. Gene 0.3 of bacteriophage T7 
encodes a protein known as OCR (Overcome Classical Restriction) (Fig. 15A). Upon invasion 
of E. coli, OCR is the first protein produced from the genome of the bacteriophage (Stephanou 
et al. 2009). It mimics the structure of the DNA double helix, and inhibits Type I enzymes by 
strongly binding to, and blocking their active site. OCR is a negatively-charged homodimer, 
which mimics a bent DNA structure of about 24 bp long. Normally, DNA is bent by R-M 
enzymes to allow efficient binding. The structure of OCR is curved by approximately 46o, and 
is therefore predisposed to bind these enzymes (Walkinshaw et al. 2002). Its negative charge 
and appropriate shape means that OCR binds with such high affinity it is almost irreversible 
(50 fold higher than DNA) (Atanasiu et al. 2001). Each of the OCR monomers is 116 amino 
acids long and has 34 carboxylate amino acids on its surface. In many cases, this combination 
of Asp and Glu residues directly corresponds to the phosphate backbone of an equivalent DNA 
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molecule. In order to retain anti-restriction function, each monomer requires at least 16 of 
these acidic residues (Kanwar et al. 2016). Another example of an anti-restriction DNA mimic 
is the ArdA (Alleviation of Restriction of DNA A) protein (Fig. 15B). The ardA gene is found 
on plasmids and conjugative transposons in many different prokaryotes (McMahon et al. 
2009). An example of this is the orf18 gene on the Tn916 conjugative transposon of 
Enterococcus faecalis (Serfiotis-Mitsa et al. 2008; Serfiotis-Mitsa et al. 2010). The crystal 
structure of ArdA shows that it shares several characteristics with OCR. The dimeric protein 
has a long, curved, negatively-charged structure, and it mimics a 42 bp long molecule of B-
form DNA (McMahon et al. 2009). In contrast to OCR, each ArdA monomer has three α/β 
domains, across which its charged Asp and Glu residues are distributed (McMahon et al. 
2009). The third domain is the dimer interface, and can be severely affected by residue changes 
(Roberts et al. 2013). Data collected from various ArdA mutants suggest anti-restriction 
activity is not dependent on dimerisation. ArdA monomers retain the ability to bind the HsdR, 
and subsequently inhibit DNA cleavage, whereas an ArdA dimer is also able to bind the MTase 
complex. As such, Domain 3 of this protein is responsible for anti-restriction function, whilst 
the other two domains coordinate anti-modification activity (G. A. Roberts, Chen, et al. 2013). 
 
 
Figure 15: The structure of the OCR dimer (A) PDB: 1S7C (Walkinshaw et al. 2002; Kennaway et al. 2009) 
and the ArdA dimer (B) PDB: 2W82 (McMahon et al. 2009). For both proteins, the acidic residues are 




1.7. Type I and Type II Systems 
 
Their beneficial characteristics and selfish nature have ensured the survival of the R-M 
systems. The consequences of intra and inter- genome movements over a significant amount 
of time have created a wealth of different genes, encoding a multitude of distinct structures. 
This in turn has meant the evolution of several different types of enzyme, which carry out the 
same function.  
 
There is clearly a wide structural diversity within the Type II systems. This is partly due to the 
problems in assigning new enzymes to an already established set of criteria. However, it is 
undeniable that there are fundamental links between what we call the Type II systems and also 
similarities to enzymes of different Types. Specifically, there are some Type II structural forms 
that resemble Type I systems. Enzymes from the unorthodox sub-types, IIB and IIG, share 
some key characteristics with Type I enzymes. For example, the enzymes from both of these 
subtypes possess REase and MTase activities in a single enzyme, and are therefore SAM 
dependent (Bujnicki 2001). Type IIB enzymes, like Type I systems, consist of more than one 
domain. Type IIB enzymes cut DNA on both sides of their recognition sequence, a defined 
number of b.p. away. Although Type I systems initially translocate their DNA substrate, they 
too eventually cut at both directions from their target site (Marshall et al. 2007). In both cases, 
a small fragment containing the recognition sequence is removed from the rest of the DNA 
sequence (Marshall et al. 2007). Type IIB systems also have two TRDs in their B, or specificity 
peptide. This is another direct similarity to a Type I system. In contrast, Type IIG systems 
possess both activities in a single peptide. They therefore possess only one TRD and cut DNA 
at one side of their recognition sequence (Bujnicki 2001). For this reason, IIG systems can be 
viewed as half of the IIB systems. Both sub-types share significant qualities with the Type I 
systems, but do not translocate DNA. With this in mind, Type IIBs can be considered a “motor-
less” type I, and by extension, IIG enzymes can be seen as half of this “motor-less” system 
(Kennaway et al. 2012). 
 
Kennaway et al proposed that the similarities between Types I and II imply that they are 
evolutionarily linked (Kennaway et al. 2012). Their structural data show that subunit 
rearrangements of the Type I enzyme, EcoR124I, give it a structure similar to that of a Type 
IIG enzyme. By removing the motor domains from the EcoR124I HsdR, and joining the C-
terminal of the remaining portion to the N-terminal of the HsdM, it has the appearance of the 
Type IIG enzymes, MmeI and BpuSI. The α-helices that stretch between the two TRDs of the 












































































































































































































1.8. Staphylococcus aureus 
 
Staphylococcus aureus is a gram-positive coccal bacterium, associated with several human 
diseases (Feil et al. 2003). It is both a prevalent commensal of the skin and nose, and a major 
pathogen of humans and animals (Kluytmans et al. 1997; Tong et al. 2015). It is estimated that 
S. aureus has colonised approximately 30 % of the human population (Tong et al. 2015). 
Although mostly carried and not leading to disease symptoms, this bacterium remains one of 
the major causes of hospital- (HA) and community-acquired (CA) infections and the most 
common cause of bacteremia (bacterial infection of blood) (Feil et al. 2003; Tong et al. 2015). 
The precise manner in which S. aureus is able to turn from a passive commensal to an 
aggressive infection is unknown, but it occurs when the immune system of the host is lowered, 
or there is a breakage of skin or mucosal barrier (Rasmussen et al. 2011). It is therefore known 
as an opportunistic pathogen (McCarthy et al. 2012).  
 
The fear over increasing case numbers of S. aureus bacteremia (SAB) is on account of its 
severity and its links to secondary infections. In over 30 % of patients, SAB leads to infective 
endocarditis (Rasmussen et al. 2011). This is an inflammation of heart tissue, particularly the 
valves, and has a strikingly high mortality rate (Heiro et al. 2006). Another serious 
consequence of SAB is the spread of infection to the blood brain barrier. This often manifests 
itself in meningitis, which is an inflammation of the areas around the brain and spine. This 
also carries a high rate of fatality (Sáez-Llorens & McCracken Jr 2003). SAB most often 
occurs in immunosuppressed patients, like sufferers of diabetes, HIV, or even patients of an 
advanced age (Rasmussen et al. 2011). The spread of S. aureus and SAB was linked to 
healthcare environments, predominantly hospitals, where infected individuals are grouped 
together with non-carriers. However, apparently healthy patients can carry the bacteria and 
infect the wider community. There are growing numbers of these CA infections. In fact, S. 
aureus is the second most common bacterium found amongst outpatients in the USA 
(Rasmussen et al. 2011). S. aureus infections can also be harmful to animals, which in the case 
of livestock, frequently carries a financial cost (McCarthy et al. 2011). 
 
First attempts to treat S. aureus infections in the 1930s used drugs containing sulphonamide 
groups. These were soon abandoned due to the increasing bacterial resistance. In the 40s, 
penicillin became the primary agent used against the bacteria. However, extensive use of the 
drug brought about the emergence of strains containing a β-lactamase gene, which conferred 
resistance against penicillin (Fig. 17) (Brumfitt & Hamilton-Miller 1989). By the next decade, 
the prevailing strains of S. aureus were resistant to nearly the entire spectrum of regularly 
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administered antibiotics. These included erythromycin, streptomycin and all the tetracyclines. 
With the production of semi-synthetic penicillins, resistant to β-lactamase, it was thought that 
the worry was over. One of the first of these was methicillin. Unfortunately, it was only a short 
time after that strains of methicillin-resistant S. aureus (MRSA) were identified. Due to the 
rarity of such occurrences, and that they seemed resistant only to the β-lactam antibiotics, this 
was not considered an issue. By the 1970s however, MRSA strains resistant to other forms of 
antibiotics were being detected in Australia. It was at this point that it was realised that MRSA 
was a significant threat (Brumfitt & Hamilton-Miller 1989). Compared to Europe, there is a 
higher prevalence of MRSA in the USA (Rasmussen et al. 2011). In the UK and France, 
techniques such as increased hand-washing and screening, and a rotation of prescribed 
antibiotics have been able to stem the exponential rise of MRSA numbers (Lindsay 2013; 
Rasmussen et al. 2011). Nevertheless, MRSA is estimated to cost the European economy 380 
million euros each year (Lindsay 2013). 
 
 
Figure 17: β-Lactam hydrolysis by β-Lactamase. Adapted from Chellat et al. 2016. 
 
More effective DNA sequencing methods enabled the determination of the entire genome of 
the S. aureus Mu50 and N315 strains in 2001 (Lindsay 2014). The genome sequence of 17 
other strains, along with the partial sequence of many others has identified that the S. aureus 
genome consists of three groups of genetic material. The first is a highly conserved set of core 
genes found in all strains. The next division is the MGEs, and makes up approximately 15% 
of the genome (Waldron & Lindsay 2006). This substantial proportion gives an indication of 
the regularity of gene transfer between these bacteria. There are also over 700 core variable 
(CV) genes that make up over 20% of the genome. Due to their uneven distribution, they are 
the characteristic that defines S. aureus lineages (Stefani et al. 2012). Most of the CV genes 
encode host specific proteins, like virulence factors (Lindsay et al. 2006). Seven of the main 
CV genes from a large collection of S. aureus isolates were sequenced via a process called 
multilocus sequence typing (MLST). Differences in these genes were used to establish 
sequence types (STs) for each isolate. Matching profiles between isolates determined them to 
be clonal, and with at least five of the seven genes shared, they were deemed part of the same 
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clonal cluster (CC). Amongst the more invasive strains, there were seven genes that encoded 
proteins for binding human tissue and toxin secretion (Lindsay et al. 2006). This indicated that 
some strains were more harmful than others (Feil et al. 2003). Another method for strain 
identification is spa typing (Harmsen et al. 2003). The spa gene encodes S. aureus protein A, 
a 42 kDa virulence factor, which binds antibodies (Graille et al. 2000). Crucially, this gene 
contains a repeat region, which is prone to mutation and changes to the repeat number. This 
variation is used to differentiate S. aureus strains, and each is denoted by an alpha-numeric 
code. Importantly, these do not correlate to CC numbers, but can be used to distinguish variants 
of the same lineage (Harmsen et al. 2003). 
 
There are ten common S. aureus lineages found in humans. These are CC1, CC5, CC8, CC12, 
CC15, CC22, CC25, CC30, CC45, and CC51 (Lindsay 2010). The predominant clones of HA-
MRSA are CC5, CC8, CC22, CC30, CC45, ST239 (Lindsay 2013). Each of these lineages 
originates from a different part of the World, and has a specific area of circulation. 
Surprisingly, other than the disparity between the MGEs, isolates from different strains but the 
same lineage can be genetically very similar. To put this in context, a methicillin-sensitive 
strain (MSSA) isolated in the UK and an American CA-MRSA strain are both from CC1. 
Within the core and CV genes (which amounts to around 2500), there were only 285 base 
differences between the two strains. On the other hand, strains from separate lineages are 
vastly different (Lindsay 2010). The discrepancy is partly due to homologous recombination, 
although evidence suggests that this is less likely than point mutations. In contrast to many 
pathogenic bacteria, such as Streptococcus pneumoniae and Helicobacter pylori, S. aureus is 
not naturally transformable (Feil et al. 2003). In fact, the only known S. aureus capable of 
accepting E. coli-derived plasmid DNA is the chemically engineered RN4220 strain (Veiga & 
Pinho 2009). However, a huge contributor to lineage diversity is clearly the MGEs, which 
show signs of high levels of horizontal gene transfer (HGT) and recombination. The main 
MGEs include bacteriophage and plasmids, which can encode resistance genes and even genes 
that enable conjugative transfer. A common S. aureus MGE is the staphylococcal cassette 
chromosome (SCC). These are large fragments of DNA, which are exclusively incorporated 
into the orfX gene, and often encode antibiotic resistance (Lindsay 2010). It was discovered 
that methicillin resistance is conferred by SCCmec. This is an MGE that has been successfully 
incorporated into several S. aureus strains, and gives resistance to all β-lactam antibiotics 
(Lindsay 2013). Interestingly, there are different classes of the SCCmec gene, which provide 
a variety of resistances. The specific gene for methicillin resistance in MRSA is MecA. From 
MecA is expressed a protein known as PBP2a, which does not hydrolyse the antibiotic, but 
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rather inhibits it through competitive binding (Chellat et al. 2016). It is thought that the smaller 
forms of SCCmec are transferred with higher frequency. The range of HGT rates for separate 
MGEs indicates that some encounter bacterial defence mechanisms (Lindsay 2010). 
 
A notable barrier to HGT between S. aureus strains is the R-M systems. The Type II enzymes, 
Sau3AI and Sau96I have been identified in some lytic strains, and there is even a Type IIB 
enzyme in the ϕ42 lysogens (staphylokinase-, and enterotoxin A- positive strains) (Veiga & 
Pinho 2009; van Wamel et al. 2006). The most abundant R-M system amongst S. aureus strains 
is the Sau1 Type I system. This is encoded by one hsdR gene and two hsdM/S loci on the 
distant genomic islands, GIα and GIβ (Sung & Lindsay 2007). Two distinct S subunits 
signifies that the system has two separate DNA target sites (Roberts et al. 2013). Interestingly, 
a stop codon in the hsdR of the transformable RN4220 strain, has rendered it restriction 
inactive, and therefore transformable. However, complementation with a functional hsdR gene 
restores restriction activity and prevents transformation (Sung & Lindsay 2007). The amino 
acid sequences of the Sau1 HsdR and HsdM are highly conserved (99%), and so this type of 
complementation is possible between all lineages (Roberts et al. 2013). The HsdS is not 
conserved between strains, but is specific to its lineage. Given that Sau1 seems to pose a 
substantial barrier to HGT, it is suggested that it is more likely to occur within lineages than 
between them (Waldron & Lindsay 2006). As such, the spread of MGEs is lineage-dependent 
and each lineage is evolutionarily diverged. This also means that despite the high levels of 
HGT, the spread of antibiotic resistance is a relatively slow process (Roberts et al. 2013).  
 
Certain MRSA strains are clearly more harmful than others, and antibiotic resistance is 
variable. Identification of specific infections is therefore extremely important. Due to the 
hazardous nature of these strains, it is often necessary for analysis to be carried out by 
experienced researchers, using specialised tools. This however, takes a substantial amount of 
time, often in situations where it cannot be afforded. There is an undeniable necessity for fast, 
effective ways of determining S. aureus lineages. The Lindsay group has developed a test, 
which uses PCR to amplify regions of the genome that are unique to the CC. A gene showing 
high variability is obviously the hsdS. By using primers specific to the hsdS of each lineage, 




1.9. S. aureus CC398 
 
MRSA from clonal complex 398 (CC398) was first identified in the Netherlands in 2003, and 
has since been detected with increasing regularity. CC398 is a particular lineage of CA-
MRSA, linked to exposure to livestock, chiefly pigs and cattle (van Loo et al. 2007). It is 
therefore also known as livestock-associated (LA-) MRSA (Ballhausen et al. 2016). Given the 
extensive transportation of these types of animals, CC398 is likely to have spread 
considerably, and has been found in Europe, North America and China (van Loo et al. 2007). 
This is of particular concern after the emergence of strains containing Panton-Valentine 
leukocidin, a virulence factor which can cause several serious diseases (McCarthy et al. 2011; 
Lindsay et al. 2006). Consequently, CC398 is regarded as a global health threat (van der Mee-
Marquet et al. 2014).  
 
A French study in 2005 that isolated methicillin-sensitive (MSSA) CC398 strains from pig 
farmers, suggests that CC398 was at first an ordinary commensal of pigs, but extensive use of 
antibiotics has selected for methicillin resistance. CC398 infection of pigs is seldom 
dangerous, but can be transferred to humans by simple contact (Armand-Lefevre et al. 2005). 
A key divergence of CC398 from other S. aureus CCs is the acquisition of SaPI-S0385. This 
is a novel pathogenicity island, derived from the SaPI5 and SaPIbov islands. The new island 
possesses two putative anti-immune response genes (Ballhausen et al. 2016). Comparison of 
CC398 isolates from different parts of the World indicates that CC398 actually originated in 
humans. MSSA CC398 is thought to have transferred to pigs, via the loss of certain MGEs, 
but was able to develop resistance by acquiring others. It is now able to infect humans as a 
form of MRSA. This sort of comparison also highlights that there is variation between CC398 
isolates from different areas but also different hosts. It was discovered that MRSA CC398 
retrieved from humans was more closely related to MRSA CC398 from animal sources, than 
MSSA CC398 from humans (Lekkerkerk et al. 2015). There is a strong correlation between 
infection and exposure to pigs, but there is also a significant proportion of infections in people 
who have had no contact with livestock. Within isolates from these hosts, there is genetic 
variation (Lekkerkerk et al. 2015). CC398 variants can be identified by spa type. The most 
common are t011, t034 and t108 (Ballhausen et al. 2016). Separate CC398 isolates appear to 
share the core genes, but as with all forms of S. aureus, the majority of difference occurs in 
the MGEs (Stegger et al. 2010). Some of these MGEs include genes that encode tetracycline 
and trimethoprim-sulfamethoxazole resistance. It is these genes that can be used to distinguish 
CC398 variants in the PCR assay.  
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It is thought that the ability to infect humans is conferred to CC398 by genetic material that 
has significant homology to bacteriophage φMR-11. The CC398 φMR-11-like prophage is 
specific to isolates from humans, and is linked to β-converting φ3 prophage (van der Mee-
Marquet et al. 2014). This prophage encodes virulence factors, which inhibit human immune 
response, and enable bacterial transfer from animals to humans. Approximately 90 % of 
MRSA isolated from humans carries the φ3 prophage. It is thought that CC398 lost this MGE 
when it transferred to livestock (Ballhausen et al. 2016). This is the basis via which McCarthy 
et al. classified CC398 isolates into two separate groups, which appear to be evolutionarily 
independent. One group possessed the φ3 prophage, but not the methicillin resistance gene, 
mecA. In the other group, the reverse is true and is thought to have been selected by the 
widespread use of antibiotics. There is worry over whether the mecA-positive strains will 




1.10. The Evolution of R-M Systems 
 
In this thesis, I present work which aims to support the theory that Type I and Type II R-M 
systems are evolutionarily linked. This proposal was put forward by Kennaway et al. in 2012, 
and is based on the similarities between the Type IIB and IIG subtypes, and Type I systems.  
 
This work gives original findings from the SauI R-M systems and original characterisation of 
the CC398-1 MTase. Abadjieva et al. showed that the second TRD of a Type I HsdS can be 
deleted, bringing about a change in recognition sequence (Abadjieva et al. 1993). An HsdM 
to HsdS fusion was created by Roberts et al., using the EcoKI MTase. This was used as the 
basis for the argument that subunit rearrangements have caused the divergence of the Type 
IA/C and Type IB subfamilies (Roberts et al. 2012). These findings have not before been used 
to bolster the argument that Types I and II are evolutionarily linked, and have never before 
been used in conjunction. Additionally, these investigations were not conducted using a Sau1 
system. By making step-wise alterations to the Sau1 Type I subunits from CC398-1 and CC5 
systems, I have engineered active enzymes with novel specificities. Soluble, recombinant M 
to S fusion, half S, and M to half S fusion proteins were successfully produced. These new 
protein structures are already comparable to Type II enzymes and are only a couple of the 



















2.1. Plasmids and Molecular Biology Techniques: 
Plasmid Resistance Tag Plasmid Map 
pJFMSEGFP Carbenicillin GFP and 
HisTag 
 
pJF Carbenicillin HisTag 
 
 
N. B. The pJF vector does not possess a Ribosome Binding Site (RBS). In order to elicit expression, 












Plasmid Resistance Tag Plasmid Map 






Engineering the pJF vector: 
 
Previous R-M systems had been expressed from a pJFMSEGFP vector, which causes the 
subsequent recombinant enzyme to carry a HisTag and green fluorescent protein (GFP). For 
the work shown in this thesis, the GFP gene was removed from the vector by using the 
polymerase chain reaction (PCR) to amplify all but the GFP sequence of the vector. The 
following primers were ordered from Invitrogen and the Phusion polymerase from New 
England Biolabs (NEB):  
 
pJF Vector Oligonucleotides: 
 
pJFMShis TS- 5’GATCGATCGAGGATCCCATCATCATCATCATCATTAAGAATTC 3’ 
 
pJFMSEGFPhis BS- 5’GAGTGAATCCCCGGGGATCCGTCGACC 3’  
 
pJFMShis TS and pJFMSEGFPhis BS primers were used in a PCR containing the following 
components: 
 
Component Volume (µL) Final Concentration (µM) 
dH2O 35.5 N/A 
5 X Phusion Buffer (NEB) 10 N/A 
dNTP Mix 1 200 
pJFMSeGFP Vector Template 1 Variable 
pJFMShis TS 1 0.5  
pJFMSEGFPhis BS 1 0.5 
Phusion Polymerase (NEB) 0.5 1.0 unit 
 
The PCR was carried out under the following conditions: 
 
Temperature (oC) Duration (seconds) Cycles 
95 300 1 
95 30 
30 55 30 
72 240 
72 600 1 
 
The PCR product was visualised by agarose gel electrophoresis and excised. A QIAquick Gel 
Extraction kit (Qiagen) was used to elute the DNA, which was then used to transform 
competent E. coli DH5α cells. 
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Preparing Vector pJF for ligation: 
 
1. Opening the vector 
 
~5 µg of vector pJF was used in a restriction digest with the following components:  
 
Component Volume (µL) Final Concentration 
dH2O 76 N/A 
10 X reaction buffer 10 N/A 
BSA 1 10 µg/µL (1X) 
Vector DNA 8 0.625 µg/µL 
Restriction enzyme (BamHI, NEB) 5 50 units 
 
The reaction was incubated at 37 oC for 1 hour. 
 
After the restriction enzyme reaction, a PCR Purification kit (Qiagen) was used in order to 
purify the vector from the rest of the reaction components. It should be assumed that there 
would be some loss of plasmid material during the purification process and so, given plasmid 
concentrations are approximate.  
 
The method for PCR purification followed the protocol provided with the Qiagen kit and was 
as follows: 
 
1. Added “Buffer PB” to the PCR in 5:1 ratio and mixed. 
2. Put QIAquick column in 2 mL collection tube. 
3. Transferred Sample mix to QIAquick column and centrifuged for 60 seconds at 18320 
x g. The flow-through was discarded. 
4. Added 750 µL “Buffer PE” to QIAquick column and centrifuged for 60 seconds. The 
flow-through was discarded. 
5. Centrifuged sample for another round of 60 seconds. 
6. Removed lid of Eppendorf tube with scalpel and placed QIAquick column into the 
Eppendorf tube. 
7. The vector DNA was eluted from the PCR purification column with 50 µL “Buffer 







2. Calf Intestinal Phosphatase Reaction 
 
As vector pJF had been linearised with only BamHI, the subsequent open ends were 
complementary to each other and could therefore re-anneal. To prevent this, the phosphate 
groups at the open ends were removed using Calf Intestinal Phosphatase (CIP).  
 
A “CIP mix” was assembled in the following way: 
 
Component Volume (µL) 
dH2O 17 
10 X “Buffer 3” (NEB) 2 
CIP 1 (10 units) 
 
The CIP reaction was then assembled in the following way: 
 
Component Volume (µL) 
dH2O 51 
10 X “Buffer 3” (NEB) 9 
Vector DNA 30 
“CIP mix” 10 (5 units) 
 
The reaction was incubated at 37 oC for 1 hour. 
 
After incubation, the reaction mix was treated to PCR purification and eluted with 30 µL of 
“Buffer EB”. 
 
Cloning Techniques:  
 
All primers were ordered from Sigma-Aldrich or Invitrogen and were used in a PCR reaction 
using Phusion polymerase (New England Biolabs). Colony PCR was conducted using Taq 
polymerase, unless otherwise stated. All genes were ligated into the engineered pJF vector, 
using the BamHI restriction enzyme to cut the gene fragment, which was then ligated into the 















Figure 18: Crossover PCR mechanism 
 
The mechanism of the crossover PCR (Fig. 18) can be summarised by the following:  
 
A primer complementary to the 5’end of the CC5 HsdR (“Primer 1”) and another, 
complementary to both the 3’ end of the same gene and the 5’ end of the MTase genes (“Primer 
2”), were used to amplify a portion of the CC5 HsdR gene, using the CC5 HsdR subunit gene 
in a pRSFDuet1 vector as a template. In the same round of reactions, a primer complementary 
to the 3’ end of the MTase genes (“Primer 4”) and a primer complementary to both the 5’ of 
the MTase and the 3’ of the CC5 HsdR gene (“Primer 3”), were used to amplify the CC398-1 
MTase genes using the CC398-1 MTase genes in pJFMSeGFP vector as a template. The PCR 
products from these reactions were used as the templates for a further PCR, using primers 1 
and 4. This subsequent reaction creates a product that is a fusion of the two previous products.  
 
Different fusion lengths were created by substituting Primers 2 and 3 in the primary PCR, for 





RM Fusion Oligonucleotides: 
 
All hsdR to hsdM gene fusions were created using the hsdR from the N315 (CC5) strain of S. 
aureus, and the hsdM from a CC398 strain of S. aureus, as templates. Therefore, the forward 
primer for the endonuclease primary PCR and the reverse primer for the specificity subunit 
(MTase) primary PCR, were the same for all of the constructs.  
 
The nucleotide sequences were as follows: 
 
Mu50nucuni TS (Primer 1)  
5’ AGTCAGTCAGGGATCCAAGAAGGAGATATACATATGGCATACCAAAGTGAATACGC 3’ 
                              BamHI            RBS                         Start           Endonuclease 
 
CC398-1BS (Primer 4) 
5’ GATCGAATTCCGGATCCAATAAACATCTTTTGAAGTAATGAC 3’ 
                                 BamHI                  Specificity subunit 
 
















































Fusion Name Label Nucleotide Sequence 
































* Gene fusion created by Christopher McLean 















Changes to the CC398-1 MTase genes were made using PCR, with the CC398-1 MTase gene 
as a template and the following oligonucleotides: 
 
Construct Name Label Nucleotide Sequence 




































CC398 -1 TRD 1 BS2 5’GATCGAATTCCGGATCCATCTTTAC
CATTCTCATCTTTAAATCG 3’ 
*The MS fusion was created using the “cross-over” PCR method. 







Ligation of DNA 
 
Ligation reactions were mostly conducted by taking an aliquot of open sample vector (of 
variable volume, depending on concentration) and adding insert DNA. T4 DNA Ligase (New 
England Biolabs), Ligase buffer and nuclease-free water. The ligation mixtures were 
incubated at room temperature for ~10 minutes. The mixture was then directly used for 
transformation of competent E. coli DH5-α cells. 
Ligation reactions were generally carried out using the following protocol: 
 
Reagent Sample Volume (µL) Concentration 
Sample vector 3 0.1 µg/µL 
Sample insert 7 Variable (3-4 X vector concentration) 
Ligase buffer 2 N/A 
Nuclease-free water 7 N/A 
T4 DNA ligase (NEB) 1 400 units 
 
Volume of insert could vary and total volume of the reaction was adjusted by an appropriate 
increase or decrease of the water component. 
 
Agarose Gel Electrophoresis of DNA 
 
Agarose gel electrophoresis was used to visualise and identify specific lengths of DNA. 
Agarose gels (0.8-1.0%  (w/v) were cast (as horizontal slab gels) and run in 1x TAE buffer (40 
mM Tris.Cl, 2 mM EDTA, 24 mM acetic acid, pH 7.7) as described by Sambrook & Russell, 
2001. Ethidium bromide was included in the molten agarose at a final concentration of 0.5 μg/ 
mL. Samples were prepared in 1X DNA loading buffer (25% v/v ficoll 400, 0.25% v/v xylene 
cyanol, 0.25% v/v bromophenol blue) and loaded into wells using a Gilson pipette. Samples 
were run alongside molecular weight markers at 100 V/h. DNA was visualised using a UV 
transilluminator, and images were acquired using a digital camera.  
 
Recovery of DNA from Agarose Gels 
 
DNA was extracted from agarose gels by using a QIAquick Gel Extraction Kit (Qiagen), a 
microcentrifuge and following the protocol provided by the manufacturer. The DNA was 










Colony PCR was used to confirm the correct orientation of genes ligated into the pJF 
expression vector. Four colonies were picked from an LB agar plate and suspended in 20 µL 
of dH2O. 10 µL of each sample was used to inoculate 5 mL of LB broth (used to establish an 
overnight culture), whilst the remaining 10 µL was used in a PCR containing: 
 
Component Volume (µL) Final Concentration (µM) 
Colony Sample N/A N/A 
pJFMS Promoter Forward Primer 1 1 
Reverse Primer 1 1 
10 X Taq Buffer 5 N/A 
MgCl2 3 1500 
dNTP Mix 1 200 (each dNTP) 
1 X Taq Bead (GE Healthcare) N/A N/A 
dH2O 39 N/A 
 
The PCR was carried out under the following conditions: 
 
Temperature (oC) Duration (seconds) Cycles 
95 300 1 
95 30 
30 55 30 
72 240 
72 600 1 
 
Preparation of Plasmid DNA 
 
A QIAprep Spin Miniprep Kit and a microcentrifuge were used. Cells from 5-10 mL overnight 
culture of E. coli DH5α (that had been previously transformed with the construct of interest) 
in LB medium (supplemented with 100 µg/ mL carbenicillin), was pelleted by centrifugation 
in a 15 mL Falcon tube at 1520 x g for 10 min. A Miniprep (Qiagen) kit was used to extract 









The protocol contained in this kit was carried out without alteration, and was as follows: 
 
1. Bacterial cell pellet was resuspended in 250 µL “Buffer P1” and transferred to an 
Eppendorf tube. 
2. To this mix was added 250 µL “Buffer P2”. This was inverted 6 times to mix. 
3. To this mix was added 350 µL “Buffer N3”. This was inverted 6 times to mix. 
4. The sample was centrifuged for 10 minutes at 18320 x g. 
5. The supernatant was transferred to a QIAprep spin column and centrifuged for 60 
seconds. Flow-through was discarded. 
6. 500 µL “Buffer PB” was added to the column, which was then centrifuged for another 
60 seconds. Flow-through was discarded. 
7. 750 µL “Buffer PE” was added to the column, which was again centrifuged for 60 
seconds. Flow-through was discarded. 
8. The column was centrifuged for a further 60 seconds. Flow-through was discarded. 
9. Lid of Eppendorf tube was removed with a scalpel and placed QIAprep spin column 
into the Eppendorf tube. 
10. 50 µL “Buffer EB” was added to the QIAprep spin column and left to stand for 60 
seconds. The plasmid DNA was then eluted by a further 60 seconds in the centrifuge. 
 
The ~50 µl of plasmid solution (~50 ng/µl) that resulted from this process was stored at either 
4°C or -20°C. 
 
Diagnostic Restriction digestion 
 
Ligation reactions were screened by diagnostic restriction BamHI (New England Biolabs) 
digests. These reactions were carried out using the following protocol: 
 
Reagent Volume (µL) 
10X reaction buffer 1 
100X BSA 0.5 (10X) 
Sample plasmid 8 
Restriction enzyme 0.5 (5 units) 
 
The results of these digests were analysed by agarose gel electrophoresis and visualised by 
UV light. A positive result would show a band of high molecular weight, corresponding to the 
plasmid vector (~5315 bp, pJF) and a smaller fragment (2754 bp, CC398 MTase), 
corresponding to the insert.  
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Phage lambda preparation 
 
Fresh dilutions of lambda (λ) phage were prepared using a Dryden lab λ phage stock. 
Comparing previous spot tests led to an estimate of the appropriate phage titre (plaque-forming 
units/ mL) to use for inoculations. A single colony of the E. coli  NM1261 strain was used to 
inoculate 5 mL of LB (supplemented with 0.2% Maltose, 10 mM MgSO4, 100 µg/ mL 
carbenicillin) in a 50 mL Falcon tube, and the culture was grown at 37 °C overnight, whilst 
shaking. 100 μL of λ phage (of the appropriate phage titre) was added to 200 μL of the E. coli 
overnight culture and incubated at 37 °C for 15 minutes. 3 mL of molten BBL top agar 
(maintained at 42 °C) was added to the cell mixture, which was then poured and spread evenly 
onto BBL bottom agar plates (supplemented with 100 µg/ mL carbenicillin). The plates were 
incubated at 37°C overnight. After the overnight incubation, a 5 mL pipette was used to flood 
the plate with 5 mL of phage buffer, which was left to soak for half an hour at room temperature 
(25 °C). After this incubation, it was assumed that the phage had been resuspended in the 
phage buffer, which was then carefully removed with a pipette and centrifuged at 1920 x g for 
10 minutes. A pipette was used to remove the top 4 mL of buffer, to which 50 μL of chloroform 
was added and mixed, in order to kill any residual bacterial cells. This was stored at 4 °C in a 
sealed, labelled container. Spot tests were used to identify the relative concentration of 





2.2. Gene sequencing and SMRT 
 
1 µL of primer (25 µM) was added to 5 µL of sample plasmid for each reaction. Sequence 
reads were reliable to at least 600 bp. All big dye reactions and subsequent gene sequencing 
was performed by Genepool (The University of Edinburgh), the results of which were analysed 
using FinchTV (FinchTV 2016) and ApE software.  
 
Bacterial Genome Sequencing 
 
Competent E. coli ER2791 cells were transformed with a plasmid containing the target MTase, 
and spread on a plate of LB agar (supplemented with 100 µg/mL carbenicillin). Plates were 
incubated at 37 oC, upside down, overnight. Genomic DNA was harvested and purified from 
the ER2791 cells in either of two methods, using the Wizard ® Genomic DNA Purification 
Kit (Promega) or Phenol/Chloroform extraction. 
 
This process was started by picking a successfully transformed colony into 5 mL of LB 
(supplemented with 100 µg/ mL carbenicillin), and incubating overnight at 37 oC, whilst 
shaking. Cells from the subsequent culture were separated into 1 mL aliquots and harvested 
by centrifugation at 2380 x g for 15 minutes. The Wizard ® Genomic DNA Purification Kit 
(Promega) was then used to lyse the cells and purify the genomic DNA. 
 
The protocol contained within the Wizard ® Genomic DNA Purification Kit (Promega) was 
carried out without significant alteration. The protocol describes a method for gram negative 
and gram positive bacteria. competent E. coli ER2791 cells are gram negative, and so the 
method was as follows:  
 
1. 1 mL cell pellet was resuspended in 600 µL of “Nucleic Lysis Solution”. 
2. Sample was the incubated in a water bath at 80oC for 5 minutes.  
3. Sample left on bench top to cool at room temperature. 
4. 3 µL of “RNase Solution” was added to sample, which was then inverted 6 times to 
mix. 
5. Mix incubated at 37oC for 60 minutes. 
6. Sample left on bench top to cool at room temperature. 
7. 200 µL “Protein Precipitation Solution” was added to sample, which was the vortexed 
carefully but at high speed. Protocol suggests vortexing for 20 seconds, longer was 
required, but was conducted with caution. 
8. Sample left on ice for 5 minutes. 
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9. Sample was centrifuged at 18320 x g for 5 minutes. 
10. Cell debris and protein created a pellet, but this did not adhere strongly to Eppendorf 
wall. Supernatant was carefully transferred to clean Eppendorf, containing 600 µL 
room temperature isopropanol. 
11. Sample was inverted several times to mix. Genomic DNA became visible. 
12. Sample was centrifuged at 18320 x g for 4 minutes. 
13. DNA created small white pellet. Liquid supernatant was carefully discarded. 
14. 600 µL 70 % ethanol added to Eppendorf, to wash pellet. Tube inverted several times 
carefully. 
15. Sample was centrifuged at 18320 x g for 2 minutes. 
16. Liquid supernatant was carefully discarded and pellet left to dry for 15 minutes with 
Eppendorf open, at room temperature on benchtop. 
17. 100 µL “DNA Rehydration Solution” added to pellet, and sample left overnight at 
4oC. 
 
Phenol/Chloroform extraction was carried out using the following protocol: 
 
A successfully transformed colony was picked from an agar plate and used to inoculate 15 mL 
of LB (supplemented with 100 µg/ mL carbenicillin), which was then incubated overnight at 
37 oC, whilst shaking. The subsequent saturated cell culture was centrifuged at 10967 x g for 
5 minutes at 4 oC. Whilst on ice, the supernatant buffer was separated from the cell pellet, 
which was then resuspended in 1100 µL Resuspension buffer (25% sucrose, 50 mM Tris pH 
8.0, 1 mM EDTA). 200 µL of fresh lysozyme (supplemented with 10 mg/ mL in 0.25M Tris 
pH 8.0) was added, mixed and then left on ice for 1 to 2 hours. 
 
After incubation on ice, the lysed cell culture was checked for viscosity. 800 µL of lysis buffer 
(1% TritonX-100, 50 mM Tris pH 8.0, 62 mM EDTA) and 200 µL 10% SDS was added and 
gently mixed with the cells, to complete the lysis.  
 
The lysed cell mix was the poured into a 50 mL centrifuge tube and 1 volume of phenol (2.5 
mL): chloroform (2.5 mL): isoamyl alcohol was added. This mix was then shaken until 
homogenous and centrifuged at 17136 x g for 10 minutes. The centrifuged sample had 
separated into different phases. 800 µL of the aqueous phase was drawn with a pipette and 
ejected into a 1.5 mL Eppendorf tube, to which was added an equal volume of phenol. This 
was then centrifuged at 17136 x g at 4 oC for 10 minutes. The aqueous phase was transferred 
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into a new Eppendorf, an equal volume of methylene chloride was added and then this was 
centrifuged at 17136 x g at 4 oC for 10 minutes. This step was repeated. The aqueous phase of 
this final step was transferred into a new Eppendorf tube, to which was added 1: 10 volume 5 
M NaCl and 0.7 volume isopropanol. A clean capillary tube was then used to hook the now 
visible fibres of DNA and twist them around the tube. The DNA could be taken out of the 
solution and washed by gently putting the capillary end into an Eppendorf containing cold 
70% ethanol. This was repeated with fresh 70% ethanol. The DNA was then left to dry on the 
capillary tube for 5 minutes and then dissolved in 400 µL of “Buffer TE” (Qiagen).   
 
Pacific Biosciences SMRT Sequencing 
 
Preparation of genomic DNA for SMRT sequencing by Pacific Biosciences was carried out in 
the laboratory of Dr. Richard Morgan (New England Biolabs). All consumables, including 
those specific to Pacific Biosciences SMRT sequencing, were supplied courtesy of Dr. Richard 
Morgan and New England Biolabs. 
 
The protocol for this procedure is specific to each experiment and was altered under expert 




2.3. Competent cells and Gene expression 
 
Cell lines used: 
 
Cell Line Cell Genotype Supplier 
BL21 F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) 
New England 
Biolabs 
DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR 
nupG Φ80dlacZΔM15 Δ(lacZYA-argF)U169, 




ER2796* λ-fhuA2 Δ (lacZ)r1 glnV44 mcr-62 trp-31 dcm-6 
zed-501::Tn10 hisG1 argG6 rpsL104 dam-16::Kan 
xyl-7 mtlA2 metR1 (mcrB-hsd-mrr)114::IS10 
New England 
Biolabs 
NM1261¥ hsdS (R+M+S-) λ(DE3) tetA cat Noreen Murray Lab 
*E. coli ER2796 cells were a gift from Dr Richard Morgan (New England Biolabs). 
¥E. coli NM1261 cells were a gift from Professor Noreen Murray (School of Biology, 
University of Edinburgh, UK) and are a derivative of NK311. The NM strains were 
converted to DE lysogens as described by McMahon et al., (2009). 
 
Chemically competent cells 
 
E. coli DH5α cells (Invitrogen) were made competent using the CaCl2 method (Sambrook & 
Russell 2001). 5 mL of LB was inoculated with a single colony of E. coli DH5α previously 
grown on an LB plate. The culture was grown at 37 °C for ~3 hours, with vigorous shaking. 
When the culture had reached an OD600 of 0.4, it was put on ice for 10 minutes. The cells were 
then harvested at 1520 x g for 15 minutes and the subsequent supernatant was discarded. The 
pellet was resuspended in 3 mL of ice-cold 80 mM MgCl2 20 mM CaCl2 and centrifuged at 
1520 x g for 10-15 minutes. This step can be repeated to improve competency. The supernatant 
was discarded and the pellet was resuspended in 200 µL of ice-cold 100 mM CaCl2. These 
competent cells were transferred to 50 µL aliquots in pre-chilled Eppendorf tubes and stored 
on ice. The efficiency of transformation increases four- to six fold during the first 12-24 hours 
of storage at 4 °C (Sambrook & Russell 2001), and as such, the transformation step can be 
carried out the next day. If the cells were not to be used within this time-frame, they were 
mixed with glycerol solution (Sambrook & Russell 2001) in a one to one ratio, frozen in a dry 




Transformation of Cells 
 
~3 μL of plasmid DNA (10 ng) was used to transform 50 μL of competent cells. The mixture 
was incubated on ice for 25 minutes. The cells were treated by heat shock at 42 °C for 45 
seconds, and then chilled on ice for 2 minutes. 400 µL of LB or SOC medium was added to 
the mixture, and the cells were incubated for 1 hour at 37 °C, whilst shaking. A pipette was 
used to transfer 50-100 μL of these cells onto an LB agar plate containing the appropriate 
antibiotic (100 µg/ mL carbenicillin). A sterile spreader was used to spread the cells evenly 




E. coli BL21 (DE3) competent cells were transformed with the target gene, which were first 
used to grow a small culture in 10 mL of LB broth (supplemented with 100 µg/ mL 
carbenicillin). Isopropyl-β-D-1-thiogalactopyranoside (IPTG) was added to 1 mM, to induce 
expression. The cells were incubated at 30 oC for 3 hours, in order to identify whether, and the 
conditions under which the genes would express. All cell cultures were grown in the presence 
of an antibiotic (carbenicillin 100 µg/ mL) appropriate to the resistance of the vector, for 
selection purposes.  
 
A further culture of the competent E. coli BL21 (DE3) cells, transformed with the target gene, 
was grown under the same conditions but on a larger scale (250 mL). This was to check 
whether the protein was soluble, and was performed by lysing the cells, centrifuging them and 
then analysing the cell-free extract by SDS-PAGE 
 
After the solubility of the target protein was known, a larger scale expression was carried out 













Large Scale Induction- Fermentation 
 
The fermentation was carried out by Dr. John White in the Fermentation Suite, School of 
Chemistry, The University of Edinburgh.  
 
A colony of successfully transformed E. coli BL21 (DE3) cells, containing the target gene was 
picked from an agar plate and used to inoculate 250 mL of LB (supplemented with 
carbenicillin 100 µg/ mL). This was then incubated at 37 oC for 5 hours, whilst shaking. The 
cell culture was then used to inoculate 10 L of LB (supplemented with carbenicillin 100 µg/ 
mL), which was then fermented in a Bioflo4500 (New Brunswick Scientific) fermenter at 37 
oC. When the A600 of the culture had reached 0.6, expression was induced by addition of IPTG 
to 1 mM, the temperature was reduced to 25 oC and left for 4 hours. Cell pellets were harvested 
by centrifugation at 7277 x g for 10 minutes and stored at -20 oC for future use. The process 
would normally yield 4 cell pellets of approximately 6 g. 
 
Baffle flask induction 
 
E. coli BL21(DE3) cells containing the target gene were used to inoculate 100 mL of LB 
(supplemented with carbenicillin 100 µg/mL). These cells were grown over night at 37°C, 
whilst shaking. The subsequent saturated cell culture was used to inoculate 3 to 5 L LB 
(supplemented with carbenicillin 100 µg/mL), in a 1 to 50 ratio. The LB was contained in 2 L 
baffle flasks, 1 L LB per flask. The cell cultures were then incubated at 37°C, whilst shaking, 
until the optical density at 600 nm had reached ~0.4. Heterologous gene expression was 
induced by the addition of IPTG (final concentration of 1 mM) and lowering the temperature 
to 30°C. The cells were then left for a further 3 hours before harvesting the cells by 
centrifugation (7277 x g for 10 min at 4°C). Cell pellets were stored at -20°C until required.  
 
It was established that with this method, the MS fusion was insoluble. Inducing expression of 
the MS fusion gene at 20 °C and then leaving the cells overnight (~16 hours) solved this issue, 






2.4. Protein Modelling, Purification and Analysis 
 
Genome Searches, Protein Sequence Alignments and Modelling: 
 
All genome searches were performed using BLAST (Altschul et al. 1990). All alignments were 
created using Clustal Omega (Sievers et al. 2011) and were edited using Boxshade 
(http://www.ch.embnet.org/software/BOX_form.html). Protein structures were downloaded 
from the RCSB Protein Data Bank (PDB) (Berman et al. 2000) and were edited using PyMOL 
(The PyMOL Molecular Graphics System, 2010). 
 
Protein models were created using Phyre2 online software (Kelley et al. 2015), and then edited 
in PyMOL. Secondary sequence prediction was performed using PsiPred (Jones 1999). 
 
Molecular weights, extinction coefficients and isoelectric points (pI) for proteins were 
estimated by inputting the predicted amino acid sequence of the target protein into Scripps 
Protein Calculator (http://protcalc.sourceforge.net/) 
 
Protein Purification  
 
All nickel affinity chromatography purifications were conducted using 20 mM sodium 
phosphate buffer with 500 mM NaCl (pH 7.5) unless otherwise stated. All proteins were 
expressed with a C-terminal HisTag unless otherwise stated. 
 
E. coli BL21 (DE3) cell pellets were resuspended in 1:10 (g: mL) buffer with 20mM imidazole 
and a dissolved EDTA-free protease inhibitor tablet (Roche). The suspension was then 
sonicated on ice for ~20 minutes (30 seconds on, 30 seconds off) and centrifuged at 7700 x g 
for 45+ minutes at 4 oC. The resultant supernatant was then loaded onto a pre-equilibrated 
Histrap FF crude 5 mL column (GE Healthcare), using a peristaltic pump at a flow rate of 100 
mL/hr. The flow-through was collected into a Falcon tube (50 mL). The column was then 
washed with 100 mL 20 mM imidazole buffer and the flow-through was collected. This was 
followed by an elution of the protein with ~10 mL of 500 mM imidazole buffer, discarding 
the first 3 mL and collecting the next 6 mL. This was then concentrated to ~4 mL, using a 20 
mL 30,000 MWCO Vivaspin (Sartorius). 
 
Further purification via size exclusion chromatography was carried out using a Superdex 200 
column (GE Healthcare) and buffer containing 20 mM Tris-HCl pH 8, 10 mM MgCl2, 500 
mM NaCl and 7 mM β-Mercaptoethanol at a flow rate of 10 mL/hr. The subsequent fractions 
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were analysed by SDS-PAGE using 4-12% gradient Bis-Tris gels (Invitrogen), run in 
NuPAGE® MES SDS Running Buffer (Invitrogen), from a 20 X stock solution. Those 
fractions containing the desired protein were concentrated and stored at -20 oC in 50% glycerol 
and 50% size exclusion buffer. The resulting concentration of the samples was obtained via a 
scan with a UV/Visible spectrometer.  
 
Purifications without a HisTag 
 
As they do not possess a HisTag and therefore could not be purified by nickel affinity, the 
CC398-1 HsdM and the CCHalfS were purified with an anion exchange step at the start, 
followed by size exclusion (as described above). The purification of the CCHalfS protein also 
involved a further step, using a heparin column. 
 
Anion exchange chromatography 
 
The pH of the buffer used in this purification was chosen on the basis of the estimated pI of 
the protein. 
 
A 0.45 μm sterile filter (Sartorius) and 10 mL syringe was used to filter the cell-free extract 
from ~5 g of lysed cells. The 55 ml DEAE column (Amersham Pharmacia) was previously 
equilibrated with buffer for 3 hours. The sample was loaded at a flow rate of 48 mL/ hour. 
After the crude extract was completely loaded onto the column, the column was washed with 
the buffer at a flow rate of 60 mL/ hour for an hour in order to remove any proteins that had 
not stuck to the column. The flow-through sample, loading wash and the buffer wash were 
collected and run on a SDS-PAGE gel to check for the absence of the target protein. Protein 
was eluted using a gradient mixture of 500 mL of 0 to 1.0 M NaCl in 20 mM Tris pH 8.0, 10 
mM MgCl2 ,7 mM β-Mercaptoethanol buffer. The gradient mixture was run overnight at a 
flow rate of 24 mL/ hour. The elution profile was detected using a UV-Vis spectrometer that 
recorded the absorbance at 280 nm. 10 µL samples of the fractions corresponding to the 
various peaks obtained were analysed by SDS-PAGE. Fractions containing the target protein 
were pooled and the concentration was determined by obtaining the absorbance at 280 nm on 








Heparin affinity column Purification 
 
The CCHalfS (without HisTag) truncated protein was purified with a heparin column step. 
After size exclusion, the protein sample was dialysed against 3 L of buffer (20 mM Tris pH. 
7.5, 10 mM MgCl2,7 mM β-Mercaptoethanol). The 120 X 20 mm heparin agarose column 
(Sigma Aldrich) was equilibrated with buffer at 50 mL/ hour for 3 hours. The sample was 
loaded at a flow rate of 50 mL/ hour. After the sample was loaded onto the column, the column 
was washed with the buffer at the same flow rate, until all unbound material had passed 
through the column and the UV absorbance at 280 nm had returned to its baseline. The flow-
through sample, loading wash and the buffer wash were collected and run on a SDS-PAGE 
gel to check for the absence of the target protein. Protein was eluted using a gradient mixture 
of 500 mL of 0 to 1.0 M NaCl in 20 mM Tris pH 7.5, 10 mM MgCl2 ,7 mM β-Mercaptoethanol 
buffer. The gradient mixture was run overnight at a flow rate of 25 mL/ hour. 10 µL samples 
of the fractions corresponding to the various peaks obtained were analysed by SDS-PAGE. 
Fractions containing the target protein were pooled and the concentration was determined by 
obtaining the absorbance at 280 nm on a Cary UV spectrometer. 
 
“Quick” Protein Purification 
 
Due to the apparent degradation of the HsdS subunit over time, a quicker purification and 
immediate subsequent assay were used. This was started with a nickel affinity chromatography 
purification as described above. The protein sample was eluted in buffer containing 500 mM 
imidazole, which was removed by buffer exchange. This was performed using a PD-10 
desalting column (GE Healthcare). The protein sample was eluted in ~6 mL and was 
concentrated to 2.5 mL, to be loaded on to the PD-10 column. 
 
The protocol included with the PD-10 column was carried out without any alteration, and was 
as follows: 
 
1. Cap was removed from the top of the column and the bottom tip was removed with a 
scalpel. The storage buffer was poured off and discarded. 
2. Column was held over empty beaker, to catch flow-through. 
3. Column was equilibrated with replacement buffer (20 mM Tris-HCl pH 8, 10 mM 
MgCl2, 500 mM NaCl and 7 mM β-Mercaptoethanol). Column was filled to the top 
with buffer, which was then left to drip through the column. This was repeated 4 times 
and each flow-through was discarded. 
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4. 2.5 mL of sample was applied to the column with a Pasteur pipette. Samples smaller 
than 2.5 mL were applied to the column, left to pass through the column and then 
supplemented with the equilibration buffer, to a final volume of 2.5 mL. Flow-through 
was discarded. 
5. Sample was eluted from the column with 3.5 mL of replacement/ equilibration buffer, 
and collected into a 6 mL 30,000 MWCO Vivaspin (Sartorius). 
 
The Sodium phosphate purification buffer was replaced with the buffer used for size exclusion, 
as described above. Sample concentration was determined by an A280 reading from a Cary50, 
and the sample was immediately used in an assay to determine presence of DNA cleavage 
activity. The remaining sample was concentrated in the Vivaspin (Sartorius) to an appropriate 
volume. 
 
Purification of the HsdR Subunit 
 
The HsdR, used in all plasmid and genomic DNA cleavage assays, was purified as described 
in Roberts et al (2013). The hsdR gene was ligated into the pRSFDuet vector, and induced 
with 1 mM IPTG. The protein was produced without a HisTag and purified by anion exchange 
chromatography, size exclusion chromatography and heparin agarose affinity 
chromatography. 
 
The hsdR gene from N315 (CC5) was amplified and cloned by Dr. John White (School of 
Chemistry, University of Edinburgh). Purification of the HsdR subunit protein was performed 




Protein samples were analysed by SDS-PAGE. 2X SDS loading buffer was added to each 
sample, which was then heated in a water bath for ~10 minutes at 90 °C. Samples were then 
centrifuged at 18320 x g for 4 minutes and ~5 μL from the top of the sample was loaded on to 
a NuPAGE® 4-12% Bis-Tris gel (Invitrogen). Following electrophoresis, gels were fixed and 
stained in a solution of methanol:acetic acid:water (3:1:6 by volume) containing 0.1% (w/v) 
Coomassie Brilliant Blue R250 for at least 30 min. The gels were destained in 30% (v/v) 








To give an indication of relative subunit yield, gel densitometry was performed. The free, 
online software, Image J, was downloaded, and used to visualise images of SDS-PAGE gels 
(Schneider et al. 2012). This software calculated the relative intensity of selected bands, the 
results from which were normalised by dividing the given value by the corresponding 
molecular weight of the protein. The values calculated by this process were compared, to give 
a ratio of subunit yield (see Appendix D for calculations). 
 
Protein Mass Spectrometry 
 
Protein samples of a range of dilutions were analysed by SDS-PAGE. Measures to achieve 
highest possible cleanliness were taken, such as clean gloves, fresh running buffer, and the gel 
tank was cleaned beforehand. Gel bands of appropriate size and density were excised from the 
gel using a scalpel, and put into a clean, dry Eppendorf tube. These were labelled and sealed 
with Parafilm® (Sigma Aldrich), and then sent for peptide fragmentation mass spectrometry 
analysis. Analysis was performed using a TripleTOF 5600 electrospray tandem mass 
spectrometer (ABSciex), by Dr Sally Shirran at the BSRC Mass Spectrometry and Proteomics 
Facility in St. Andrews. 
 
Gel Filtration HPLC 
 
Gel filtration HPLC was carried out as described in Atanasiu et al (Nucleic Acids Research, 
2002). All runs were carried out using a BioSep-SEC-S 3000 (Phenomenex) column and a 20 
mM Tris pH 6.5 buffer (20 mM MES, 10 mM MgCl2, 200 mM NaCl, 0.1 mM EDTA, 7 mM 
β-mercaptoethanol). This buffer was used to dilute the samples to a concentration of 
approximately 4 µM, 50 µL of which were then injected onto the HPLC system for each run. 
A flow rate of 0.5 mL/ minute was set for each run, which took approximately 10 minutes to 
complete. The absorbance at 280 nm was monitored and recorded by a data logger.  
 
First, the column was calibrated using several protein standards (Sigma Aldrich) of various 





Figure 19: Calibration curve for the BioSep-SEC-S 3000 HPLC column 
 
50 µL of the samples were injected into the 50 µL loop for each run. The rheostat on the HPLC 
was turned to bring the 50 µL loop into the system and allow the sample to load onto the 
column. Simultaneously the time logged by the data logger was noted and this was taken as 
the start of the run. The data gathered from this process was recorded and processed by using 











MS Fusion Cross-Linking  
 
Several different amounts of MS fusion protein (10, 20, 30, 40 and 50 µg) were used, in order 
to get the best chance of success. The protein solutions were diluted with Tris buffer, to a 
volume of 10 mL. To this was added 400 µL 25% (W/V) glutaraldehyde, to give a final 
concentration of 1% glutaraldehyde. This was incubated at room temperature for 2 minutes, 
after which the reaction was stopped with 250 µL of fresh 2M NaBH4, dissolved in 0.1M 
NaOH. This was incubated for 20 minutes in a fume cupboard. After incubation, 10 µL of 
10% (W/V) sodium deoxycholate solution (100 mg C24H40O4 in 900 µL ddH2O). 
 
The protein was then precipitated with 78% (W/V) trichloroacetic acid (TCA) in water. Small 
amounts of TCA were added incrementally, until the protein precipitate was visible. 
Approximately 270 µL TCA was added in total. This solution was then split into eight 
Eppendorf tubes and centrifuged at 18320 x g for 10 minutes at room temperature. The 
supernatant was then removed from these samples, two of which were selected and to one was 
added 12 µL SDS-PAGE buffer, to the other was added 25 µL. The blue SDS PAGE is turned 
yellow by the precipitate, but was returned to blue with the addition of ~1 µL of 1M Tris HCl 
pH 8.8. The samples were then heated at 90 oC for 10 minutes, left to cool and then centrifuged 




2.5. Enzyme Assays 
 
Assay to Determine Target Recognition Sites 
 
Assays to determine target recognition sites were carried out as described by Roberts et al., 
2013. Briefly, assays were conducted by incubating the enzyme under investigation with a 
library of plasmids. These plasmids were created by the insertion of known DNA sequences, 
ligated into the EcoRI- BamHI interval of pUC19. MTases under investigation were 
supplemented with R subunit from S. aureus CC5 and incubated with the plasmid library in 
separate reactions. Incubations were left for 12 minutes in a water bath set at 37 oC. The 
reactions were stopped by the addition of Proteinase K (Roche) and incubated in a 60  oC water 
bath for 25 minutes. Samples were then analysed by gel electrophoresis.  
 
Enzyme solutions were made up in the following way: 
 
Reagent Final Concentration (µM) 
1 X “Buffer 4” (NEB) N/A 
MTase 3 
R’ subunit 7.5 
 
Each reaction contained the following: 
 
Reagent Volume (µL) Final Concentration 
Nuclease-free H2O 36.75 N/A 
10 X Buffer 4 (NEB) 5.00 N/A (1X) 
100X BSA (NEB) 0.50 10 µg/µL (1X) 
Uncut plasmid 5.00 3.0 nM 
SAM 0.75 0.5 nM 
ATP 1.00 2 mM 
Enzyme 1.00 MTase- 60 nM 
R’- 150 nM 
 
The place at which Type I R-M systems cleave DNA is not at the recognition sequence. 
Therefore, a computer program called “RMsearch” (Ellrott et al. 2002) was used to identify 
the target sequences present in plasmids that had been cut by the enzyme and not present in 






The CC1-2 MTase was identified as having a recognition site on the pUC19 plasmid, and so 
every plasmid in the library showed signs of cleavage. This issue was resolved by digestion 
with 0.5 µL of BamHI (New England Biolabs) for 15 minutes at 37  oC, to linearise the plasmid 
library. The assay was then conducted as described above. Inserts in the plasmid library 
containing the recognition site for CC1-2 showed a smear on gel electrophoresis.   
 
The plasmids in the library were based on the DNA sequence of phage PhiED1 (a gift from 
Dr. Garry Blakely, The University of Edinburgh), with inserts from phage λ (a gift from Dr. 
Iain Murray, New England Biolabs). These plasmids are known as “Eddys” and are numbered 
sequentially from 1E to 20E. N.B. 3E and 8E are not included. The plasmid and specific insert 
sequences of the Eddys can be found in the supplementary data of Roberts et al. 2013.    
 
Assaying RM Fusion Enzymes for DNA Cleavage activity 
 
Assays of restriction activity in the engineered fusion protein were conducted in Eppendorf 
tubes containing the following: 
  
Reagent Volume (µL) Final Concentration 
Nuclease-free H2O 32 N/A 
10 X Buffer 4 (NEB) 5 N/A (1X) 
100X BSA (NEB) 1 10 µg/µL (1X) 
Uncut plasmid 5 3.0 nM 
Fusion protein 5 60 nM 
SAM (NEB) 2 0.5 nM 
± SAM and ± recognition site controls were conducted. 
 
A positive control was conducted in an Eppendorf tube containing the following: 
 
Reagent Volume (µL) Final Concentration 
Nuclease-free H2O 35 N/A 
10 X Buffer 4 (NEB) 5 N/A (1X) 
100X BSA (NEB) 1 10 µg/µL (1X) 
Uncut plasmid 5 3.0 nM 
CC398-1 protein 1 MTase- 60 nM 
R’- 150 nM 
SAM (NEB) 2 0.5 nM 
ATP 1 2 mM 




The mixtures were incubated at 37 oC for 30 minutes, then placed on ice for ≥3 minutes. 2 µL 
Proteinase K was added and the mixture was then incubated at 60 oC for 25 minutes. The assay 
mixture was subsequently analysed by agarose gel electrophoresis. 
 
Agarose gel electrophoresis analyses were conducted using 0.9% agarose gels in 130 mL 
buffer made from 50 X TAE stock solution. The stock solution was made up as follows: 242 
g Tris-HCl, 57.1 mL glacial acetic acid and 100 mL 0.5 M EDTA (pH 8). 
 
Genomic DNA Cleavage Assays 
 
Genomic DNA cleavage assays were conducted by incubating the enzyme with ~0.6 µg of E. 
coli ER2796 genomic DNA or λ phage DNA. MTases were supplemented with R subunit 
from S. aureus CC5 and incubated with the genomic DNA and λ phage DNA, in separate 
reactions. Incubations were left for 12 minutes in a water bath set at 37 oC. The reactions 
were stopped by the addition of Proteinase K and incubated in a 60 oC water bath for 25 
minutes. Samples were then analysed by gel electrophoresis.  
Each reaction contained the following: 
 
Reagent Volume (µL) Final Concentration 
Nuclease-free H2O 36.75 N/A 
10 X Buffer 4 5.00 N/A (1X) 
100X BSA (NEB) 0.50 10.0 µg/µL (1X) 
Genomic DNA 5.00 1.2 µg/µL 
SAM (NEB) 0.75 0.5 nM 
ATP 1.00 2 mM 
Enzyme 1.00 MTase- 60 nM 
R- 150 nM 
 
In vivo R-M assays 
 
Virulent unmodified bacteriophage λ (λv.o) were provided by Professor Noreen Murray. The 
letter "v" indicates that the phage are virulent and unable to form lysogens. 
 
Initially, spot tests were performed to detect the presence of restriction or modification activity 
in the wild-type, truncated and fusion Sau1 enzymes. The first stage of this procedure involved 
transforming E. coli NM1261 (restriction and modification deficient) cells with a plasmid 
containing the desired Sau1 gene. The cells were also transformed with the empty pJF plasmid, 
to act as a control. One colony from each type of the subsequent transformants was then used 
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to inoculate 5 mL of LB (100 µg/ mL carbenicillin), in a 50 mL Falcon tube. This was left 
overnight, shaking at 37 oC. 200 µL of the overnight cultures was mixed with 3 mL of molten 
BBL “Top” agar (held at 45 oC) and then poured over the surface of a BBL agar plate  
(100 µg/mL carbenicillin). This was left for approximately 30 minutes to set, creating ±MTase 
plates, on which unmodified virulent λ phage was spotted. 5 µL of phage solution was spotted 
at dilutions from 10-1 to 10-8. The plate was left to dry and then placed upside down in an 
incubator overnight at 37 oC. The result of this process was plates covered in a bacterial lawn, 
in which phage plaques had formed. The concentration of the plaques was directly proportional 
to the concentration of the initial phage concentration. The spot at the dilution at which the 
plaques were few and separate was ascertained and single plaques were picked from this with 
a cut pipette tip, and placed in 70 µL phage buffer. 10 µL of chloroform was then added to the 
buffer and the mix was left at 4 oC for at least 10 hours. Phage that had been passaged through 
cells containing the empty plasmid were considered unmodified, whilst phage that had been 
passaged through cells containing the target gene were potentially modified.  
 
NM1261 cells containing the pJF plasmid with the target gene, were transformed with either 
an empty pRSFduet plasmid or the plasmid with the CC5 hsdR gene. Subsequent transformants 
were used to produce an overnight culture by the method described previously. 200 µL of this 
culture was then used to inoculate 3 mL of molten BBL “Top” agar, the mix was poured over 
a plate of BBL “Bottom” agar (with 100 µg/ mL carbenicillin, 50 µg/ mL kanamycin) and left 
to set. This produced two types of plate, a + and a – HsdR, on which the retrieved phage was 
spotted. The phage mix was centrifuged at 18320 x g for 3 minutes and used to make dilutions 
from 10-1 to 10-5. 5 µL of each dilution of the unmodified phage, starting from neat solution, 
was spotted onto the surface of the plate. The plate was left to dry and then placed upside down 
in an incubator overnight at 37 oC. The result of this process was a plate, covered in a bacterial 
lawn, in which phage plaques had formed. If the +R strain of NM1261 cells were exhibiting 
restriction activity, there would be “cut-back” of the phage plaques. This is to say that there 
would be at least one order fewer phage plaques on the +R plates, relative to the –R plates. 
The same process was used to identify modification activity. The potentially modified phage 
was spotted in the same fashion. Modified phage would show little to no degree of cut-back 







Efficiency of plating (E.O.P.) assay 
 
To establish the efficiency of plating (E.O.P.) of the modified and unmodified λ phage, whole 
plate assays were conducted. This aimed to produce plaques across a whole plate, which could 
be counted by eye. Restriction activity was tested by plaque formation with the +R strain, 
relative to the –R strain, using unmodified phage. Methylation activity was tested by plaque 
formation with the +R strain, relative to the –R strain, using modified phage. 
 
The titre at which the modified and unmodified phage produced separate plaques in the spot 
tests indicated the appropriate dilution of the new stock phage to use in whole plate assays, 
using the ±R strains. The phage stock was diluted accordingly and mixed with 200 µL of an 
overnight culture of cells containing the target gene. The mixture was added to 3 mL of molten 
BBL “Top” agar (held at 45 oC) and then poured over the surface of a BBL agar plate 
(supplemented with 100 µg/mL carbenicillin). This was left for approximately 30 minutes to 
set and then placed upside down and left to incubate overnight at 37 oC. The following day, 
the plates were removed from the incubator and the individual plaques were counted. The 
assay was performed three times, with at least 50 phage plaques per plate. The E.O.P. for the 
modified and unmodified phage λ was determined using the titre in R proficient strains 
(NM1261 r+) relative to the titre in R deficient strains (NM1261 r-), and was calculated using 
the following equation: 
 

















3.1. Staphylococcus aureus Sau1 Methyltransferases 
 
Several of the Sau1 MTases have been cloned, expressed and the subsequent recombinant 
proteins purified successfully by the Dryden group (Chen et al. 2010). These recombinant 
proteins were produced with hexahistidine and GFP tags, from a pJFHisEGFP vector plasmid. 
With a view to using this plasmid to clone new fusions and other, longer gene sequences, it 
was decided to remove from it the extra GFP sequence. Although the Sau1 enzymes had been 
purified and assayed with success, it was also thought that removing this relatively large tag 
might have a positive effect on the activity of the subsequent recombinant proteins. A 
thermocycler was used to perform the PCR to eliminate the GFP sequence and produce a 
vector with a single C-terminal HisTag. This vector was called pJF.  
 
There is a very high degree of conservation between the Sau1 R-M systems from different 
strains of Staphylococcus aureus. In particular, the MTase subunits from these systems only 
differ to any significant extent in their target recognition domains (TRDs). It is this aspect that 
gives rise to their difference in DNA sequence recognition. Four MTases from three S. aureus 
lineages (clonal clusters), CC1-1, CC1-2, CC5-1 and CC133-771, had been studied by the 
Dryden lab for their investigation into R-M systems. Alignment of the amino acid sequences 
of these MTases (along with that from a CC398 strain, work on which is described later in this 
thesis), shows the degree of sequence conservation between them (Fig. 20). The almost 
complete coverage between the HsdM subunits (conserved residues are highlighted in green) 
and the sequence divergence in the TRDs of the HsdS subunits (conserved residues are 
highlighted in yellow) is notable. In each case, between the two TRDs is the central conserved 
region (red outline), which corresponds to the random nucleotides (or N number) in the DNA 
target. This amino acid spacer sequence is highly conserved across all five examples, as it is 
across all the Sau1 MTases. The published data from the Dryden lab describes the different 
DNA recognition sequences of these MTases and specifically, which TRD corresponds to 
which half of the bipartite sequence (Table 1) (Roberts, et al. 2013). It should also be observed 
that MTases CC1-1 and CC1-2 (two MTases from CC1) share a high degree of similarity in 
















Figure 20: An annotated alignment of the amino acid sequences of five Sau1 HsdM and HsdS 
subunits from four different strains of S. aureus. Conserved residues in the HsdM are highlighted in 
green, whilst those in the HsdS are highlighted in yellow. Residues with chemically similar side-
chains are highlighted in grey. The central conserved region is indicated by the red outline, and 




HsdS Origin Strain TRD1 N number TRD2 
CC1-1 CCAY 5 TTAA 
CC1-2 CCAY 6 TGT 
CC5-1 AGG 5 ATC 
CC133/771 CAG 5 RTGA 
CC398-1 ACC 5 RTGA 
Table 1: The DNA recognition sequences of the separate Sau1 
TRDs of five different Type I MTases. 
 
The four sets of Sau1 genes encoding the CC1-1, CC1-2, CC5-1 and CC133-771 MTases, 
were ligated into vector pJF, which was then used to transform competent E. coli DH5-α cells. 
Plasmid DNA was then purified from cultures of these cells and used to transform competent 
E. coli BL-21 (DE3) cells. The eight (four M, four S) genes were over-expressed and the 
recombinant proteins were purified successfully (Fig. 21).  
 
 
Figure 21: SDS-PAGE gels showing samples from the purification process of four Sau1 MTases. 
 
By observing each protein in solution, it could be seen that the purified Sau1 MTases no longer 
possessed a GFP tag. Comparisons with the previously purified GFP-tagged proteins showed 




Figure 22: Visual comparison of GFP-tagged (A) 
to non-tagged (B) recombinant Sau1 MTases. 
 
The proteins were then used in an assay to identify restriction activity. To each MTase was 
added HsdR subunit protein from the N315 (CC5) strain of S. aureus, and these were incubated 
with a plasmid (“Eddy”) library (see Materials and Methods for more details). The results were 
then visualised on a transilluminator. The pattern of absence and presence of DNA cleavage 
identifies the recognition sequence of the enzyme, via the computer programme, RMSearch 
(Ellrott et al. 2002). Each protein was shown to possesses restriction activity and the correct 




Figure 23: Gel electrophoresis analysis of a plasmid cleavage assay of the CC1-1 MTase. Linearised 
(cleaved) plasmid species appears on the agarose gel, between supercoiled species (below) and 




The Sau1 CC1-1 MTase from S. aureus CC1 was incubated with the Eddy library. The 
results showed that it had cleaved Eddys 5E, 10E and 12E (Fig. 23), which is supported by 
the previously published data from the Dryden lab.  
 
 
Figure 24: Gel electrophoresis analysis of a plasmid cleavage assay of the CC1-2 MTase. 
 
Previous data from the Dryden lab had shown that the DNA recognition sequence for the Sau1 
CC1-2 MTase occurs in the pUC19 plasmid, and so the restriction active CC1-2 MTase would 
cleave every member of the Eddy library. It had also been discovered that this issue can be 
resolved by linearising the plasmids beforehand. The CC1-2 MTase was then incubated with 
the linearised Eddy library. Gel electrophoresis showed that the Eddys had been linearised but 
that some had been cleaved further and produced a smear. It could be concluded from this that 
the smears were created by the action of the CC1-2 MTase, and that it had therefore cleaved 
Eddys 6E, 7E, 14E and 15E (Fig. 24). This result is supported by the previously published data 
from the Dryden lab. 
 
 
Figure 25: Gel electrophoresis analysis of a plasmid cleavage assay of the CC5-1b MTase. 
 
The Sau1 CC5-1b MTase from S. aureus CC5 was incubated with the Eddy library. The results 
showed that it had cleaved Eddys 1E, 2E, 5E, 6E, 7E, 9E, 10E, 11E, 13E, 15E, 16E 17E, 19E 





Figure 26: Gel electrophoresis analysis of a plasmid cleavage assay of the CC133-771 MTase. 
 
The Sau1 MTase from S. aureus CC133-771 was incubated with the Eddy library. The results 
showed that it had cleaved Eddys 1E, 6E, 9E and 14E (Fig. 26). This too corresponded with 
the expected results. 
 
Results showed successful purification and assay of the MTases, and that removal of the GFP 
did not inhibit either aspect. Due to the nature of the assay, it was not possible to get an 
indication of any effect on reaction rate. 
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3.2. Staphylococcus aureus CC398-1 Methyltransferase 
 
The Sau1 MTase from an S. aureus CC398 strain had been purified and assayed successfully 
by the Dryden lab, but had not been fully characterised. Like the other Sau1 MTases described 
here, this recombinant protein had originally been purified with an attached GFP tag. This was 
removed by ligating the gene into vector pJF. 
 
 
Figure 27: Plasmid map of the CC398-1 MTase genes in vector pJF. 
 
A plasmid map of the CC398-1 MTase in pJF shows how the genes were ligated into the 
vector, between two BamHI restriction sites (Fig 27). This was the case whenever the pJF 
vector was used in this work. A potential problem with this cloning strategy is that the genes 
could be ligated backwards into the vector and would therefore not express. A straightforward 
screening technique to identify succesful ligation reactions was developed, and involved the 
culturing of a high number of successful transformants of the ligation reactions, purifying the 
plasmid DNA from these and then subjecting that to diagnostic BamHI digests. Subsequent 
analysis by gel electrophoresis identified the presence of an insert in the vector. Selected 
positives from this stage were sent for gene sequencing, to verify their sequence and determine 
the orientation of the genes.  
 
A 3D model of the CC398-1 MTase was generated by the free, online software, Phyre2 (Kelley 
et al. 2015). This program models the query amino acid sequence against the sequences of 
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similar proteins of known structure (see Appendix B for matched sequences) . The model of 
the CC398-1 MTase (M1S1 form) shows both constituent HsdM and HsdS subunits (Fig. 28). 
The two TRDs (highlighted in orange and yellow) of the HsdS subunit can also be observed 
clearly. The long α-helices separate the two TRDs, and correspond to the spacer sequence (N 
number) between each part of the bipartite DNA recognition sequence. The results from Phyre2 
stated that the position of 198 amino acids of this model were predicted ab initio, and that this 
is unreliable. However, there was over 90% confidence in 86% of the structure (1234 residues), 
and so this model does give a very good impression of the structure of the CC398-1 MTase. 
 
Figure 28: Amino acid sequence of the CC398-1 MTase (A) and 3D model of the protein (B). 
The HsdM is highlighted in green, TRD1 in yellow and TRD2 in orange. 
 
Positives from the ligation reactions, with the correct gene sequence (as confirmed using 
FinchTV and ApE software) could then be used for expression tests. One of these was selected 
and used to transform E. coli BL21 (DE3) cells, a single colony of which was then used to 
create 4 L of culture in LB. Gene expression was induced with IPTG and left for 3 hours. The 
cells in this culture were then pelleted into two separate aliquots, one of which was 
resuspended in purification buffer and then sonicated. The sample was then centrifuged and 
the subsequent cell-free extract was passed over a nickel affinity column, and the target 
proteins were eluted with imidazole. The eluted protein solution was then purified further by 
gel filtration chromatography. Samples from selected fractions, along with samples from the 





Figure 29: SDS-PAGE analysis of the nickel affinity purification of the CC398-1 MTase. 
 
SDS-PAGE analysis showed the target protein had expressed well and had then been purified 
(Fig. 29). Protein bands at around the 47 kDa mark (yellow box) corresponded to the HsdS 
subunit with an additional HisTag. Protein bands at around the 59 kDa mark (green box) 
corresponded to the HsdM subunit. Gel filtration fractions 17 and 18 appeared to contain a 
significant level of contaminating protein, whilst fractions 16, 19 and 20 were considered to 
be of usable purity. These samples of greater purity were pooled and concentrated to 
approximately 350 µL, and an equal amount of glycerol was added. The final concentration of 
protein in the solution was calculated to be 20.2 µM, in ~700 µL. The result of this purification 
was 3.7 mg of the target protein from a 2 L bacterial cell culture. This final solution was 
analysed by SDS-PAGE to determine its purity (Fig. 30) 
 
 
Figure 30: SDS-PAGE analysis 




Active MTase complexes have a M2S1 stoichiometry. The HisTag attached to this recombinant 
protein occurs at the C-terminal of the HsdS subunit and as such, this method of purification 
relies on the strong affinity between the HsdM and HsdS subunits. It is the S subunit that 
adheres to the nickel column, and the M is separated from the rest of the cell-free extract by 
association with the S. Therefore, in order to purify the greatest amount of active MTase, there 
should be a large amount of HsdS subunit protein and twice as much HsdM protein. The SDS-
PAGE gel showed that there was a large amount of HsdM protein (relative to HsdS) but that 
there seemed to be a relatively low amount of HsdS protein. This would mean a reduced 
amount of active MTase, but would also be a surprising result given the location of the HisTag. 
To support this assumption, gel densitometry was performed using the free, online software, 
Image J (Schneider et al. 2012). An image of an SDS-PAGE gel can be opened in the software, 
which can then calculate the relative density of selected bands. However, larger proteins bind 
more Coomassie stain than smaller proteins, and so band intensity is not directly proportional 
to the amount of the protein. As the bands in question correspond to M and S proteins, which 
are of different sizes, the values calculated by Image J were normalised by dividing by the 
molecular weights of the proteins. This process was carried out using four separate sets of the 
M and S protein bands, the values from which were used to obtain an average. Standard 
deviation from these values was also calculated, in order to obtain an idea of the margin of 
error (see Appendix D). The average value for the M subunit was 0.2660 ±0.04, whilst the 
average value for the S subunit was 0.1270 ±0.05. Normalising these values gave an M:S ratio 
of 2.09 (±0.31):1 (±0.39). This result indicates that wild-type CC398-1 MTase is being purified 
successfully, with the correct stoichiometry.  
 
 
Figure 31: CC98-1 MTase with GFP (A)  




By comparing this MTase protein solution with that of the recombinant, GFP-tagged CC398-
1 MTase, it was observed that the new CC398-1 MTase did not possess the GFP tag (Fig. 31). 
Gel filtration HPLC was used to provide further information about the stoichiometry of the 
MTase and the purity of the protein solution (Fig. 32).  
 
 
Figure 32: Graph of UV absorbance at 280 nm, against elution 
volume. Data taken from gel filtration HPLC of 4 µM CC398-1 MTase. 
 
Using a calibration curve (see Materials and Methods) and the elution volume (~3.1 mL) of 
the MTase from the HPLC column, an estimate of the molecular weight of the protein can be 
calculated. Carrying out this process gives a result of ~210 kDa. This value does not agree 
with the expected molecular weight of the CC398-1 MTase is ~166 kDa. Previous work in the 
Dryden lab has shown that the complete Sau1 MTases do not pass through the HPLC column 
in the manner that is expected, and so the exact figure calculated for the molecular weight is 
not reliable. However, the data retrieved from the process can be used qualitatively, and 
compared with data from other MTases. The HPLC trace from the CC398-1 MTase indicated 
that the protein solution was relatively pure, as it showed one neat and sharp peak 
corresponding to the target protein. After this peak, there was a sudden decrease in absorbance, 
leading to a second peak at an elution volume of around 4.5 mL. This was due to a change in 
the refractive index, caused by the glycerol in the protein solution. The trace for this wild-type 





Figure 33: Normalised elution profiles of decreasing concentrations 
of the CC398-1 MTase. 
 
By comparing the elution profiles of decreasing concentrations of the CC398-1 MTase, the 
stability of the enzyme’s quaternary structure can be observed. The concentration of the 
protein solutions was halved successively (starting from 4 µM), and analysed by gel filtration 
HPLC (Fig. 33). A peak corresponding to the enzyme in its natural state occurred at an elution 
volume of approximately 3.1 mL, as observed previously. With decreasing concentration, a 
shoulder on the right side of the peak begins to form. This occurs when an M subunit 
dissociates from the M2S1 complex, resulting in the M1S1 inactive form. The preparation of 
protein solution used in this investigation was reliably pure. It could be seen that this wild-
type enzyme complex was remarkably stable under the experimental conditions (Tris pH. 6.5), 
until the curve shifts at a concentration of 0.25 µM and below. As the signal produced by this 
low concentration is more susceptible to the background signal of the system, it is difficult to 
determine whether the curve’s shift is due solely to the loss of the second HsdM. However, it 
could be stated that the enzyme complex was stable to at least a concentration of 0.25 µM.  
 
To assess the activity of the CC398-1 MTase, a restriction assay with the Eddy library was 
carried out. Samples from this assay were analysed by agarose gel electrophoresis and 
visualised by UV light. The agarose gel showed a clear and precise pattern of cleavage (Eddys 
5E, 6E, 7E, 12E and 14E) that corresponded to the data previously obtained by the Dryden lab 





Figure 34: Gel electrophoresis analysis of a plasmid cleavage assay of CC398-1 MTase. 
 
This result showed that the CC398-1 MTase, without EGFP, had restriction activity in vitro. 
In vivo studies were used to identify whether this MTase also exhibited modification activity 
(Fig. 35). The CC398-1 MTase gene in pJF vector was used to transform E. coli NM1261 
cells. These cells were then transformed with either the empty pRSFDuet plasmid (-R), or the 
pRSFDuet plasmid containing the CC5 hsdR (+R). 
 
 
Figure 35: Diagram of spot test dilutions (A). In vivo spot test assay of the CC398-1 MTase (B). “-R” 
plates describe bacteria lacking the hsdR subunit gene, whilst those with “+R” do possess it. pJF is an 
empty plasmid, which would otherwise carry the MTase genes. pRSFDuet is an empty plasmid, which 
would otherwise carry the hsdR gene. U/Mλ denotes phage that are unmodified. CC398-1λ denotes 
phage that have survived bacteria containing the CC398-1 MTase genes, and are therefore expected 
to possess the pattern of DNA methylation specific to the CC398-1 MTase. 
 
When these cells also contained the gene for the CC5 HsdR subunit, they showed evidence of 
restriction activity against unmodified λ phage. Unmodified λ phage was used to infect 
NM1261 cells that contained the CC398-1 MTase, and the subsequent phage plaques were 
used infect NM1261 cells that contained both the CC398-1 MTase and the CC5 R genes. In 
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this instance, there was little evidence of restriction activity. It can be inferred from this result 
that specific sites along the λ phage DNA had been modified by the CC398-1 MTase, and that 
these sites were therefore protected from restriction by the restriction complex containing this 
CC398-1 MTase.  
 
Spot tests indicated that the CC398-1 MTase was modifying λ phage with what appeared to 
be complete efficiency (E.O.P.= ≥1), and could restrict the phage by at least 3 orders (from 4 
to 1 full spots of phage plaques). However, given the difficulty inherent in resolving plaques 
of such a small size, more accurate data was obtained from whole plate assays. Several rounds 
of whole plate assays were conducted and the phage plaques were counted (Table 2). 
 
CC398-1 MTase In vivo Assay Results: 
 
Phage Type Phage Dilution Phage Volume R-M System Number of Plaques 
Unmodifiedλ 10-5 100 µL None 1516 
10-3 40 µL CC398-1 + R 910 
10-6 100 µL None 263 
10-4 80 µL CC398-1 + R 644 
10-6 100 µL None 238 
10-4 50 µL CC398-1 + R 1898 
10-6 100 µL None 219 
10-5 50 µL CC398-1 + R 256 
10-6 100 µL None 208 
10-5 50 µL CC398-1 + R 314 
398-1λ 10-6 50 µL CC398-1 80 
10-6 50 µL CC398-1 + R 79 
10-6 50 µL CC398-1 74 
10-6 50 µL CC398-1 + R 70 
10-6 50 µL CC398-1 135 
10-6 50 µL CC398-1 + R 89 
10-6 50 µL CC398-1 90 
10-6 50 µL CC398-1 + R 96 
Table 2: Raw data collected from several rounds of full plate in vivo assays of the CC398-1 MTase. The 
table shows ±R pairs, which are the results from the experiment (+R) and control (-R), and the 
subsequent repeats. The plaque numbers cannot be compared without adjusting for volume and 
dilution. 
 
The E.O.P. of the unmodified λ phage against the restriction active 398-1 MTase was 0.15 (see 
Appendix E for calculations). This value shows that the restriction complex is active. 
However, the high degree of error (±0.11) highlights that there is significant variability, and 
so a measure of activity is not possible. The E.O.P. of the 398-1 modified λ phage was 0.88. 
This agrees nicely with the value estimated from the spot tests of ≥1. It indicates that this is a 
prolific MTase, as it is modifying the phage such that most are surviving restriction. 
Nevertheless, there is also a high degree of uncertainty (±0.27) for this value. 
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3.3. CC398-1 HsdM 
 
An HsdM to HsdS fusion protein had been created by the Dryden lab, using genes from EcoKI 
(Roberts et al., 2012). This fusion showed both methylation and restriction activity in vivo, but 
to elicit activity in vitro, stoichiometric amounts of purified HsdM subunit protein needed to 
be added. This was in order to establish the M2S1 active complex. It was assumed that an MS 
fusion of the CC398-1 MTase (work on which is presented later in this thesis) would also need 




Figure 36: Plasmid map of the CC398-1 hsdM in vector pJF. 
 
A plasmid map of the CC398-1 hsdM shows the gene ligated into the vector pJF in the manner 
previously described (Fig. 36). When observing the map, the absence of a HisTag sequence at 
the 3’ of the hsdM gene should be noted. The lack of a HisTag on the protein product of this 
gene means that it is different from the other proteins described in this work. Strictly speaking, 
the HisTag sequence has been retained on the plasmid, but a stop codon introduced 
immediately upsteam prevents its transcription. The HsdM subunit was to be used to 
supplement an MS fusion protein, a process which could be affected by the presence of a 
HisTag. The hsdM gene would express protein without a tag. This could not therefore be 




The hsdM sequence was verified by Sanger sequencing and the plasmid was then used to 
transform E. coli BL21 (DE3) cells. A small scale induction (250 mL LB) was carried out to 
determine the solubility of the HsdM protein. The subsequent cell culture was sonicated and 
the cell-free extract was analysed by SDS-PAGE (Fig. 37).   
 
 
Figure 37: SDS-PAGE analysis of samples from a 
small scale induction of the hsdM gene. 
 
The SDS-PAGE gel showed that the hsdM gene had expressed. A strong band at around 59 
kDa in the cell-free extract sample corresponded to the size of the HsdM, and indicated that 
the protein was largely soluble under these conditions. On the basis of this result, a larger scale 
induction was performed, in order to purify the HsdM protein. The estimated pI of the HsdM 
protein was 4.79, and so the cell-free extract from 2 L E. coli cell culture was passed through 
an anion exchange column. The samples from the subsequent fractions were subjected to SDS-
PAGE analysis (Fig. 38) 
 
 
Figure 38: SDS-PAGE analysis of samples 
from the anion exchange purification of the HsdM protein. 
 
Large bands at the 59 kDa mark on the SDS-PAGE gel indicated that the HsdM protein began 
to elute from the column at a NaCl concentration of 240 mM. The gel showed that the majority 
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of HsdM protein was contained in Fractions 20 to 24. Fractions 19 to 22 were pooled and 
subjected to purification by size exclusion. Samples from the size exclusion step were analysed 
by SDS-PAGE (Fig. 39). 
 
 
Figure 39: SDS-PAGE analysis of samples  
from the size exclusion purification of the HsdM protein. 
 
SDS-PAGE analysis of fractions from the size exclusion purification showed a large amount 
of relatively pure protein was contained in Fractions 18, 19 and 20. These fractions were 
pooled and concentrated, and the concentration of the solution was estimated by UV/vis 
spectroscopy. From this purification of 2 L of cell culture, the estimated yield of HsdM protein 
was 20.6 mg. 
 
 
Figure 40: Purified sample of HsdM. 
 
The mixed sample was then subjected to SDS-PAGE to check the relative purity of the HsdM 
protein (Fig. 40). The sample showed very little sign of contamination, and as such the 





Figure 41: Gel filtration HPLC trace of the HsdM protein. 
 
The gel filtration HPLC data (Fig. 41) supports the other work on the HsdM protein. A single, 
tight peak on the trace suggests the protein solution was relatively pure. The elution volume 
of the HsdM protein was 3.48 mL. This value can be used to calculate a molecular weight of 
~60.3 kDa, which is close to the expected molecular weight of the protein (59.4 kDa). This 
also gave confidence that this experiment was providing reliable results.  
 
Having successfully purified the CC398-1 HsdM, a Phyre2 model was created of the protein, 
in order to get an impression of its structure (Fig. 42). 
 
 
Figure 42: Model of the CC398-1 HsdM (A). A close-up image of the protein (B). The active site 






The model showed the SAM binding motif towards the N-terminal of the protein, co-ordinated 
by F171, G182 and G190. These residues make up the triangular SAM binding pocket in the 
protein, shown in orange. Towards the C-terminal is the MTase active site, coloured red. P302, 
P303 and Y304 are the key catalytic residues, and form a β-strand and coil, amongst a largely 
α-helical domain. The model also possesses a long C-terminal tail. In the model of the M1S1 
structure, this tail interacts with the first TRD of the HsdS. This is perhaps how the TRDs are 
stabilised by the HsdM. 
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3.4. CC5 HsdR to CC398-1 MTase Fusion 
 
Kennaway et al. (2012) proposed that there is an evolutionary link between Type I and Type 
II R-M systems. That the types share important characteristics has led to the suggestion that 
removing the motor domains from a Type I system would create a pseudo-Type II system, 
similar to the structures of the Type IIG and IIB system subtypes. The difficulty with testing 
this theory is in estimating to where in the amino acid sequence the Type I HsdR subunit 
should be truncated. The sequence needed to be altered in order to disable its DNA 
translocation activity but retain its nuclease activity.  
 
As there is not yet a crystal structure of the Sau1 HsdR subunit from the N315 (CC5) strain of 
S. aureus, a model was created using Phyre2 online software, using the EcoR124I HsdR as a 
template (Fig. 43) (See Appendix B for further details). This was used in conjunction with 
results from an online secondary sequence prediction software called PsiPred (Jones 1999), 
to identify appropriate regions to which the protein could be shortened (Fig. 44).  
 
 
Figure 43: Model of the CC5 Sau1 HsdR Subunit (A), with the nuclease domain highlighted in yellow, the 
two motor domains in cyan and purple, and the helical domain coloured green. A close-up view of the 
nuclease active site (B). The conserved α-helical and β-strand structural motif is coloured red, with the 
key Pro-Asp-Lys catalytic motif in blue. 
 
The model of the CC5 HsdR gave a good impression of the domain organisation of the protein. 
It indicated that in order to create a successful R to M fusion, the nuclease (yellow) region of 
the HsdR should be retained. However, it is unclear whether truncating the protein to this point 
would result in the correct folding of the protein. With this in mind, sites to which the enzyme 
would be truncated were deemed appropriate on the basis of maintaining its predicted 
secondary structure. In simple terms, these peptide sequences were shortened, up to the end of 




































































Over the course of this project, a total of 13 ΔhsdR to hsdM gene fusion constructs were made. 
A cartoon representation of the different sequence lengths was drawn to give a basic 
impression of the fusion proteins, and their relative difference in peptide sequence length (Fig. 
45). From this diagram, it can be seen that the R subunit (Red) is joined directly to the M 
subunit (Green), and that the S subunit (Yellow) is not connected to this fusion. This is 
because, as with all the other wild-type Sau1 RM systems, the HsdS protein is translated as a 
separate peptide. 
 
Figure 45: Diagram to show the relative sizes of the R to M fusion genes. The title “RM” 
denotes an HsdR to HsdM fusion. “CM” denoted that the fusion was created by Chris 
McLean. “EB” denotes that the fusion was created by Edward Bower. 
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Two of the RM fusions, RM_CM_1 and RM_CM_2 (2315 and 2325 bp fusion genes 
respectively), were created at the beginning of this study. All work on these fusions was 
conducted by Chris McLean but is presented here to give a complete view of the project so 
far.  
 
The RM_CM_1 and RM_CM_2 genes were ligated into vector pJFMSEGFP. The product of 
this reaction was used to transform competent E. coli DH5-α cells. The plasmid DNA was 
purified from these cells and then used to transform competent E. coli BL-21 (DE3) cells. A 
small scale IPTG induction of these cells was conducted to test whether the fusion genes would 
be expressed. 1 mL samples from these cells were taken before induction, 3 hours after 
induction and 22 hours after induction. These samples were then subjected to analysis by SDS-
PAGE (Fig. 46).  
 
 
Figure 46: SDS-PAGE analysis of the small scale induction of 
the RM_CM_1 and 2 genes. The red boxes indicate the 
presence of over-expressed protein of the expected 
molecular weight of RM_CM_1 and 2. 
 
The results of this analysis indicated a successful expression of the two different fusion genes. 
On this evidence, a large scale induction by fermentation was carried out, in order to produce 
a large amount of the fusion protein. The subsequent recombinant protein possessed GFP and 
hexahistidine tags, which resulted in protein with a bright green colour that could be purified 
by nickel affinity chromatography. The cell pellets from the fermentations were resuspended 
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and lysed by sonication, and the subsequent cell-free extract was purified with a nickel affinity 
column. The results of this step were run on an SDS-PAGE gel (Fig. 47). 
 
 
Figure 47: SDS-PAGE analysis of the final 
eluates from the nickel affinity purification of 
the first two RM fusion proteins. 
 
SDS-PAGE analysis showed a significant yield of only one of the two proteins (RM_CM_2). 
To confirm this result, and to check for restriction activity in RM_CM_2, the two protein 
solutions were used in a DNA cleavage assay. As the fusions contained the complete CC398-
1 MTase, it could be assumed that the protein products would have the same DNA recognition 
sequence as the wild-type MTase. Given this, the protein solutions from the purification of 
RM_CM_1 and RM_CM_2 were incubated with a known positive (plasmid 7E) and a known 
negative (plasmid 15E). The results of this assay were run on an agarose gel and visualised on 
a transilluminator (Fig. 48). 
 
 




Results from the DNA cleavage assays showed no signs of restriction activity in either of the 
first two fusions and as such, new fusion proteins were designed and produced. The next two 
fusion genes to be expressed were RM_EB_1 and RM_EB_2 (2332 and 2337 bp fusion genes 
respectively). The genes were created by PCR, ligated into the pJF vector and expressed on a 
large scale. The subsequent recombinant proteins were then purified, samples from which were 
subjected to SDS-PAGE. 
 
 
Figure 49: Nickel affinity purification of RM_EB_1 and 2 (A) 
and size exclusion purification of RM_EB_2 (B). 
 
Results from SDS-PAGE analysis showed that RM_EB_2 had been successfully eluted from 
the nickel column, whereas RM_EB_1 had not (Fig. 49A). With an objective overview of 
these results, the reason for the absence of the RM_CM_1 and RM_EB_1 proteins after the 
nickel affinity step could be seen. The portion of the hsdR gene contained in the RM_CM_1 
fusion is 758 bp. This means that transcription of the downstream hsdM gene would be out of 
frame by 1 bp, and subsequent translation produces several peptide fragments. In the case of 
the RM_EB_1 fusion, the hsdR is 775 bp in length, and so transcription of the hsdM is 2 bp 
out of frame. This too would not produce the desired protein. This also means that both 
proteins will not be produced with a C-terminal HisTag, and so cannot be purified via this 
nickel affinity chromatography purification method. For this reason, no further work was 
conducted with these two constructs. On the other hand, RM_EB_2 was purified by nickel 
affinity and so further purification by size exclusion was performed (Fig. 49B). The purified 





Figure 50: DNA cleavage assay using the RM_EB_2 protein. 
 
The assay was conducted as before and returned no positive results (Fig. 50). It was thought 
that it was possible that the lack of identifiable activity was due to sub-optimal conditions, and 
so different conditions were tested. It had been previously discovered by the Dryden group, 
that the Sau1 R-M systems showed activity when the reaction was conducted in Buffer 4 (New 
England Biolabs). As such, this was the reaction buffer that was used for all subsequent 
reactions. However, Buffer 4 might not produce the ideal conditions for these novel fusion 
enzymes. Therefore, Buffers 1, 2 and 3 (New England Biolabs) were also tested in the plasmid 
cleavage assay for restriction activity in RM_EB_2. To rule out false positives due to 
contamination, each different buffer had ± SAM. The results of this experiment were run on 
an agarose gel and visualised on a transilluminator (Fig. 51).  
 
 
Figure 51: Plasmid cleavage assay for restriction activity on RM_EB_2, using Buffers 1, 2 and 3. 
 
The multiple buffer assay proved inconclusive. Whilst Buffers 1 and 2 showed no discernible 
signs of a cleaved plasmid product, there was a difference using Buffer 3. Whilst the other test 
reactions contained a mixture of supercoiled and nicked species, Lanes 11 and 12 contained 
entirely supercoiled species. Although this occurred in two reactions that were expected to 
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give a negative result (due to lack of recognition sequence and lack of SAM respectively), this 
result was checked. A new plasmid cleavage assay was conducted, using only Buffer 3 (Buffer 
4 for positive control). RM_EB_2 was incubated with “Eddys” 4E, 7E, 12E and 15E, with no 




Figure 52: Plasmid cleavage assay for restriction activity in RM_EB_2, using Buffer 3. 
 
The positive control reaction produced linearised plasmid species, whilst there seemed to be 
no complete cutting in the test reactions, and no identifiable pattern to nicked species. It was 
concluded from this that RM_EB_2 did not possess restriction activity. 
 
The succession of negative results after a relatively large amount of preparation, suggested 
that a new method of investigating the novel R to M fusions would have to be found. The task 
would potentially involve high numbers of screening and as such, a high-throughput strategy 
was necessary. Success in in vivo assays of the engineered MTase proteins (shown later in this 
thesis), identified a possible method for assaying the R to M fusions. In vivo studies not only 
remove the need to produce a usable amount of soluble protein but also remove the concern 
over buffer conditions.  
 
Nine more fusion genes (RM_EB_3 to 11) were designed and cloned. The PCR and cloning 
work for RM_EB_4 to 11 was performed by Dr John White (University of Edinburgh). The 
new genes, together with the previous two fusion genes (RM_CM_2 and RM_EB_2), were 
used to transform E. coli NM1261 cells, in preparation for the in vivo assays (Figs. 53 to 63). 
 





Figure 53: Amino acid sequence of RM_CM_2 (A), protein model of CC5 HsdR (B), and in vivo assay of 
RM_CM_2 (C). The section of the HsdR used in the fusion is highlighted in red. (A and B). 
 
Figure 54: Amino acid sequence of RM_EB_2 (A), protein model of CC5 HsdR (B), and in vivo assay of 




Figure 55: Amino acid sequence of RM_EB_3 (A), protein model of CC5 HsdR (B), and in vivo assay of 
RM_EB_3 (C). The section of the HsdR used in the fusion is highlighted in red. (A and B). 
 
Figure 56: Amino acid sequence of RM_EB_4 (A), protein model of CC5 HsdR (B), and in vivo assay of 




Figure 57: Amino acid sequence of RM_EB_5 (A), protein model of CC5 HsdR (B), and in vivo assay of 
RM_EB_5 (C). The section of the HsdR used in the fusion is highlighted in red. (A and B). 
 
Figure 58: Amino acid sequence of RM_EB_6 (A), protein model of CC5 HsdR (B), and in vivo assay of 




Figure 59: Amino acid sequence of RM_EB_7 (A), protein model of CC5 HsdR (B), and in vivo assay of 
RM_EB_7 (C). The section of the HsdR used in the fusion is highlighted in red. (A and B). 
 
Figure 60: Amino acid sequence of RM_EB_8 (A), protein model of CC5 HsdR (B), and in vivo assay of 




Figure 61: Amino acid sequence of RM_EB_9 (A), protein model of CC5 HsdR (B), and in vivo assay of 
RM_EB_9 (C). The section of the HsdR used in the fusion is highlighted in red. (A and B). 
 
Figure 62: Amino acid sequence of RM_EB_10 (A), protein model of CC5 HsdR (B), and in vivo assay of 




Figure 63: Amino acid sequence of RM_EB_11 (A), protein model of CC5 HsdR (B), and in vivo assay of 
RM_EB_11 (C). The section of the HsdR used in the fusion is highlighted in red. (A and B). 
 
In vivo assays of the RM fusions yielded no signs of restriction activity. In every case, the 
dilution order of the phage plaques was the same in the control and RM fusion plates (Figs 
53C to 63C).  
 
As the RM fusions were created with an intact CC398-1 MTase, it was thought possible that 
they would retain their methylase activity. E. coli cells containing each of the RM fusions was 
infected with λ phage, which was then retrieved and used to infect E. coli cells containing the 
wild-type CC398-1 MTase genes and the CC5 hsdR. In every case, the dilution order of the 
phage plaques was the same in the plus and minus hsdR plates. This provided evidence that 
each of the RM fusions possessed an active MTase. This result is encouraging, as it suggests 
that the fusions are able to fold correctly and produce an active enzyme. Unfortunately, the 




3.5. CC398-1 HsdM to HsdS Fusion 
 
The two Type I MTase genes occur at the same locus but are expressed from separate frames. 
The first few base pairs at the 5’ of the hsdS gene overlap with the 3’ of the hsdM gene (Fig. 
64). An MS fusion was created by the Dryden lab by removing the frameshift between the 
genes of the MTase from the EcoKI R-M system (Roberts et al. 2012). This resulted in joining 
the two MTase genes and producing a single peptide product. This construct showed R-M 
activities in vivo and restriction activity in vitro, when supplemented with stoichiometric 




Figure 64: Cartoon diagram of the genetic arrangement  
of the wild-type (above) and MS fusion (below) MTases. 
 
Primers to create an MS fusion gene from the CC398-1 MTase genes were designed and used 
in a PCR. The PCR was conducted in two stages and involved a set of primers complementary 
to both the 3’ end of hsdM and the 5’ of hsdS (see Materials and Methods for the Crossover 
PCR mechanism). After the second round of PCR, a single fusion sequence was created, which 
had removed the frameshift between the two genes (Fig. 65A). The CC398-1 MS fusion gene 
had been made successfully, and its nucleotide sequence was verified by Sanger sequencing. 
 
The expression of the wild-type MTase genes results in two distinct subunits, which closely 
associate to form an active methyltransferase in an M2S1 conformation. Fusing these genes 
removes the gap between the subunits and results in an M1S1 fusion protein (Fig. 65B). Using 
the model of the CC398-1 MTase, this gap was estimated to be ~3.6 Angstroms, a distance 


























Figure 65: Sections of CC398-1 MTase and MS fusion nucleotide sequences, showing 
the removal of the overlap between the hsdM and hsdS genes (A). Amino acid 
sequence of the two CC398-1 MTase subunits becoming one peptide (B). Cartoon of 
the subunits becoming one single peptide (C). The C-terminal of HsdM is coloured 
yellow and the N-terminal of HsdS is coloured green to show where they will be 
joined. The CC398-1 subunit interface (D). The C-terminal glutamate of the HsdM and 
the N-terminal methionine of the HsdS. In this model of the CC398-1 MTase, the α-
carbons in these residues are 3.6 Angstroms apart. 
 
The fusion gene was successfully ligated into vector pJF (see Appendix C for plasmid map), 
and was cloned by using the product to transform E. coli DH5-α cells. After the successful 
cloning of the MS fusion gene in vector pJF (subsequently known as pJFMSF), it was then 
used in expression studies. Expression of the MS fusion gene was initially conducted on a 
small scale. It was induced with IPTG and left for ~3 hours at 37 oC. The cells were then 
pelleted, resuspended in buffer, lysed by sonication and then centrifuged to pellet the insoluble 





Figure 66: SDS-PAGE analysis of the first inductions of the CC398-1 MS fusion 
gene (A). To test the solubility of the fusion protein, the cells were suspended 
in buffer, lysed and centrifuged, separating the mixture into two fractions. 
These were analysed by SDS-PAGE (B). The green box highlights an over-
expressed protein at the expected molecular weight of the fusion protein. 
 
SDS-PAGE showed that the MS fusion gene had expressed but that none had been recovered 
in the cell-free extract. Under these conditions, the MS fusion protein was insoluble, and so a 
new method of investigation had to be employed. The in vivo assays proved a relatively quick 
and convenient way of identifying activity, and so this method was also used for the MS fusion 
(Fig. 67). 
 
Figure 67: Diagram of spot test dilutions (A) in vivo spot test assay of the CC398-1 MS fusion (B). 
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Preliminary in vivo spot tests of the MS fusion showed evidence of both restriction and 
modification activities. The plaques formed by the MS fusion modified λ appeared to be the 
same in both the + and – R plates, whilst there appeared to be a significant level of cut back to 
the unmodified (U/M) λ (at least one log difference). To verify this result, full plate assays 
were conducted (Table 3). 
 
MS fusion (MSF) MTase In vivo Assay Results: 
 
Phage Type Phage Dilution Phage Volume R-M System Number of Plaques 
Unmodifiedλ 10-5 22.5 µL None 384 
10-4 35 µL MSF + R 650 
10-6 100 µL None 192 
10-5 223 µL MSF + R 808 
10-6 100 µL None 274 
10-5 40 µL MSF + R 34 
10-5 100 µL None 1516 
10-6 40 µL MSF + R 6 
10-6 100 µL None 263 
10-5 40 µL MSF + R 66 
MSFλ 10-5 32.3 µL MSF 401 
10-5 38.5 µL MSF + R 511 
10-6 167 µL MSF 219 
10-6 400 µL MSF + R 383 
10-6 200 µL MSF 368 
10-6 200 µL MSF + R 241 
10-6 200 µL MSF 341 
10-6 200 µL MSF + R 237 
10-6 200 µL MSF 292 
10-6 200 µL MSF + R 247 
Table 3: Raw data from several rounds of full plate in vivo assays of the MS fusion MTase. The table 
shows ±R pairs, which are the results from the experiment (+R) and control (-R), and the subsequent 
repeats. The plaque numbers cannot be compared without adjusting for volume and dilution. 
 
The E.O.P. for the unmodified λ phage against the restriction active MS fusion MTase was 
0.09 ±0.05 (see Appendix E for calculations). Comparing this to the wild-type value (0.15 
±0.11), indicated that the restriction active MS fusion was cutting back the phage to a similar 
extent as the wild-type. This value showed that the restriction complex is active. The E.O.P. 
of the MS fusion (MSF) modified λ phage was 0.78 ±0.14. Given the value calculated for the 
wild-type enzyme was 0.88 ±0.27, this suggests that the MS fusion is a comparable MTase. 
However, the high degree of uncertainty inherent in this assay means that these results were 
considered to be within experimental error from those gathered from the wild-type enzyme. 
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As such, no further assumptions could be made. Nevertheless, they do confirm that the MS 
fusion forms an active R-M system. 
 
In vivo analysis had provided evidence that the MS fusion protein could modify λ phage DNA. 
It was assumed that it could also modify the genomic DNA in E. coli cells and as such, could 
be used in the process of SMRT sequencing. The pJFMSF plasmid was used to transform  
E. coli ER2796 cells, from which an overnight culture was established. The genomic DNA 















































































































































































































































































































































































As the MS fusion had been created without any alteration to the HsdS subunit, it was not 
expected to have a modification activity different from that of the wild-type CC398-1 enzyme. 
Results from SMRT sequencing confirmed this assumption was correct, but also raised some 
questions (Fig. 68). As expected, the MS fusion strongly preferred to methylate adenine, and 
had modified over 76 % of the wild-type DNA recognition sequences (ACCNNNNNRTGA) 
occurring in the E. coli genome. The second highest occurring sequence (also at over 76 %) 
was the reverse complement of the target sequence. However, analysis of the sequencing data 
by the Pacific Biosciences software not only indicated that the enzyme was methylating at 
other sites, but also that it was not necessarily a purine (R) at the 9th position of the sequence 
(Fig. 68D). Further scrutiny of the results suggests that some of the motifs generated may have 
been called erroneously. For example, the 5th motif from the top of the list, 
ACCNNNNNRAGA, would not be possible, as it suggests that the MTase is methylating a 
thymine on the bottom strand. 
 
To clarify these results, further data analysis was conducted using New England Biolabs 
software. The R at position 9 of the recognition sequence was substituted with each base (ie. 
ACCNNNNN(A/T/C/G)TGA), and checked against the collected data for percentage 








































































































Figure 69: NEB software analysis of SMRT sequencing (Pacific Biosciences) data. 
from the MS fusion modified E. coli genomic DNA. 
 
These results indicated that although the enzyme seemed to accept cytosine or thymine at the 
9th position, it strongly preferred adenine or guanine (R). This confirms that the DNA 


































































Data collected from the SMRT sequencing of the wild-type (CC398-1) modified DNA (Fig. 
70), supports the legitimacy of that collected from the genomic DNA modified by the MS 
fusion. Multiple DNA motif results in both cases suggests that the results from the MS fusion 
are reliable. There is also a similar incidence of error in the results from the wild-type. Once 
again, the complementary sequence to the 5th motif in the list would not contain the requisite 
adenine base at the 5’ end. Again, as this error happens in both cases, it suggests a limitation 
in the experiment, and not unusual activity in the MS fusion enzyme. 
 
Since it was determined by the in vivo assays and SMRT sequencing that the MS Fusion 
produced an active enzyme, it was considered worthwhile to make further attempts to express 
and purify the protein. The MS fusion was an unnatural construct and therefore potentially 
more fragile than the wild-type enzyme. Therefore, a slower expression of the gene could help 
the protein product remain soluble. An overnight expression (~18 hours) at 20 oC was 
conducted on a small scale and the cell-free extract from these cells was then analysed for 
signs of soluble MS fusion protein (Fig. 71).  
 
 
Figure 71: SDS-PAGE gel of a small scale induction of 
the MS fusion gene and subsequent solubility 
determination of the MS fusion protein. 
 
Analysis of the cell-free extract showed signs of soluble MS fusion, indicating that it could be 
expressed on a larger scale and purified. A bigger cell culture (4 L of LB media) was produced, 
and the gene was induced under these new conditions. The cells were lysed and centrifuged, 
and the cell-free extract was passed through a nickel affinity column. SDS-PAGE analysis of 
samples from this purification identified that the MS fusion protein was successfully adhering 
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to the nickel and that a large proportion of it could be eluted from the column with 500 mM 
imidazole (Fig. 72).  
 
 
Figure 72: SDS-PAGE analysis of the nickel affinity 
purification of the overnight expression of the MS 
fusion protein. 
 
The concentration of the partially purified sample was estimated by UV/vis spectroscopy and 
then used in a plasmid cleavage assay to identify restriction activity. Work with the EcoKI MS 
fusion indicated that this CC398-1 MS fusion protein would require the addition of 
stoichiometric amounts of its M subunit in order to be active. In this preliminary assay, no 
extra M subunit was added. 
 
 
Figure 73: Plasmid cleavage assay of the MS fusion protein. 
 
Results from the Eddy cleavage assay were surprising (Fig. 73). The CC398-1 MS fusion 
protein appeared to be restriction active, without any supplementary protein. Data collected 
from SMRT sequencing suggested that this enzyme would show the same pattern of cleavage 
as the wild-type enzyme (5E, 6E, 7E, 12E and 14E positive), and this indeed was the case. A 
negative result in the control sample (MS fusion sample without the addition of the R’ subunit) 
(Lane 3), suggested that the positive result was not due to background activity from 
contaminants. The observed activity was due the MS fusion protein. However, the data from 
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EcoKI MS fusion suggested that this would not be possible and as such, it was believed that 
the complementary HsdM had to have been co-purified and retained in the MS fusion sample. 
This led to the conclusion that the CC398-1 MS fusion protein should undergo further 
purification to separate it from any potential proteolysis product, such as free HsdM protein. 
 
 
Figure 74: SDS-PAGE analysis of the nickel 
affinity purification of the MS fusion protein. 
 
A fresh, large-scale culture of cells containing the MS fusion gene was created and lysed. The 
cell-free extract was purified by nickel affinity (Fig. 74) as before, but then subjected to size 
exclusion chromatography. The resolution of the S200 gel filtration column meant that any 
HsdM protein (~59 kDa) co-eluting from the nickel column, would be separated from the much 
larger MS fusion (~106 kDa). 
 
 
Figure 75: SDS-PAGE analysis of the size exclusion purification of 
the MS fusion protein. The MS fusion protein is highlighted by 




SDS-PAGE analysis of samples from the size exclusion purification of the MS fusion protein 
sample showed that there was still a substantial amount of the contaminant (Fig. 75, black 
box). This suggested that it has a strong affinity for the MS fusion protein, and as such would 
most likely be some form of the HsdM subunit. With this in mind, the sample was used in a 
plasmid cleavage assay, again without addition of supplementary HsdM protein. 
 
 
Figure 76: Gel electrophoresis analysis of samples from a plasmid cleavage assay 
of the MS fusion protein, purified by size exclusion. 
 
Results from the Eddy cleavage assay showed that the MS fusion was indeed active in the 
same way as before (Fig. 76). The MS fusion was also used in a cleavage assay against 
modified and unmodified E. coli genomic DNA (Fig. 77). Results showed that the fusion 
protein was restriction active against unmodified (U/M) genomic DNA (Lanes 5 and 6) and λ 
phage DNA (Lanes 9 and 10), and was inactive against self-methylated genomic DNA (Lanes 
7 and 8).  
 
 
Figure 77: Gel electrophoresis analysis of samples from a genomic DNA (GDNA) cleavage 
assay of the MS fusion protein. Lane 1 contains unmodified (U/M) genomic DNA alone. 
Lane 2 shows that with the addition of wild-type CC398-1 MTase (+ve control), the 
genomic DNA no longer appears on the gel. 398-1/M GDNA denotes genomic DNA that 
has been modified by the wild-type enzyme. MSF/M denotes genomic DNA that has 




The purified MS fusion protein was also subjected to analysis by gel filtration HPLC. If the 
MS fusion were purified without the extra fragment, it is reasonable to assume that it would 
be unable to take on the quaternary structure of the wild-type enzyme. As the M and S subunits 
are fused, if the protein were to dimerise, it would form an M2S2 structure. However, evidence 
suggests that the contaminant is some form of the HsdM, and is allowing the enzyme to take 
on a pseudo M2S1 conformation. Gel filtration data would give an indication as to which 
structure is most likely. 
 
 
Figure 78: Gel filtration HPLC elution profile of the MS fusion protein. 
 
Data received from the gel filtration HPLC analysis of the MS fusion was reasonably clear 
(Fig. 78). Due to the unstable nature of the enzyme, it was only possible to purify the protein 
partially. As such, it was not expected that the protein solution would produce a neat elution 
profile. There was a shoulder to left side of the main peak occurring at an elution volume of 
2.99 mL, suggesting a larger contaminant. There were three smaller peaks at a higher elution 
volume, but were due to glycerol and small contaminants. As the elution volume of the CC398-
1 wild-type was 3.1 mL, a smaller elution volume for the MS fusion indicates that it is indeed 
larger. The poor resolution of these complete MTase complexes in gel filtration means that it 
was not possible to get an accurate mass from these data. However, the values can be compared 
relatively. Using the obtained elution volumes, the calculated mass of the MS fusion is 311.5 
kDa, whilst the calculated mass of the wild-type was 210 kDa (actual mass, 166 kDa). The 
extra fragment had a molecular weight of approximately 60 kDa (estimated from SDS-PAGE 





Figure 79: Normalised elution profiles of decreasing concentrations of the MS fusion. 
 
As with the wild-type MTase, HPLC elution profiles of decreasing concentrations of the MS 
fusion protein gave an indication of the stability of this enzyme complex (Fig. 79). The pseudo 
M2S1 form of the protein appeared to start breaking down to any significant extent at a 
concentration of 0.25 µM. Although it should be appreciated that this concentration is not 
definite (due to the level of impurity of the protein solution), it did seem that the MS fusion 
showed the same level of stability as the wild-type enzyme. Additionally, if the concentration 
were inaccurate, it would be lower than calculated. This would mean that this MTase was 
stable at lower concentrations than the wild-type. 
 
 
Figure 80: SDS PAGE gel of purified MS fusion 
and HsdM samples. The contaminating 
species is highlighted by the black box. 
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Comparison of SDS-PAGE gel bands of the purified MS fusion and HsdM subunit samples 
indicated that the contaminant was not exactly the same species as the HsdM (Fig. 80). The 
gel showed two different bands (black box), both of a higher molecular weight than the HsdM 
protein. If the fragment is an MS fusion proteolysis product, it would also include part of the 
HsdS sequence. Evidence suggested that the contaminating fragment was binding the fusion 
protein in a manner that was not inhibiting activity. It can be inferred from this that the 
fragment was able to fold correctly, suggesting that the peptide sequence had degraded to a 
specific point in the secondary structure that had maintained its tertiary structure. It was 
therefore thought most likely that the fragment would contain at least the first TRD of the 
HsdS. To examine the association between the MS fusion protein and the unknown fragment, 
a cross-linking experiment was carried out. The fusion protein sample was incubated with 
glutaraldehyde and examined by SDS-PAGE. If the unknown fragment was closely associated 
with the MS fusion protein, the incubation would result in a cross-linked product of the two 
species, and would therefore appear at a higher molecular weight on the SDS-PAGE gel. 
 
 
Figure 81: MS fusion sample ± treatment with glutaraldehyde. 
 
Comparing plus and minus glutaraldehyde samples identified that the MS fusion species in the 
glutaraldehyde positive sample had increased in molecular weight (Fig. 81). It could also be 
observed that the increase could be attributed to the molecular weights of either of the 
unknown fragments (60 to 70 kDa). This proved that there was a strong association between 
the MS fusion and the bound fragment, and provided further evidence that the fragment 
contained the HsdM subunit.  
 
Peptide fragmentation mass spectrometry analysis of this protein was carried out, in order to 
identify the unknown proteins in the MS fusion sample. An SDS-PAGE gel of the partially 
purified MS fusion sample was run, and the MS fusion and contaminating bands were excised 





Figure 82: SDS-PAGE gel showing nickel affinity purified MS 
fusion (Lane 1) and a 2X dilution (Lane 2) (A). The gel after 
band excision (B). 
 
The data retrieved from analysis by mass spectrometry identified three separate species. The 
first, from the band of highest molecular weight was confirmed as the MS fusion protein. The 
~70 kDa molecular weight protein was identified as a contaminating protein from E. coli 
(ArnA), whilst the smallest protein species (~60 kDa) contained peptides from both HsdM and 
HsdS subunits, as expected (See Appendix F for Mass spectrometry results). It was concluded 
from this data that the protein fragment associating with the MS fusion was a product of 
proteolysis.  
 
Evidence suggested that the bound fragment was not only relatively stable and strongly 
associating with the MS fusion protein, but was also inducing the MS fusion activity. The 
stability of this fragment led to the belief that it would include the first TRD of the HsdS 
subunit, in order for it to fold correctly. The estimated molecular weight of the MS fusion, up 
to the C-terminal of the first TRD is ~81 kDa. However, by comparing SDS-PAGE gels of the 
MS fusion protein, the fragment does not appear large enough (<65 kDa). Although there was 
not total peptide sequence coverage of the protein fragment, there were hits across the full 
length of the HsdM. This was not the case for the HsdS, and as such there was relatively low 
confidence in the protein match (a score of 120, compared to 1271 for the HsdM). If the final 
peptide hit on the HsdS occurs at the end or near the end of the fragment, the molecular weight 
of this fragment would be ~ 73 kDa. This too seems too large when compared to the molecular 
weight estimated from the SDS-PAGE gel. If the fragment has a molecular weight of 
approximately 65 kDa, then the first peptide hit on the HsdS is a good candidate for the end 
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of the fragment. The estimated molecular weight of the MS fusion protein, truncated to the 
end of this peptide match is 62 kDa. 
 
 
Figure 83: Cartoon model of the MS fusion protein (A). Cartoon model of the contaminating fragment, 
truncated to the final peptide mass spectrometry hit on the HsdS (B). Cartoon model of the 
contaminating fragment to the first peptide hit on the HsdS (C) 
 
Matching the experimental data from the fragment to the model of the MS fusion raised further 
questions. Using both estimates for the molecular weight of the fragment created two distinct 
models. Enzyme assays showed that the fragment was stabilising the MS fusion and enabling 
its activity, yet neither estimate included the complete first TRD (Fig. 83B and C). The 
structure in the smaller estimate (Fig. 83C) contains only four residues after the N-terminal 
region. As this is the section of the HsdS that is proposed to associate with the HsdM subunit, 
this is the estimate that seems most likely. However, the MS fusion contains the complete 
HsdS and as such would be associating with the HsdM in the extra fragment. This could 
possibly prevent the N-terminal sequence on the fragment from binding. If this is the case, the 
extra sequence might be moving freely. This again makes the shorter sequence more likely. 
Nevertheless, it was clear that this C-terminal sequence was not affecting its association with 




3.6. CC398-1 HsdM Half HsdS  
 
The HsdS of a Type I MTase contains two TRDs, which each correspond to one half of the 
bipartite DNA recognition sequence. These TRDs are joined by an amino acid sequence, 
which is highly conserved within its enzyme family, and is therefore known as the central 
conserved region. It is proposed that the Type I MTase has a symmetrical organisation, where 
the C-terminal of the HsdS loops around to meet its N-terminal (Kneale 1994). Work from 
several research groups provided evidence for this circular model by creating mutants of the 
HsdS, where each mutant possessed a different C-terminal but retained wild-type specificity 
(Taylor et al. 1994; Janscak & Bickle 1998). Investigations using the Type IC enzyme, 
EcoDXXI, also found that removing either the N-terminal or C-terminal TRD gives rise to a 
new DNA specificity (MacWilliams & Bickle 1996). Given this evidence, it was thought that 
the HsdS of the CC398-1 MTase could be truncated to the end of the first TRD, and that this 
would cause the structure to form a homodimer and therefore recognise a palindromic DNA 
sequence (Fig. 84B).  
 
 
Figure 84: Cartoon diagram of the genetic arrangement of 
the two Half HsdS constructs (A), and the proposed protein 
subunit conformation (B). 
 
Two different half HsdS constructs were designed from the CC398-1 MTase template (Fig. 
84A). One of these ended directly after the estimated end of the helical spacer, whilst the other 
incorporated the rest of central conserved region. It was thought that only by including the 
entire sequence up to the second TRD, would the enzyme subunit be able to dimerise and form 
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a circular structure. The first structure was named “HalfSHis”, whilst the second was known 
as “CCHalfSHis” or “CHS”, as it contained all of the central conserved region (Fig. 85). These 
two structures were created by PCR, and subsequently ligated into the pJF vector (see 
Appendix C for plasmid maps). Under normal circumstances, proteins produced from this 
vector possess a C-terminal HisTag, hence the suffix “His”.  
 
 
Figure 85: Amino acid sequence of the HalfSHis MTase (A) Model of the HalfSHis MTase (B). Amino 
acid sequence of the CCHalfSHis MTase (C) Model of the CCHalfSHis MTase (D). The extra residues 




The S subunit of the HalfSHis enzyme had a predicted molecular weight of 25896.5 Da. The 
CCHalfSHis construct had an extra nine residues (Fig. 85. highlighted in purple) and a 
predicted molecular weight of 26986.6 Da. 
 
Small scale tests showed that both of the halved HsdS constructs could be expressed and were 
soluble. Expression was then carried out on a larger scale, in order to purify an amount of the 
proteins that could be analysed. First produced was the “HalfSHis” enzyme, which was 
subsequently purified by nickel affinity chromatography (Fig. 86). 
 
 
Figure 86: SDS-PAGE analysis of samples 
from the nickel affinity purification of HalfSHis. 
 
The HalfSHis enzyme appeared to purify well after one chromatography step, and so was then 
assayed for restriction activity with a plasmid cleavage assay (Fig. 87). As the activity of this 
novel construct was unknown at this stage, it was first checked against positives for the wild-
type enzyme, Eddys 5E and 7E. 
 
 
Figure 87: Plasmid cleavage assay of the HalfSHis protein. 
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No signs of restriction activity were found in the preliminary test. At this juncture, the other 
half HsdS construct, CCHalfSHis, was purified by nickel affinity. A further size exclusion 
chromatography step was added, to reduce the risk of inhibition by contaminants. The gene 
expressed and seemed to produce a large amount of the target protein. The recombinant protein 
was successfully purified by nickel affinity, and further by size exclusion (Fig. 88). 
 
 
Figure 88: SDS-PAGE analysis of samples from the purification of the CCHalfSHis protein. 
 
The lack of restriction activity in HalfSHis was thought to be due to the fact that the specificity 
of the enzyme was not yet known. Therefore, a wider range of plasmid species were tested in 
a new cleavage assay of CCHalfSHis.  
 
 
Figure 89: Plasmid cleavage assay of the CCHalfSHis protein. 
 
As with the HalfSHis assay, CCHalfSHis produced no linearised species in the plasmid 
cleavage assay (Fig. 89). It was assumed that to become active, the Half HsdS proteins would 
have to dimerise. With this in mind, it was proposed that the HisTag on the end of this subunit 
could be interfering with this process. It was therefore decided that the truncated MTase should 
be expressed and purified without the tag. 
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At this stage, CCHalfSHis was considered the most likely to produce an active enzyme, due 
to its inclusion of the entire central conserved region. It was therefore the species used for 
investigating the effects of removing the HisTag. A stop codon was introduced to the end of 
the cchalfS gene by PCR, and the product was ligated into the pJF vector. The gene was then 
expressed and the solubility of the protein product was verified by SDS-PAGE. The gene was 
then expressed in a larger amount of medium, in order to purify the protein. As the pI of the 
CCHalfS protein was estimated to be 5.05, the cell-free extract of the subsequent cell culture 
was first passed through an anion exchange column, and then a gel filtration column. A final 
purification step was carried out, using a heparin agarose column. Heparin agarose binds to 
DNA-binding proteins, which can then be eluted with an increasing salt gradient. Samples 
from all of these purification steps were analysed by SDS-PAGE (Fig. 90). 
 
 
Figure 90: SDS-PAGE analysis of samples from the purification of the CCHalfS protein, without HisTag. 
In chronological order, anion exchange (A), gel filtration (B) and heparin agarose (C). 
 
The SDS-PAGE gels showed that the purification of the CCHalfS protein was unsuccessful. 
Successive purification steps saw a reducing amount of the Half HsdS subunit and an increase 
in a smaller band on the gels (Fig. 90, highlighted by the black box), which appeared to be a 





As with the MS fusion protein, it was considered more effective to test the activity of the half 
hsdS enzymes in an in vivo assay. This would confirm whether the constructs were viable and 
postpone the need to produce large amounts of soluble, stable protein. 
 
 
Figure 91: In vivo spot tests to assay for R-M activity in the HalfSHis protein. Diagram of spot test 
dilutions (A) The HalfSHis MTase in restriction complex, against unmodified (U/Mλ) and HalfSHis 
Modified λ phage (HalfSHisλ) DNA (B) Wild-type CC398-1 control and the HalfSHis in restriction 
complex. against CC398-1 modified (CC398λ) λ phage DNA (C). 
 
The spot test in vivo assays of the HalfSHis MTase were successful (Fig. 91). When tested 
against unmodified λ phage DNA, the HalfSHis (with supplementary R subunit) showed clear 
restriction activity, to at least one log dilution. The MTase also appeared to be modification 
active, as the restriction complex seemed unable to restrict the phage that had been passed 
through the same system (Fig. 91B). Yet more encouraging was that the HalfSHis MTase was 
able to restrict phage that had been modified by the wild-type enzyme (Fig. 91C). This was 
good evidence that the new construct had a new DNA recognition sequence. To verify these 












HalfSHis MTase In vivo Assay Results: 
 
Phage Type Phage Dilution Phage Volume R-M System Number of Plaques 
Unmodifiedλ 10-5 22.5 µL None 384 
10-4 27.8 µL HalfSHis + R 1097 
10-6 100 µL None 192 
10-5 286 µL HalfSHis + R 1270 
10-6 100 µL None 274 
10-5 40 µL HalfSHis + R 512 
10-5 100 µL None 1516 
10-6 40 µL HalfSHis + R 36 
10-6 100 µL None 263 
10-5 40 µL HalfSHis + R 493 
HalfSλ 10-5 28.5 µL HalfSHis 264 
10-5 35.7 µL HalfSHis + R 273 
10-6 167 µL HalfSHis 185 
10-6 334 µL HalfSHis + R 253 
10-6 200 µL HalfSHis 311 
10-6 200 µL HalfSHis + R 215 
10-6 200 µL HalfSHis 324 
10-6 200 µL HalfSHis + R 229 
10-5 20 µL HalfSHis 343 
10-5 20 µL HalfSHis + R 221 
Table 4: Raw data from full plate in vivo assays of the HalfSHis MTase. The table shows ±R pairs, which 
are the results from the experiment (+R) and control (-R), and the subsequent repeats. The plaque 
numbers cannot be compared without adjusting for volume and dilution. 
 
The E.O.P. of the unmodified λ phage against the restriction active HalfSHis MTase was 0.40 
±0.20 (see Appendix E for calculations). Comparing this value to those gathered from the 
wild-type and MS fusion enzymes (0.15 and 0.09 respectively), it suggests that the HalfS is 
less active in a restriction complex. However, due to the large margin of error in this assay, 
this value should be considered the same as wild-type. The E.O.P. of the HalfSHis modified λ 
phage was 0.70 ±0.20. This indicates that the HalfSHis has similar MTase activity to both the 
MS fusion (0.78) and the wild-type (0.88) enzymes. This was quite surprising given that this 





Figure 92: In vivo spot tests to assay for R-M activity in the CCHalfSHis protein. Diagram of spot test 
dilutions (A) The CCHalfSHis MTase in restriction complex, against unmodified (U/Mλ) and CCHalfSHis 
modified (CCHalfSHisλ) λ Phage DNA (B) Wild-type CC398-1 control and the CCHalfSHis in restriction 
complex. against CC398-1 modified (CC398-1λ) λ phage DNA (C).  
 
The same procedure was carried out using the cchalfS gene in the pJF vector, and this too was 
a success. When tested against unmodified λ phage DNA, the CCHalfSHis (with 
supplementary R subunit) was restricting the phage by at least one log dilution. Modification 
activity was identified, as this MTase in restriction complex was also unable to restrict the 
phage that had been passed through the same system (Fig. 92B). As with the HalfSHis MTase, 
the CCHalfSHis was able to restrict CC398-1 modified phage, and therefore also had a 
different DNA recognition sequence from wild-type. These results were interesting. From the 
in vivo work, it appeared that the two half HsdS constructs had similar activity, despite one of 
them lacking the central conserved region. This result was investigated further by using full 














CCHalfSHis MTase In vivo Assay Results: 
 
Phage Type Phage Dilution Phage Volume R-M System Number of 
Plaques 
Unmodifiedλ 10-5 22.5 µL None 384 
10-4 16 µL CCHalfSHis + R 1164 
10-6 100 µL None 192 
10-5 84 µL CCHalfSHis + R 716 
10-6 100 µL None 274 
10-5 40 µL CCHalfSHis + R 575 
10-5 100 µL None 1516 
10-6 40 µL CCHalfSHis + R 62 
10-6 100 µL None 263 
10-5 40 µL CCHalfSHis + R 596 
CCHalfSHisλ 10-6 96 µL CCHalfSHis 294 
10-6 286 µL CCHalfSHis + R 616 
10-6 100 µL CCHalfSHis 360 
10-6 100 µL CCHalfSHis + R 274 
10-6 100 µL CCHalfSHis 371 
10-6 100 µL CCHalfSHis + R 274 
10-5 10 µL CCHalfSHis 434 
10-5 10 µL CCHalfSHis + R 339 
Table 5: Raw data from full plate in vivo assays of the CCHalfSHis MTase. The table shows ±R pairs, 
which are the results from the experiment (+R) and control (-R), and the subsequent repeats. The 
plaque numbers cannot be compared without adjusting for volume and dilution. 
 
The E.O.P. of the unmodified λ phage against the restriction active CCHalfSHis MTase was 
0.58 ±0.21 (see Appendix E for calculations). This is a relatively high value, and suggests that 
the CCHalfSHis forms a less active restriction complex than any of the previous MTases. 
Factoring in the error could give a E.O.P of around 0.37. This still seems to lie outside the 
values obtained with the other MTases but does make it comparable to the HalfSHis MTase. 
The CCHalfSHis modified λ phage produced an E.O.P. of 0.75 ±0.15. This value lies within 
the error margins of the other MTases, and suggests this MTase has a modification activity 
similar to its HalfSHis counterpart.  
 
The two half hsdS genes were able to express enzymes with in vivo activity. It was therefore 
possible to use SMRT sequencing to identify where they were methylating DNA, and therefore 




































































































































































































































































































































































































































SMRT sequencing of the HalfSHis modified genomic DNA was successful. After only a single 
run, the obtained data showed that the HalfSHis MTase was modifying DNA, had a strong 
preference for modifying adenine bases (Fig. 93A), and modified adenines within a single, 
distinct DNA sequence motif (ACCN5GGT) (Fig. 93B). The DNA motif is palindromic, which 
confirms that the new construct is dimerising and supports the idea that the MTase has a 
circular conformation. If the two HalfSHis units were side by side, the expected motif would 
be ACCNNNNNCCA. However, as the second half of the bipartite sequence is the 
complement of this, it suggests the second HalfS unit is recognising the ACC on the anti-sense 
strand. What was particularly interesting, was that this new palindromic sequence 
(ACCN5GGT) is a single nucleotide shorter than the wild-type recognition sequence 
(ACCN5RTGA). What is more, the distance between the methylated bases is one nucleotide 
further away, relative to the wild-type sequence (See Appendix G for additional results).  
 
The SMRT sequencing of CCHalfSHis modified genomic DNA was also a success, and 
produced very similar results to the other half HsdS MTase (Fig. 94). This supports the 
conclusions from the in vivo assays, that the two MTase have similar activities. That the 
CCHalfSHis MTase possessed the same DNA recognition sequence as the HalfSHis species, 
and that they share the same difference from the wild-type sequence was interesting. The 
longer primary amino acid sequence of the CCHalfSHis species did not appear to have an 
effect on recognition sequence length (See Appendix F for additional results). 
 
In vivo assays and SMRT sequencing had proven the half HsdS proteins were active MTases. 
This suggested that it might be possible to overexpress the genes and purify the subsequent 
protein, in order to perform work in vitro. Previous attempts at this had shown that the enzymes 
were relatively unstable and that this caused a breakdown of the proteins over time. A faster 
method of purification (“Quick”) was developed, which involved nickel affinity 
chromatography to separate the MTases from most of the cell extract, and then buffer exchange 
via a PD-10 desalting column (GE Healthcare) (see Materials and Methods), to remove 
imidazole from the protein solutions. This was successfully performed for both MTases and 




Figure 95: SDS-PAGE analysis of samples from the "Quick" purifications of the HalfSHis (A) 
and the CCHalfSHis (B) MTases. 
 
The Quick purification yielded more than enough of the two different MTases. 6 g of bacterial 
cell pellet yielded 25.6 mg of HalfSHis, and 24.1 mg of CCHalfSHis. The vast majority of 
other proteins had been removed from the protein solutions, leaving them reasonably pure. 
The calculated yield is therefore fairly reliable. 
 
 
Figure 96: SDS-PAGE gel showing the CC398-1 wild-type MTase, 
and the two half HsdS proteins. 
 
SDS-PAGE analysis of the two half HsdS enzymes clearly shows their difference in size (Fig. 
96). The M subunit remains the same apparent size as the wild-type enzyme, whilst the S 
subunit has decreased in size. The CCHalfSHis S subunit looks bigger than that of the 
HalfSHis, corresponding to the predicted difference in molecular weight of 1090.1 Da. Image 
J analysis of band intensity was again used to provide an impression of the amount of the half 
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S subunits, relative to the HsdM. The difference in yield between the two MTase subunits was 
of particular concern, given the degradation of the half S over time. Comparing protein bands 
in SDS-PAGE gels from four separate purifications of the HalfSHis and CCHalfSHis MTases, 
provided average band intensities. These were then used to calculate standard deviation in 
order to gauge the margin of error. The ratio of HsdM to HalfSHis was 1.00 (±0.46):1.04 
(±0.72). The ratio of HsdM to CCHalfSHis was 1.83 (±0.79):1.00 (±0.80) (See Appendix D 
for calculations). In contrast to the wild-type MTase, the two subunits in both of these two half 
HsdS constructs needed to purify with an even stoichiometry. If the wild-type is M2S1, then 
the half S enzymes should be one M and one S½. This supports the Image J results from the 
HalfSHis MTase, despite the substantial degree of error. If the results from the CCHalfSHis 
are taken at face value, an explanation for the extra amount of HsdM could be that the central 
conserved region loosely associates with a second M subunit. Taking the errors into account 
though, the CCHalfSHis MTase could have also purified in an even ratio. Nevertheless, in 
both cases the purifications seemed to be providing enough of the proteins to form active 
MTases.  
 
Figure 97: Plasmid cleavage assay of HalfSHis (A) and CCHalfSHis (B). 
 
Having successfully purified the two half HsdS proteins, they could be assayed for in vitro 
activity. They were used in plasmid cleavage assays against the Eddy library. At this stage in 
the investigation, it had already been shown that the truncated genes produced viable MTases, 
but also their DNA sequence specificity had been established. It was interesting to see whether 
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the pattern of plasmid cleavage was in agreement with the pattern that was expected from the 
results from SMRT sequencing. 
 
The linearised 7E, 11E and 15E plasmid species from the plasmid cleavage assay showed that 
the HalfSHis MTase was active in vitro, and that it possessed the expected DNA recognition 
sequence of ACCN5GGT (interpreted by RMSearch) (Fig. 97A). This was also the case for 
the CCHalfSHis MTase (Fig. 97B). Given this success, the activity of the two MTases was 
checked against modified and unmodified genomic DNA (Fig. 98).  
 
 
Figure 98: Genomic DNA (GDNA) restriction assay of HalfSHis (A) and CCHalfSHis (B). 
On both gels, Lane 1 contains unmodified (U/M) genomic DNA alone. Lane 2 shows 
that with the addition of wild-type CC398-1 MTase (+ve control), the genomic DNA no 
longer appears on the gel. 398-1/M GDNA denotes genomic DNA that has been 
modified by the wild-type enzyme. HalfSHis/M denotes genomic DNA that has been 
modified by the HalfSHis protein. CCHalfSHis/M denotes genomic DNA that has been 
modified by the CCHalfSHis protein. On both gels, Lanes 9 and 10 contain lambda (λ) 
phage DNA. 
 
Both MTases showed in vitro restriction of phage DNA (Lane 10 A and B), and unmodified 
E. coli genomic DNA (Lane 6, A and B). As hoped, both MTases were inactive against self-




The half HsdS enzymes had activity in vivo and in vitro. The data obtained from these 
experiments had indicated that the half HsdS enzymes were dimerising, in order to become 
active. Gel filtration HPLC was used to gain evidence for this arrangement in their quaternary 
structure (Fig. 99). 
 
 
Figure 99: Gel filtration HPLC elution profile of the HalfSHis (A) and CCHalfSHis (B) MTases. 
 
The elution profiles of the two MTases were similar. Both showed clean, sharp peaks, 
corresponding to the target enzymes, although both also contained contaminating species. Due 
to the small difference in molecular weight of the two half hsdS species, it was not possible to 
resolve the difference on the HPLC, so both had an elution volume of 3.125 mL. However, as 
both gave a retention time similar to the wild-type enzyme (3.1 mL), it can be assumed that 
this is indeed further evidence for the dimerisation of the half HsdS enzymes.  
 
 
Figure 100: Normalised elution profiles of decreasing concentrations of the HalfS MTase (A)  
and the CCHalfS MTase (B). 
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Comparing the elution profiles of decreasing concentrations of the half HsdS enzymes gave 
interesting results (Fig. 100) The break-down of the HalfSHis enzyme appears to occur at a 
concentration of 2 µM, as the elution profiles shift to the right. This is far higher than any of 
the previous MTases. What was encouraging though, was that the CCHalfSHis appeared to be 
far more stable, and only began to turn to its M1S1 form at a concentration of 0.25 µM. This 
supports the idea that the addition of central conserved region is allowing the CCHalfSHis to 
form the wild-type, circular configuration, but also bind the second HsdM more strongly.  
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3.7. CC398-1 HsdM to Half HsdS Fusion 
 
With the structure of the Type IIG systems in mind, the natural progression from the MS fusion 
and half HsdS enzymes was to create an M to HalfS fusion. Results indicated that both half 
HsdS MTases were active, and so it was not hugely important which of these was used as a 
template. At the time of manufacture however, it was considered that retaining the entire 
central conserved region would more likely produce an active enzyme. Therefore, the primers 
used to create the CCHalfS MTase were used, with MS fusion gene as a template. This 
produced an hsdM to half hsdS gene fusion, which incorporated all of the central conserved 
region. This was called MCCHalfS fusion or MCHSF. 
 
 
Figure 101: Cartoon diagram of the genetic rearrangement 
of CCHalfS to MCCHalfS fusion. 
 
The new MCCHalfS fusion protein would have the same amino acid sequence as the CCHalfS MTase 






Figure 102: Amino acid sequence of the MS fusion, truncated to the MCCHalfS fusion (A) 
and the corresponding structural change on the protein model (B). 
 
A PCR product of the expected size for the MCCHalfS fusion gene was purified and ligated 
into vector pJF (see Appendix C for plasmid map), the product of which was sequenced and 
verified. 
 
The MCCHalfS fusion was expressed on a small scale and the solubility of the protein product 
was confirmed. The protein was then produced on a larger scale and purified by nickel affinity 
and size exclusion chromatography. Selected samples from these purification steps were 
analysed by SDS-PAGE (Fig. 103). 
 
 
Figure 103: SDS-PAGE gel of the nickel affinity and size 
exclusion chromatography purification of MCCHalfS protein. 
 
The MCCHalfS fusion had expressed successfully, and the protein appeared to purify well. 
UV/vis spectroscopy was used to estimate the concentration of the protein, which was then 





Figure 104: Agarose gel electrophoresis of the results of a plasmid cleavage assay 
of the MCCHalfS fusion protein. 
 
A lack of a coherent cutting pattern through several plasmid cleavage assays showed that this 
fusion preparation did not possess restriction activity (Fig. 104). Therefore, the in vivo assay 
was used as a quick way of identifying whether the new construct possessed activity. This 
would establish whether it was worthwhile to pursue investigations in vitro. 
 
 
Figure 105: Diagram of dilutions (A) In vivo spot tests to assay the MCCHalfS fusion for R-M activity (B). 
 
In vivo spot tests showed that the MCCHalfS fusion was restriction and modification active 
(Fig. 105). When tested against unmodified (U/M) λ phage, there was cut back by two log 
dilutions compared to the control. When λ phage that had been used to infect cells containing 
the MCCHalfS fusion gene was used to infect cells containing the restriction active fusion, 
there was no difference in plaque formation compared to the control. This indicated that the λ 
phage had been modified by the MCCHalfS fusion and was subsequently resistant to 
restriction by the restriction active form of the fusion. These results were verified by 




MCCHalfS fusion MTase In vivo Assay Results: 
 
Phage Type Phage Dilution Phage Volume R-M System Number of Plaques 
Unmodifiedλ 10-6 100 µL None 43 
10-5 100 µL MCCHalfS fus. + R 57 
10-6 100 µL None 19 
10-5 100 µL MCCHalfS fus. + R 8 
10-6 100 µL None 51 
10-5 100 µL MCCHalfS fus. + R 46 
MCCHalfS 
fus.λ 
10-6 100 µL MCCHalfS fus. 87 
10-6 100 µL MCCHalfS fus. + R 98 
10-6 100 µL MCCHalfS fus. 133 
10-6 100 µL MCCHalfS fus. + R 142 
10-6 100 µL MCCHalfS fus. 145 
10-6 100 µL MCCHalfS fus. + R 133 
Table 6: Raw data from full plate in vivo assays of the MCCHalfS fusion MTase. The table shows 
±R pairs, which are the results from the experiment (+R) and control (-R), and the subsequent 
repeats. The plaque numbers cannot be compared without adjusting for volume and dilution. 
 
The E.O.P. of the unmodified λ phage against the restriction active MCCHalfS fusion was 
0.10 ±0.04 (see Appendix E for calculations). The MCCHalfS fusion protein appeared to be 
forming a highly active restriction complex. This value was the same as that calculated for the 
MS fusion, and suggests the possibility that the subunits being contained in a single peptide 
was having a positive effect on activity. It was hard to compare the MTases accurately given 
the high error values, but it did confirm that the MCCHalfS fusion is restriction active. The 
MCCHalfS fusion modified λ phage produced an E.O.P. of 1.02 ±0.26 (see Appendix E for 
calculations). This result is higher than that of the wild-type enzyme, but again is within error. 
It does suggest that the MCCHalfS fusion MTase is a highly efficient methylase. A possible 
explanation for this is its ability to form the wild-type, circular conformation, due to the 
inclusion of all of the central conserved region.  
 
Having observed activity in vivo, SMRT sequencing was then used to identify any pattern of 
methylation that the MCCHalfS fusion might cause. E. coli genomic DNA, modified by the 
MCCHalfS fusion was SMRT sequenced and the results were analysed by Pacific Biosciences 























































































































































































































































Results from the half HsdS MTases gave an indication of the mode of action of the MCCHalfS 
fusion. SMRT sequencing confirmed that the new fusion did indeed share the same DNA 
recognition sequence as the half HsdS MTases (ACCN5GGT) (see Appendix G for additional 
results). This palindromic sequence was further evidence that the MCCHalfS fusion was 
dimerising.  
 
It was considered possible that the protein form of this new fusion suffered from similar issues 
to the half HsdS MTases, and as such would need to be purified using a faster method. The 
Quick purification method was used to prepare more of the protein, the presence and quality 
of which was then checked by SDS-PAGE (Fig. 107). 
 
 
Figure 107: SDS-PAGE analysis of samples from the “Quick” purification 
of MCCHalfS fusion protein. 
 
SDS-PAGE analysis confirmed that the Quick purification method had successfully retained 
and purified the MCCHalfS fusion protein. In Lane 1 of the gel was run a sample of the same 
protein from the previous preparation. It was quite apparent that the previous method produced 
a far cleaner sample, but one that showed no signs of restriction activity. The new MCCHalfS 
fusion protein sample alone was analysed by SDS-PAGE, and showed few contaminants (Fig. 
108). It was hoped that activity would be observed now that the speed of the process had 
increased. The level of contamination in the sample made it difficult to get an accurate 
concentration for the target protein. However, the yield was estimated to be 11.3 mg from a 5 





Figure 108: SDS-PAGE gel of the purified  
MCCHalfS fusion protein. 
 
In theory, this half S fusion was dimerising. This idea was supported by data from SMRT 
sequencing, but further evidence was sought via gel filtration HPLC (Fig. 109). 
 
 
Figure 109: Gel filtration HPLC elution profile of the MCCHalfS fusion protein, 
after Quick purification. 
 
The elution profile of the protein was untidy. A large peak at the start of the trace corresponded 
to a very high molecular weight. This peak had noticeable shoulders, indicating aggregated 
species, which was eluting into the void volume. The largest peak on the trace was assumed 
to have been created by the target protein. Once again, the resolution of this protein was poor 
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but a similar elution volume (3.0 to 3.2 mL) to the wild-type enzyme indicated that the 
MCCHalfS fusion was forming a dimer in solution.  
 
 
Figure 110: Normalised elution profiles of decreasing concentrations of the MCCHalfS fusion MTase. 
 
Once again, the elution profiles of decreasing concentrations of the protein were compared 
(Fig. 110). This MTase appeared to have a similar level of stability to the HalfSHis enzyme. 
In both cases the elution profiles begin to shift to the right at a concentration of 2 µM. 
However, with this enzyme, the HsdM and half HsdS are fused and so this shift would 
correspond to the dissociation of two M1S½ fusion monomers. Gel filtration HPLC results from 
the CCHalfSHis MTase suggested that the inclusion of the central conserved region was 
having a positive effect on the stability of the enzyme complex. Despite the presence of this 
same peptide sequence in this protein, this fusion appears relatively unstable. When purified, 
this MTase would often precipitate and/ or lose activity within a few days, despite storage in 
50 % glycerol at -20 oC. The lack of stability seen in HPLC was most likely due to the fragility 
of the fusion peptide itself, and not its ability to form a dimer.  
 
The fusion protein had purified successfully and seemed to be adopting a conformation that 
would generate activity in solution. The plasmid cleavage assay was used to identify in vitro 





Figure 111: Agarose gel electrophoresis of samples from a plasmid cleavage assay 
of the MCCHalfS fusion protein. 
 
The pattern of cleavage in the plasmid cleavage assay of the new preparation of the MCCHalfS 
fusion was identical to that of the half HsdS MTases (7E, 11E and 15E positive). This was an 
exciting result, confirming that the MCCHalfS fusion was active in vitro. 
 
A genomic DNA cleavage assay of the MCCHalfS fusion MTase showed that the fusion was 
also restriction active against genomic DNA and λ phage DNA (Fig. 112). 
 
 
Figure 112: Genomic DNA (GDNA) cleavage assay of the MCCHalfS fusion MTase. Lane 
1 contains unmodified (U/M) genomic DNA alone. Lane 2 shows that with the addition 
of wild-type CC398-1 MTase (+ve control), the genomic DNA no longer appears on the 
gel. 398-1/M GDNA denotes genomic DNA that has been modified by the wild-type 
enzyme. MCCHalfS fus./M denotes genomic DNA that has been modified by the 























The aim of this work was to show the structural similarities between Type I and Type II R-M 
systems, to provide evidence for their evolutionary relationship. It sought to manipulate the 
structure of a Type I R-M system, to create a structure similar to a Type II system. The Type 
II systems are categorised into several different sub-types. The Type IIB systems cleave 
double-stranded DNA either side of their recognition sequence, whilst Type IIG systems are a 
single peptide, and so cleave at only one side. Both sub-types carry out both restriction and 
methylation functions, and are dependent on S-adenosylmethionine. This project intended to 
engineer an enzyme with these properties, using a Sau1 Type I system as a template. 
 
Removing the motor domain from the CC5 HsdR, and fusing it to the CC398-1 MTase, 
attempted to make a complete R-M system in a single peptide. Type I systems bind their 
recognition sequence but then translocate the DNA at both ends, eventually cleaving it at 
unpredictable locations either side of their recognition sequence. Removing the motor domain 
would prevent the movement of the DNA and elicit the same type of action as the Type IIB 
enzymes. By fusing HsdR to M, the R-M domains would be brought into a single peptide, 
which would be SAM dependent. This would create a Type IIB-like structure (Fig 113). 
 




As there is still very little structural information on the Sau1 enzymes, it was extremely 
difficult to estimate the amino acid sequence of the CC5 HsdR that was specific only to motor 
activity. Structural data shows that the HsdR contains four distinct domains, the first of which 
is the nuclease (Lapkouski et al. 2009). However, it has been shown that mutations to one of 
the domains can have an effect on the activity of another (Šišáková, Weiserová, et al. 2008). 
It is therefore unlikely to be as simple as removing all the sequence after the nuclease, in the 
hope of retaining cleavage activity. Given this problem, a high-throughput method of 
engineering and subsequent screening would be necessary to identify a restriction-active 
construct. The method used to create the gene fusions was not reliable and the method of 
screening, involving large-scale expression and purification, was time consuming. In vivo 
assays were a quicker way of conducting this process, but unfortunately returned no 
restriction-active candidates. What is encouraging however, is that all the R-M fusions studied 
did seem to possess methylase activity. This suggests that the process can create an enzyme, 
which can fold correctly and produce activity but that it was the HsdR domain that was not 
viable. All it would take therefore, is further attempts with several different truncations to the 
R subunit. On the other hand, perhaps simply truncating the HsdR sequence is an error. If all 
the domains help coordinate each activity, then removing any part may prevent the desired 
nuclease activity. Additionally, structural data shows that the C-terminal, helical domain, 
interacts with the MTase complex. This suggests that a new approach should focus on deleting 
the two central motor domains, or mutating them to inhibit their activity. The primary target 
for this approach should be the DEAD-box motifs, which are necessary for activity on all 
helicases. 
 
A great deal more success was found when concentrating on the Type I MTases. This project 
shows the incremental change in structure, from the wild-type CC398-1 Type I MTase, to an 
active MTase in a single, fused peptide, to a single peptide MTase with one TRD. The 
characteristics of this final, novel construct are shared by the Type IIG system, BpuSI. 
Although this construct produced an apparently fragile protein, it did possess activity both in 
vivo and in vitro. The structure dimerises, and therefore recognises a symmetrical DNA 
sequence. This aspect brings the structural relationship closer to the Type IIB systems, which 
also dimerise. The IIB systems do however possess two TRDs, and so a better comparison 
would be the MS fusion. Unfortunately, the MS fusion created here did not dimerise but took 
on a pseudo M2S1 conformation, due to the presence of a bound product of proteolysis. Despite 
attempts at further purification, this extra fragment remained bound to the MS fusion. More 
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stringent methods could be used to remove this contaminant, in order to investigate the 
quaternary structure of the protein more thoroughly.  
 
Size exclusion HPLC results from the CCHalfSHis enzyme support the theory that the central 
conserved region is important to the domain organisation of these MTases. However, evidence 
of activity in vivo and in vitro with the HalfSHis enzyme showed that the complete central 
conserved region does not appear entirely necessary. If one were to imagine the proposed 
circular organisation of the M and S subunits, the two TRDs are bridged by the central 
conserved region and the sequences of N and C-termini. In addition, the central conserved 
region is proposed to correspond to the N number of the recognition sequence. In the case of 
the two HalfS species presented here, the first TRD possesses both the central conserved 
region (only in part, in the case of HalfSHis) and the N-terminal sequence, which is more than 
half of the total peptide sequence of the HsdS. Upon direct, homogenous dimerisation of these 
HalfS species, it is possible that the circular structure is larger than wild-type. It is therefore 
surprising that both species recognise the same sequence, it is shorter than that of the wild-
type sequence, and that the methylated bases are further apart. In the case of the TRD-2 
deletion mutant created by Abadjieva et al., the new palindromic sequence was the same length 
as that of the wild-type and the distance between methylated bases remained the same 
(GAAN7TTC and GAAN6RTCG respectively). This mutant also possessed the N-terminal 
sequence and the entire central conserved region sequence (Abadjieva et al. 1993; Abadjieva 
et al. 2003). Taylor et al., 1994 and Janscak & Bickle, 1998 showed that alternative C-termini 
can be introduced to the HsdS, but that it would maintain MTase activity. Here, it is shown 
that the addition of amino acid sequence does not affect activity, nor is it affected by the lack 
of a complete central conserved region. Size exclusion HPLC data indicate that the second 
HsdM of the HalfSHis complex dissociates at a higher concentration, relative to most of the 
other MTases examined here. A reasonable assumption for why this is happening is the 
missing section of the central conserved region leaves less of the HsdS sequence to which the 
HsdM can bind, and as such it has less affinity for it. The HPLC data, SMRT sequencing 
results and other evidence of activity suggest that the HalfSHis does still form an active dimer, 
and therefore is adopting the circular conformation. Unfortunately, these proteins appear 
relatively unstable, making the acquisition of structural information by x-ray crystallography 
unlikely. Therefore, it will be difficult to discover how the two HalfS monomers are 
interacting. However, these results do indicate that the central conserved region is not acting 
in the manner in which it has hitherto been thought. The amino acid sequence between the two 
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TRDs cannot be directly specific to the random sequence between the two parts of the bipartite 
recognition sequence. 
 
When investigating the relationship between Types I and II, Type ISP systems are clearly 
important. Given that they possess both modification and restriction activities in a single 
peptide, they can be seen as the link that bridges the gap between Type I systems and Type 
IIG systems. The proposal by Kennaway et al. (2012) was that IIG enzymes should be 
considered half of a Type I enzyme, which is lacking its motor domains. In the Type ISP 
systems, we have a structure akin to a Type IIG enzyme with an ATP-dependent helicase 
domain (Fig. 114). 
 
 
Figure 114: Proposed progression from Type I systems to Type IIG, via the Type ISP link. 
 
The creation of an MTase and REase active MCCHalfS fusion is the final step before a Type 
ISP system (Fig. 114). This suggests that the next step in this investigation is not to remove 
the motor domains from the HsdR at all, but to fuse the entire subunit to the N-terminal of the 
MCCHalfS fusion. This would give it a structure similar to a Type ISP. The step after this 
would be to remove some or all of the peptide sequence from the motor domains, in an effort 
to make the final step to a Type IIG system. 
 
A key aim in this project was to create a new restriction-active enzyme, which had a structure 
similar to that of a Type II R-M system. Although this was unsuccessful, this work has 
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identified that a significant portion of an HsdR can be appended to an MTase, without loss of 
methylation activity. It has also highlighted that this task should be approached differently, 
with an emphasis on decreasing the time taken to rule out inactive constructs. Fortunately, 
there were several other aspects of the project that proved successful and therefore indicate a 
method that could be applied to achieve the main goal of producing a DNA-cutting enzyme. 
By mimicking the step by step changes proposed for the evolution of these systems, viable 
structural changes were engineered incrementally. A new M to S fusion was created, and two 
novel half S subunits were created, purified and assayed in vitro. This had not before been 
achieved. The M to half S fusion is entirely new and was also successfully purified and assayed 
in vitro. Not only that, but these modifications elicited a new topology and a new DNA 
recognition sequence. This work satisfies its goal to support the claim that Types I and II are 
evolutionarily linked. It has shown that these structures can be manipulated to produce 
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The protocol for plasmid preparation, using the QIAprep Spin Miniprep kit can be found via 





Product information and protocols for the Wizard ® Genomic DNA Purification Kit 





All protocols and publications on the subject of SMRT sequencing by Pacific Biosciences can 





















Phyre2 software aligned the target CC398-1 MTase amino acid sequence with 120 similar 
protein sequences. Eight of these were chosen, to which sections of target sequence were 







PDB codes for these structures are: 
 
1. 3LKD 
8.    1YF2 
9.    1YDX 
     10.    3OKG 
     11.    2Y7C 
     12.    5HR4 
     13.    1AQI 




Phyre2 software aligned the target CC5 HsdR amino acid sequence with 120 similar protein 
sequences. Two of these were chosen, to which sections of target sequence were modelled. 
















Figure 115: Plasmid map of the MS fusion gene in vector pJF. 
 
 





Figure 117: Plasmid map of the hsdM and CCHalfSHis genes in vector pJF. 
 










M- 18406.7 ÷ 59454 = 0.310 
      11663.9 ÷ 59454 = 0.196                                        0.310 + 0.196 + 0.269 + 0.288 = 0.266 
      16016.6 ÷ 59454 = 0.269                                                               4 
      17126.0 ÷ 59454 = 0.288 
 
(0.31 - 0.266)2 = 0.0019                                                      
(0.196 - 0.266)2 = 0.0049                                0.0019 + 0.0049 + 0.000009 + 0.0048 = 0.0018 
(0.269 - 0.266)2 = 0.000009                                                        4 
(0.288 - 0.266)2 = 0.00048 
 
√0.0018 = 0.04 
 
S- 5821.5 ÷ 47229 = 0.123 
     2523.0 ÷ 47229= 0.053                                            0.123 + 0.053 + 0.146 + 0.185 = 0.127 
     6873.2 ÷ 47229= 0.146                                                                   4 
     8730.1 ÷ 47229= 0.185 
 
(0.123 - 0.127)2 = 0.000016                                                      
(0.053 - 0.127)2 = 0.0055                              0.000016 + 0.0055 + 0.00036 + 0.0034 = 0.0023 
(0.146 - 0.127)2 = 0.00036                                                           4 
(0.185 - 0.127)2 = 0.0034 
 
√0.0023 = 0.05 
 
Ratio = 0.266:0.127 
 
1 ÷ 0.127 = 7.87 
0.266 X 7.87 = 2.09 
0.04 X 7.87 = 0.31 
0.05 X 7.87 = 0.39 
 























M- 11110.8 ÷ 59454 = 0.187 
      11393.1 ÷ 59454 = 0.192                                        0.187 + 0.192 + 0.484 + 0.200 = 0.266 
      28793.3 ÷ 59454 = 0.484                                                               4 
      11908.6 ÷ 59454 = 0.200 
 
(0.187 - 0.266)2 = 0.0062                                                      
(0.192 - 0.266)2 = 0.0055                                    0.0062 + 0.0055 + 0.0475 + 0.0001 = 0.0148 
(0.484 - 0.266)2 = 0.0475                                                                4 
(0.254 - 0.266)2 = 0.0001 
 
√0.0148 = 0.122 
 
HalfS- 3205.4 ÷ 24930 = 0.129 
            3158.7 ÷ 24930 = 0.127                                    0.129 + 0.127 + 0.621 + 0.231 = 0.277 
            15484.1 ÷ 24930 = 0.621                                                         4 
            5765.6 ÷ 24930 = 0.231 
 
(0.129 - 0.277)2 = 0.0219                                                      
(0.127 - 0.277)2 = 0.0036                                    0. 0219+ 0. 0036+ 0. 1183+ 0. 0021= 0.0365 
(0.621 - 0.277)2 = 0.1183                                                                4 
(0.231 - 0.277)2 = 0.0021 
 
√0.0365 = 0.191 
 
Ratio = 0.266:0.277 
 
1 ÷ 0.266 = 3.76 
0.277 X 3.75 = 1.04 
0.122 X 3.75 = 0.46 
0.191 X 3.75 = 0.72 
 



























M- 31641.0 ÷ 59454 = 0.532 
      9673.5 ÷ 59454 = 0.163                                        0. 532+ 0. 163 + 0. 320 + 0. 254= 0.317 
      19027.4 ÷ 59454 = 0.320                                                              4 
      15110.0 ÷ 59454 = 0.254 
 
(0.532- 0.317)2 = 0.0462 
(0.163 - 0.317)2 = 0.0237                            0. 0462 + 0. 0237 + 0. 000009 + 0. 0040 = 0.0185 
(0.320 - 0.317)2 = 0.000009                                                     4 
(0.254 - 0.317)2 = 0.0040 
 
√0.0185 = 0.136 
 
CCHalfS- 10406.3 ÷ 26020 = 0.400 
                 1047.5 ÷ 26020 = 0.040                            0. 400+ 0. 040 + 0. 158 + 0. 093 = 0.173 
                 4109.5 ÷ 26020 = 0.158                                                     4 
                 2408.9 ÷ 26020 = 0.093 
 
(0. 400 - 0.173)2 = 0.0515 
(0. 040 - 0.173)2 = 0.0177                               0. 0515 + 0. 0177 + 0. 0002 + 0. 0064 = 0.0190 
(0.158 - 0.173)2 = 0.0002                                                              4 
(0.093 - 0.173)2 = 0.0064 
 
√0.0190 = 0.138 
 
Ratio = 0.317:0.173 
 
1 ÷ 0.173 = 5.78 
0.317 X 5.78 = 1.83 
0.136 X 5.78 = 0.79 
0.138 X 5.78 = 0.80 
 



























Unmodifiedλ Calculations:  
 
1 mL ÷ 100 µL = 10 
1516 plaques X 10 X dilution = 15160 X 10-5 
 
= 1516 X 106 undiluted phage 
 
Control (None) average- ([1516 + 2630 + 2380 + 2190 +2080] X 106) ÷ 5 = 2159.2 X 106 
 
(1516 – 2159.2)2 = 413706 
(2630 – 2159.2)2 = 221653                     413706 + 221653 + 48753 + 949 + 6273 = 138266.8 
(2380 – 2159.2)2 = 48753                                                    5 
(2190 – 2159.2)2 = 949 
(2080 – 2159.2)2 = 6273 
 
√138266.8 = 371.8 X 106 
 
1 mL ÷ 40 µL = 25 
910 plaques X 25 X dilution = 22750 X 10-3  
 
= 22.8 X 106 undiluted phage 
 
CC398 MTase + R average- ([22.8 + 80.5 + 379.6 + 512 + 628] X 106) ÷ 5 = 324.6 X 106 
 
(22.8 – 324.6)2 = 91083 
(80.5 – 324.6)2 = 59585                            91083 + 59585 + 3025 + 35119 + 92052 = 56172.8 
(379.6 – 324.6)2 = 3025                                                           5 
(512 – 324.6)2 = 35119 
(628 – 324.6)2 = 92052 
 




371.8 X 100 = 17%                               237.0 X 100 = 73% 




172 + 732 = combined error2 = 941 
 
√5618 = 75.0 % 
 





E.O.P. of Unmodifiedλ 
 
324.6 ÷ 2159.2 = 0.15 (±0.11) 
 
CC398λ Calculations:  
 
CC398 MTase average- ([1600 + 1480 + 2700 + 1800] X 106) ÷ 4 = 1895 X 106 
 
(1600 – 1895)2 = 87025 
(1480 – 1895)2 = 172225                                      87025 + 172225 + 648025 + 9025 = 229075 
(2700 – 1895)2 = 648025                                                                 4 
(1800 – 1895)2 = 9025 
 
√229075 = 478.6 X 106 
 
CC398 MTase + R average- ([1580 + 1400 + 1780 + 1920] X 106) ÷ 4 = 1670 X 106 
 
(1580 – 1670)2 = 8100 
(1400 – 1670)2 = 72900                                              8100 + 72900 + 12100 + 62500 = 38900 
(1780 – 1670)2 = 12100                                                                     4 
(1920 – 1670)2 = 62500 
 




478.6 X 100 = 29 %        197.2 X 100 = 10 % 




292 + 102 = combined error2 = 941 
 
√941 = 30.6 % 
 
0.88 X 30.6 = 0.27 
100 
 
E.O.P. of CC398λ 
 
1670 ÷ 1895 = 0.88 (±0.27) 
 
 
MS fusion MTase: 
 
Unmodifiedλ Calculations:  
 
1 mL / 22.5 µL = 44.4 
 
384 X 44.4 X dilution = 17066.6 X 10-5 




Control (None) average - ([1706.7 + 1920.0 + 2740.0 + 1516.0 + 2630.0] X 106)/ 5 =  
2102.5 X 106 
 
(1706.7 – 2102.5)2 = 156657.6 
(1920 – 2102.5)2 = 33306.3                                                                                                 
(2740 – 2102.5)2 = 406406.3                                                                          
(1516 – 2102.5)2 = 343982.3 
(2630 – 2102.5)2 = 278256.3 
 
156657.6 + 33306.3 + 406406.3 + 343982.3 + 278256.3 = 243721.8 
                                           5 
 
√243721.8 = 493.7 
 
MSF MTase + R average- ([185.7 + 362.3 + 85 + 150 + 165] X 106)/ 5 = 189.6 X 106 
 
(185.7 – 189.6)2 = 15.2 
(362.3 – 189.6)2 = 29825.3                                                                                                      
(85 – 189.6)2 = 10941.2                                                                                                
(150 – 189.6)2 = 1568.2 
(165 – 189.6)2 = 605.2 
 
15.2 + 29825.3 + 10941.2 + 1568.2+ 605.2 = 8591.0 
                                 5 




 493.7  X 100 = 23.5 %        92.7    X 100 = 46.7 % 




23.52 + 46.72 = combined error2 = 2733.2 
 
√2733.2 = 52.3 % 
 
0.09 X 52.3 = 0.05 
100 
 
E.O.P. of Unmodifiedλ 
 
189.6/ 2102.5 = 0.09 (±0.05) 
 
MSFλ Calculations:  
 
1 mL / 32.3 µL = 30.96 
 
401 plaques X 30.96 X dilution = 12952.3 X 10-5 
 




MSF MTase average- ([1295.2 + 1311.4 + 1840 + 1705 + 1460] X 106)/ 5 = 1522.3 X 106 
 
(1295.2 – 1522.3)2 = 51574.4 
(1311.4 – 1522.3)2 = 44478.8                                                                                                
(1840 – 1522.3)2 = 100933.3    
(1705 – 1522.3)2 = 33379.3 
(1460 – 1522.3)2 = 3881.3 
 
51574.4 + 44478.8 + 100933.3 + 33379.3 + 3881.3 = 46849.4 
                                        5 
 
√46849.4 = 216.4 
 
MSF MTase + R average- ([1327.3 + 957.5 + 1205 + 1185 + 1235] X 106)/ 5 = 1182.0 X 106 
 
(1327.3 – 1182.0)2 = 21112.1 
(957.5 – 1182.0)2 = 50400.3                           21112.1 + 50400.3 + 529 + 9 + 2809 = 14971.9 
(1205 – 1182.0)2 = 529                                                                 5 
(1185 – 1182.0)2 = 9 
(1235 – 1182.0)2 = 2809 
 




 216.4  X 100 = 14.2 %        122.4    X 100 = 10.4 % 
1522.3                                  1182.0 
Combined error 
 
14.22 + 10.42 = combined error2 = 309.8 
 
√309.8 = 17.6 % 
 
0.78 X 17.6 = 0.14 
100 
 
E.O.P. of MSFλ 
 





Unmodifiedλ Calculations:  
 
1 mL / 22.5 µL = 44.4 
 
384 X 44.4 X dilution = 17066.6 X 10-5 
= 1706.7 X 10-6  
 
 
Control (None) average- ([1706.7 + 1920 + 2740 + 1516 + 2630] X 106)/ 5 = 2102.5 X 106 
204 
 
(1706.7 – 2102.5)2 = 156657.6 
(1920 – 2102.5)2 = 3306.3                                                                                                   
(2740 – 2102.5)2 = 406406.3  
(1516 – 2102.5)2 = 343982.3 
(2630 – 2102.5)2 = 278256.3 
 
156657.6 + 3306.3 + 406406.3 + 343982.3 + 278256.3 = 237721.8 




HalfSHis MTase + R average- ([394.6 + 444.1 + 1280 + 900 + 1232.5] X 106)/ 5 =  
850.2 X 106 
 
(394.6 – 850.2)2 = 207571.4 
(444.1 – 850.2)2 = 164917.2                                                                                                     
(1280 – 850.2)2 = 184728.0   
(900 – 850.2)2 = 2480.0 
(1232.5 – 850.2)2 = 146153.3 
 
207571.4 + 164917.2 + 184728.0 + 2480.0 + 146153.3 = 141170.0 
                                            5 
 




 487.6   X 100 = 23.2 %        375.7    X 100 = 44.2 % 




23.22 + 44.22 = combined error2 = 2491.8 
 
√2491.8 = 49.9 % 
 
0.40 X 49.9 = 0.20 
100 
 
E.O.P. of Unmodifiedλ 
 
850.2 / 2102.5 = 0.40 ±0.20 
 
HalfSλ Calculations:  
 
1 mL / 28.5 µL = 35.1 
 
264 plaques X 35.1 X dilution = 9263.1578 X 10-5 
 





HalfSHis MTase average- ([926.3 + 1107.8 + 1555.0 + 1620.0 + 1715.0] X 106)/ 5 =  
1384.8 X 106 
 
(926.3 – 1384.8)2 = 210222.3 
(1107.8 – 1384.8)2 = 76729.0                                                                                                
(1555 – 1384.8)2 = 28968.0     
(1620 – 1384.8)2 = 55319.0 
(1715 – 1384.8)2 = 109032.0 
 
210222.3 + 76729.0 + 28968.0 + 55319.0 + 109032.0 = 96054.1 
                                          5 
 
√96054.1 = 309.9 
 
HalfSHis MTase + R average- ([764.7 + 757.5 + 1075.0 + 1145.0 + 1105.0] X 106)/ 5 = 
969.4 X 106 
 
(764.7  – 969.4)2 = 41902.1 
(757.5 – 969.4)2 = 44901.6                        41902.1 + 44901.6 + 11151.4 + 30835.4 + 18387.4 
= 29435.6 
(1075 – 969.4)2 = 11151.4                                                                    5 
(1145 – 969.4)2 = 30835.4 
(1105 – 969.4)2 = 18387.4 
 




 309.9   X 100 = 22.4 %        171.6    X 100 = 17.7 % 




22.42 + 17.72 = combined error2 = 815.1 
 
√815.1 = 28.5 % 
 
0.70 X 28.5 = 0.20 
100 
 
E.O.P. of HalfSλ 
 





Unmodifiedλ Calculations:  
 





384 X 44.4 X dilution = 17066.6 X 10-5 = 17066.6 X 105 
= 1706.7 X 106 undiluted phage 
 
Control (None) average- ([1706.7 + 1920 + 2740 + 1516 + 2630] X 106)/ 5 = 2102.5 X 106 
 
(1706.7 – 2102.5)2 = 156657.6 
(1920 – 2102.5)2 = 3306.3                                                                                                    
(2740 – 2102.5)2 = 406406.3   
(1516 – 2102.5)2 = 343982.3 
(2630 – 2102.5)2 = 278256.3 
 
156657.6 + 3306.3 + 406406.3 + 343982.3 + 278256.3 = 237721.8 




CCHalfSHis MTase + R average- ([727.5 + 852.3 + 1437.5 + 1550.0 + 1490.0] X 106)/ 5 = 
1211.5 X 106 
 
(727.5 – 1211.5)2 = 234256 
(852.3 – 1211.5)2 = 129024.6 
(1437.5 – 1211.5)2 = 51076 
(1550.0 – 1211.5)2 = 114582.3 
(1490.0 – 1211.5)2 = 77562.3 
 
234256 + 129024.6 + 51076 + 114582.3 + 77562.3 = 121300.2 
                                 5 
 




 487.6   X 100 = 23.2 %        348.3    X 100 = 28.7 % 




23.22 + 28.72 = combined error2 = 1361.9 
 
√1361.9 = 36.9 % 
 
0.58 X 36.9 = 0.21 
100 
 
E.O.P. of Unmodifiedλ 
 
1211.46/ 2102.54 = 0.58 ±0.21 
 
CCHalfSλ Calculations:  
 




294 plaques X 10.42 X dilution = 3063.5 X 10-6 
= 3063.5 X 106 undiluted phage 
 
CCHalfSHis MTase average- ([3063.5 + 3600.0 + 3710.0 + 4340.0) X 106)/ 4 =  
3678.4 X 106 
 
(3063.5 – 3678.4)2 = 378102.0 
(3600.0 – 3678.4)2 = 6146.6                      378102.0 + 6146.6 + 998.6 + 437714.6 = 205740.5 
(3710.0 – 3678.4)2 = 998.6                                                       4 
(4340.0 – 3678.4)2 = 437714.6 
 
√205740.5 = 453.6 
 
CCHalfSHis MTase + R average- ([2153.8 + 2740.0 + 2740.0 + 3390.0] X 106)/ 4 =  
2756.0 X 106 
 
(2153.8 – 2756.0)2 = 362644.8 
(2740.0 – 2756.0)2 = 256.0                          362644.8 + 256.0 + 256.0 + 401956.0 = 191278.2 
(2740.0 – 2756.0)2 = 256.0                                                      4 
(3390.0 – 2756.0)2 = 401956.0 
 




 453.6   X 100 = 12.3 %        437.4    X 100 = 15.9 % 




12.32 + 15.92 = combined error2 = 404.1 
 
√404.1 = 20.1 % 
 
0.75 X 20.1 = 0.15 
100 
 
E.O.P. of CCHalfSλ 
 















MCCHalfS fusion MTase: 
 
Unmodifiedλ Calculations:  
 
1 mL / 100 µL = 10 
 
87 plaques X 10 X dilution = 430 X 10-6 
 
= 430 X 106 undiluted phage 
 
Numbers of phage plaques are adjusted for differences in dilution. 
 
Control (None) average- ([430 + 190 + 510] X 106)/ 3 = 376.6 X 106 
(430.0 – 376.6)2 = 2916.0 
(190.0 – 376.6)2 = 34819.6                                           2916.0 + 34819.6 + 17795.6 = 18510.4 
(510.0 – 376.6)2 = 17795.6                                                                3 
 
√18510.4 = 136.1 
 
MCHSF MTase + R average- ([57 + 8 + 46] X 106)/ 3 = 37 X 106 
 
(57 – 37)2 = 400 
(8 – 37)2 = 841                                                                                       400 + 841 + 81 = 440.6 
(46 – 37)2 = 81                                                                                                   3 
 




 136.1   X 100 = 36.1 %        21.0    X 100 = 4.8 % 




36.12 + 4.82 = combined error2 = 1326.3 
 
√1326.3 = 36.4 % 
 
 0.1 X 36.4 = 0.04 
100 
 
E.O.P. of Unmodifiedλ 
 
37/ 376.6 = 0.10 ±0.04 
 
MCHSFλ Calculations:  
 
1 mL / 100 µL = 10 
 
87 plaques X 10 X dilution = 870 X 10-6 
 
= 870 X 106 undiluted phage 
209 
 
MCHSF MTase average- ([870 + 1330 + 1450] X 106)/ 3 = 1216.6 X 106 
 
(870.0 – 1216.6)2 = 120131.6 
(1330.0 – 1216.6)2 = 12859.6                                   120131.6 + 12859.6 + 54475.6 = 62488.9 
(1450.0 – 1216.6)2 = 54475.6                                                          3 
 
√62488.9 = 250.0 
 
MCHSF MTase + R average- ([980 + 1420 + 1330] X 106)/ 3 = 1243.3 X 106 
 
(980.0 – 1243.3)2 = 69326.9 
(1420.0 – 1243.3)2 = 31222.9                                       69326.9 + 31222.9 + 7516.9 = 36022.2 
(1330.0 – 1243.3)2 = 7516.9                                                              3 
 




 250.0   X 100 = 20.5 %        189.8    X 100 = 15.3 % 




20.52 + 15.32 = combined error2 = 654.3 
 
√654.3 = 25.6 % 
 
1.02 X 25.6 = 0.26 
100 
 
E.O.P. of MCHSFλ 
 

























































































































































Figure 122: DNA sequence motif detection (B). The graph shows DNA sequence motif 
detection against detection of methylated motifs. ACCN5GGT (Red) is the only detected motif. 
Figure 123: Example of a detected motif. The bars are proportional to the time 
taken for the nucleotide to be incorporated into the growing chain. The high bars 
on the top and bottom adenines indicate that it was a relatively longer period to 
add these bases, and they are therefore recognised as being methylated. 
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Figure 124: DNA sequence motif detection (B). The graph shows DNA sequence motif 
detection against detection of methylated motifs. ACCN5GGT (Red) is the only detected motif. 
Figure 125: Example of a detected motif. The bars are proportional to the time 
taken for the nucleotide to be incorporated into the growing chain. The high bars 
on the top and bottom adenines indicate that it was a relatively longer period to 
add these bases, and they are therefore recognised as being methylated. 
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Figure 126: DNA sequence motif detection (B). The graph shows DNA sequence 
motif detection against detection of methylated motifs. ACCN5GGT (Red) is the 
most frequently detected motif 
Figure 127: Example of a detected motif. The bars are proportional to the time 
taken for the nucleotide to be incorporated into the growing chain. The high bars 
on the top and bottom adenines indicate that it was a relatively longer period to 
add these bases, and they are therefore recognised as being methylated. 
